Psychiatry

• 

  Subject Areas on Research

  • "A Résumé for the Baby": Biosocial Precarity and Care of Substance-Using, Pregnant Women in San Francisco. 
  • "Flipping" the Academic Half-Day to Create an Opportunity for Faculty Development. 
  • "Go here-to there" performance after amphetamine: the importance of the response requirement in successive discrimination. 
  • "Hope that is seen is no hope at all:" theological constructions of hope in psychotherapy. 
  • "I felt like a slut": the cultural context and women's response to being raped. 
  • "John Henryism" and blood pressure in a Dutch population. 
  • "Vascular depression": A new subtype of geriatric depression 
  • 108. Hippocampal Subfield Volumes Relate to Unique Phenotypes of PTSD: International Analysis by the PGC-ENIGMA PTSD Working Group 
  • 116. Results of the NIMH FAST-MAS Phase IIa Proof of Mechanism Study of the Effects of the Selective κ Opioid Antagonist JNJ-67953964 on fMRI Ventral Striatal Activity in Anhedonic Patients 
  • 12-month prevalence and concomitants of DSM-IV depression and anxiety disorders in two violence-prone cities in Brazil. 
  • 12-month trajectories of depressive symptoms among nurses-Contribution of personality, job characteristics, coping, and burnout. 
  • 139. Methlyome-Wide Changes Associated With Childhood Trauma and its Long-Term Outcomes 
  • 142 Withdrawal Symptom Assessment in an Esketamine Safety Study in Patients with Treatment-resistant Depression. 
  • 144. Cognitive Neurostimulation: Volitional Regulation of Ventral Tegmental Area 
  • 15 Years of clinical experience with bupropion HCl: From bupropion to bupropion SR to bupropion XL 
  • 16.1 EPIGENETIC SIGNATURES OF CHILDHOOD AND ADOLESCENT VICTIMISATION USING A GENETICALLY SENSITIVE LONGITUDINAL COHORT STUDY. 
  • 18-Month outcome of clozapine treatment for 100 patients in a state psychiatric hospital 
  • 185. Magnetic stimulation of the brain: correlates of antidepressant response 
  • 196. Onset of alzheimer's disease in susceptible subjects: Influence of APOE 
  • 2. ECT and Anticonvulsant Medications 
  • 2011 Annual report of the American Board of Psychiatry and Neurology, Inc. 
  • 2015 in Review. 
  • 24-h smoking abstinence potentiates fMRI-BOLD activation to smoking cues in cerebral cortex and dorsal striatum. 
  • 26.2 FORMATIVE RESEARCH TO INFORM A CULTURALLY TAILORED FAMILY PSYCHOEDUCATION INTERVENTION FOR ADULTS WITH PSYCHOTIC DISORDERS IN TANZANIA 
  • 3-HYDROXYKYNURENINE AND COGNITIVE IMPAIRMENT IN FIRST-EPISODE NEUROLEPTIC-NAIVE PATIENTS WITH SCHIZOPHRENIA 
  • 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. 
  • 3. Magnetic Resonance Spectroscopic Correlates of the Response to ECT 
  • 333. Intracerebral measurement of rTMS and ECS induced voltage in vivo 
  • 34. Serotonin transporter genotypes, CSF 5HIAA, and cardiovascular reactivity to stress 
  • 4. Neuroimaging Studies of ECT 
  • 4. Overview of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment Resistant Depression 
  • 4. Transforming Mental Health Treatment through Innovation in Tools, Targets, and Trials 
  • 410. Interactive effects in the anterior cingulate of sadness and selective attention: a PET study 
  • 456. Cortical excitability in cocaine-dependent subjects; preliminary data 
  • 5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice. 
  • 5-HTTLPR and DISC1 risk genotypes for elevated PTSD symptoms in US military veterans. 
  • 5-HTTLPR genotype potentiates the effects of war zone stressors on the emergence of PTSD, depressive and anxiety symptoms in soldiers deployed to iraq. 
  • 5HTTLPR genotypes and environmental stress interact to affect sleep quality 
  • 641. Neurocognitive Predictors of Antidepressant Efficacy to Transcranial Direct Current Stimulation: Results from an International Randomized Controlled Trial 
  • 644. Neurocognitive Effects of Transcranial Direct Current Stimulation (tDCS) in Unipolar and Bipolar Depression: Results from an International Randomized Controlled Trial 
  • 7. Retrograde Memory Effects of Electroconvulsive Therapy 
  • 73. Efficacy of Transcranial Direct Current Stimulation in Unipolar and Bipolar Depression: Results from an International Randomized Controlled Trial 
  • 9 -Tetrahydrocannabinol: a hypotensive effect in rats. 
  • Electroconvulsive Therapy, 4th edn . By R. Abrams. (Pp. 328; £49.50.) Oxford University Press: Oxford. 2002. 
  • How Healthy Are We?: A National Study of Well-being at Midlife . Edited by O. G. Brim, C. D. Ryff and R. C. Kessler. (Pp. 687; $42.00; ISBN 0-226-07475-7.) University of Chicago Press: Chicago. 2003. 
  • A 102-center prospective study of seizure in association with bupropion. 
  • A 12-Month prospective study of the effects of PTSD-depression comorbidity on suicidal behavior in Iraq/Afghanistan-era veterans. 
  • A 2-year follow-up of social phobia. Status after a brief medication trial. 
  • A 3-year longitudinal study examining the effect of resilience on suicidality in veterans. 
  • A 43-year-old woman with symptoms of PTSD 
  • A 60-year-old man with major depression 
  • A Bayesian model averaging approach to examining changes in quality of life among returning Iraq and Afghanistan veterans. 
  • A Brief Clinical Tool to Estimate Individual Patients' Risk of Depressive Relapse Following Remission: Proof of Concept. 
  • A Brief Interview to Detect Panic Attacks and Panic Disorder in Emergency Department Patients with Cardiopulmonary Complaints. 
  • A Call for a Mental Health Services Research Agenda for Youth with Serious Emotional Disturbance 
  • A Call to Restructure Psychiatry General and Subspecialty Training. 
  • A Cohort Study of Mortality in Individuals With and Without Schizophrenia After Diagnosis of Lung Cancer. 
  • A Common Polymorphism in a Williams Syndrome Gene Predicts Amygdala Reactivity and Extraversion in Healthy Adults. 
  • A Comparison of the QIDS-C16, QIDS-SR16, and the MADRS in an Adult Outpatient Clinical Sample. 
  • A Complex Systems Approach to Causal Discovery in Psychiatry. 
  • A Connectome Wide Functional Signature of Transdiagnostic Risk for Mental Illness 
  • A Consensus Meeting on Effective Research Practice in PTSD 
  • A DNA methylation biomarker of alcohol consumption. 
  • A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials. 
  • A Functional Interleukin-18 Haplotype Predicts Depression and Anxiety through Increased Threat-Related Amygdala Reactivity in Women but Not Men. 
  • A Geriatrics Perspective on Dementia Prevention and Treatment. 
  • A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neurons. 
  • A Longitudinal Study to Assess Antidepressant Treatment Patterns and Outcomes in Individuals with Depression in the General Population. 
  • A Multi-Site, Naturalistic Study of RTMS for Major Depressive Disorder 
  • A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective Disorder. 
  • A New Empirical Definition of Major Depressive Episode Recovery and Its Positive Impact on Future Course of Illness. 
  • A Next Step in Suicide Prevention. 
  • A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study. 
  • A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial. 
  • A Pharmacogenetics Supported Clinical Trial to Delay Onset of Mild Cognitive Impairment due to Alzheimer's Disease Using Low Dose Pioglitazone: The Tommorrow Study 
  • A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. 
  • A Pilot Study of Neuroplasticity Based Cognitive Remediation in Adolescents with Psychosis 
  • A Preliminary Investigation of a Relapse Prevention Mobile Application to Maintain Smoking Abstinence Among Individuals With Posttraumatic Stress Disorder. 
  • A Primer on Foraging and the Explore/Exploit Trade-Off for Psychiatry Research. 
  • A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care. 
  • A Qualitative Study of Mental Health Problems Among Orphaned Children and Adolescents in Tanzania. 
  • A Randomized Clinical Trial of Nicotine Preloading for Smoking Cessation in People with Posttraumatic Stress Disorder. 
  • A Randomized Clinical Trial of a Money Management Intervention for Veterans With Psychiatric Disabilities. 
  • A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness. 
  • A Randomized Controlled Trial of Team-Based Learning Versus Lectures with Break-Out Groups on Knowledge Retention. 
  • A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. 
  • A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder. 
  • A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder. 
  • A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder. 
  • A Reanalysis of Arrest Rates. 
  • A Response to Proposed Budget Cuts Affecting Children's Mental Health: Protecting Policies and Programs That Promote Collective Efficacy. 
  • A Statistical Analysis of the Classification of Depression in a Mixed Community and Clinical Sample 
  • A Step Toward Optimizing Treatment Schedules for Continuation ECT: Response to Rasmussen. 
  • A Stepped-Care Evaluation of a Package of eHealth HIV Prevention Programs for Adolescent Gay and Bisexual Boys: The SMART Program 
  • A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction. 
  • A Survey of Medical Student Experiences of Patients' Religion and Spirituality at One Medical School. 
  • A Test of Causal Hypotheses of Psychopathic Traits: Reduced Emotional Responsiveness or Anomalous Attentional Control? 
  • A Tribute to Kristina Orth-Gomér - an Outstanding Scientist for Women's Health in Behavioral and Psychosomatic Medicine. 
  • A Unique Dual Cortico-Striatal Action of a Beta-Arrestin Biased Dopamine D2 Receptor Ligand 
  • A brain magnetic resonance imaging study of pituitary gland morphology in anorexia nervosa and bulimia. 
  • A brief cognitive assessment tool for schizophrenia (B-CATS): Scale construction 
  • A brief cognitive assessment tool for schizophrenia: construction of a tool for clinicians. 
  • A brief depression scale for use in the medically ill. 
  • A brief history of psychiatric classification. From the ancients to DSM-IV. 
  • A case for developing domain-specific vocabularies for extracting suicide factors from healthcare notes. 
  • A case of delirium, motor disturbances, and autonomic dysfunction due to baclofen and tizanidine withdrawal: a review of the literature. 
  • A case of intermittent delirious mania. 
  • A case of transient hallucination with ropinirole augmentation antidepressant in a patient with treatment-resistant depression: Is there differential effect of ropinirole dose on developing psychotic symptom? 
  • A caution on the use of the MMPI K-correction in research on psychosomatic medicine. 
  • A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA). 
  • A clinical trial comparing interviewer and computer-assisted assessment among clients with severe mental illness. 
  • A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial. 
  • A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives 
  • A combined treatment approach to anxiety in the medically ill. 
  • A comparative evaluation of three discriminant scales for endogenous depression. 
  • A comparison between the growth hormone responses to amphetamine and clonidine [comment] 
  • A comparison of alternative assessments of depressive symptom severity: a pilot study. 
  • A comparison of alternative assessments of depressive symptom severity: a pilot study. 
  • A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: a STAR*D report. 
  • A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. 
  • A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. 
  • A comparison of inpatients with primary unipolar depression and depression secondary to anxiety. 
  • A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. 
  • A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. 
  • A comparison of phenelzine and imipramine in depressed inpatients. 
  • A comparison of psychotic and nonpsychotic substance users in the psychiatric emergency room. 
  • A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. 
  • A comparison of self-reported versus clinician-related symptoms in depression. 
  • A comparison of stereology and segmentation techniques for volumetric measurements of lateral ventricles in magnetic resonance imaging. 
  • A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls 
  • A comparison of the SPRINT and CAPS assessment scales for posttraumatic stress disorder. 
  • A comparison of the cortisol suppression index and the dexamethasone suppression test. 
  • A conceptual introduction to cognitive remediation for memory deficits associated with right unilateral electroconvulsive therapy. 
  • A controlled study of cellular immune function in affective disorders before and during somatic therapy. 
  • A critical evaluation of the complex PTSD literature: implications for DSM-5. 
  • A critique of the effectiveness of assertive community treatment. 
  • A cross-sectional study of the effects of depression on REM latency. 
  • A curbstone consult to applicants for National Institute of Mental Health grant support. 
  • A day-centered approach to modeling cortisol: diurnal cortisol profiles and their associations among U.S. adults. 
  • A descriptive analysis of minor depression. 
  • A diagnostic and family study of posttraumatic stress disorder. 
  • A dimensional approach to understanding severity estimates and risk correlates of marijuana abuse and dependence in adults. 
  • A dimensional liability model of age differences in mental disorder prevalence: Evidence from a national sample 
  • A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial. 
  • A distress-continuum, disorder-threshold model of depression: a mixed-methods, latent class analysis study of slum-dwelling young men in Bangladesh. 
  • A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression 
  • A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder. 
  • A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal 
  • A double-blind comparison of bupropion and amitriptyline in depressed inpatients. 
  • A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. 
  • A double-blind comparison of sertraline and fluoxetine in depressed elderly patients 
  • A double-blind comparison of three dosages of flutroline (CP-36,584) in the treatment of schizophrenia 
  • A double-blind crossover comparison of antiparkinson drug therapy: Amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function 
  • A double-blind pilot dosing study of low field magnetic stimulation (LFMS) for treatment-resistant depression (TRD). 
  • A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). 
  • A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A study):(Psychotherapy and Psychosomatics (2012) 81, (87-97)) 
  • A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression (Journal of Clinical Psychiatry (2010) 71, 1 (32-40)) 
  • A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression. 
  • A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome. 
  • A family study of chronic post-traumatic stress disorder following rape trauma. 
  • A family-systems model for inpatient treatment of adolescents. 
  • A fidelity measure for integrated management of depression in primary care. 
  • A follow-up study of post partum illness, 1946-1978. 
  • A functional alternative splicing mutation in human tryptophan hydroxylase-2. 
  • A functional prodynorphin promoter polymorphism and opioid dependence. 
  • A genome-wide analysis of putative functional and exonic variation associated with extremely high intelligence 
  • A genome-wide analysis of putative functional and exonic variation associated with extremely high intelligence. 
  • A genome-wide association study for extremely high intelligence. 
  • A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing. 
  • A genome-wide association study of depressive symptoms. 
  • A genome-wide association study of suicide attempts and suicidal ideation in U.S. military veterans. 
  • A genome-wide association study of suicide attempts in the million veterans program identifies evidence of pan-ancestry and ancestry-specific risk loci. 
  • A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. 
  • A guide to guidelines for the treatment of PTSD and related conditions. 
  • A heavy burden on young minds: the global burden of mental and substance use disorders in children and youth. 
  • A history of the concept of atypical depression 
  • A history of the concept of atypical depression. 
  • A history of the concept of atypical depression. 
  • A hospital-based treatment of suicide attempt patients with problematic alcohol use: Rationale and treatment development. 
  • A knowledge network for a dynamic taxonomy of psychiatric disease. 
  • A latent class analysis of physical, emotional, and sexual abuse history among suicidal inpatients. 
  • A latent variable model of evidence-based quality improvement for substance abuse treatment. 
  • A longitudinal analysis of the overlap between violence and victimization among adults with mental illnesses. 
  • A longitudinal study of neurocognitive function in individuals at-risk for psychosis. 
  • A magnetic resonance imaging study of putamen nuclei in major depression 
  • A magnetic resonance imaging study of putamen nuclei in major depression. 
  • A magnetic resonance spectroscopic imaging study of adult nonhuman primates exposed to early-life stressors. 
  • A meta-analysis of the relationship between symptom severity of Posttraumatic Stress Disorder and executive function. 
  • A model comparison approach to trauma-related guilt as a mediator of the relationship between PTSD symptoms and suicidal ideation among veterans. 
  • A multi-scanner study of subcortical brain volume abnormalities in schizophrenia. 
  • A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. 
  • A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. 
  • A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. 
  • A multiplicity of approaches to characterize geriatric depression and its outcomes. 
  • A national study of violent behavior in persons with schizophrenia. 
  • A naturalistic study of maintenance ECT: Implications for optimizing the inter-treatment interval. 
  • A naturalistic study of the effects of smoking on the cognitive side effects of ECT. 
  • A naturalistic, multi-site study of repetitive transcranial magnetic stimulation therapy for depression. 
  • A network analysis of risk factors for suicide in Iraq/Afghanistan-era veterans. 
  • A neuroanatomic model for depression. 
  • A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology. 
  • A new MRI ratio method for in-vivo estimation of signal hypointensity in aging and Alzheimer's disease. 
  • A new and timely delusion: the complaint of having AIDS. 
  • A new measure of authentic auditory emotion recognition: Application to patients with schizophrenia. 
  • A new method of classification for psychophysiologic disorders. 
  • A new treatment algorithm for posttraumatic stress disorder 
  • A novel Alzheimer disease locus located near the gene encoding tau protein. 
  • A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. 
  • A one-year double-blind comparison of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in patients with schizophrenia 
  • A path model of chronic stress, the metabolic syndrome, and coronary heart disease. 
  • A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia. 
  • A phenomenological investigation of women with Tourette or other chronic tic disorders. 
  • A pilot proton magnetic resonance spectroscopic imaging study of hippocampus in adult nonhuman primates who underwent stressful rearing conditions as infants 
  • A pilot randomized controlled trial in subthreshold PTSD with paroxetine in veterans who served after September 11th, 2001 
  • A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans. 
  • A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment. 
  • A pilot study of PTSD symptoms among Kalahari Bushmen. 
  • A pilot study of a structured interview addressing sexual function in men with schizophrenia. 
  • A pilot study of a weight management program with food provision in schizophrenia. 
  • A pilot study of an electronic, adolescent version of the quick inventory of depressive symptomatology. 
  • A pilot study of assertive community treatment for patients with chronic psychotic disorders. 
  • A pilot study of high frequency prefrontal rTMS for the treatment of the negative symptoms of schizophrenia 
  • A pilot study of mirtazapine in post-traumatic stress disorder. 
  • A pilot study of phenelzine in the treatment of post-traumatic stress disorder. 
  • A placebo-controlled study of Kava kava in generalized anxiety disorder. 
  • A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. 
  • A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. 
  • A polygenic score for body mass index is associated with depressive symptoms via early life stress: Evidence for gene-environment correlation. 
  • A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo. 
  • A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. 
  • A practical approach to the early identification of antidepressant medication non-responders. 
  • A practical guide to biobehavioral assessment and treatment of chronic pain 
  • A preliminary metabolomic analysis of older adults with and without depression 
  • A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. 
  • A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. 
  • A primate model of anterograde and retrograde amnesia produced by convulsive treatment. 
  • A program to include persons after first psychotic episode in national service 
  • A prospective study examining the effects of gender and sexual/physical abuse on mood outcomes in patients with co-occurring bipolar I and substance use disorders. 
  • A prospective study of religion/spirituality and depressive symptoms among adolescent psychiatric patients. 
  • A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. 
  • A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR)- a measure of suicidality-in patients with stimulant use disorder. 
  • A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder. 
  • A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD). 
  • A psychopharmacology course for psychiatry residents utilizing active-learning and residents-as-teachers to develop life-long learning skills. 
  • A psychotherapeutic approach to silent children. 
  • A public health approach to address the mental health burden of youth in situations of political violence and humanitarian emergencies. 
  • A quality improvement process for implementing the Texas algorithm for schizophrenia in Ohio. 
  • A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale. 
  • A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. 
  • A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder. 
  • A randomized controlled trial of ganaxolone in posttraumatic stress disorder. 
  • A randomized controlled trial of outpatient commitment in North Carolina. 
  • A randomized controlled trial of paroxetine for noncardiac chest pain. 
  • A randomized controlled trial to assess effectiveness of a spiritually-based intervention to help chronically ill adults. 
  • A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP). 
  • A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. 
  • A randomized trial of the effect of prayer on depression and anxiety. 
  • A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia 
  • A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. 
  • A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder 
  • A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. 
  • A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. 
  • A randomized, double-blind, placebo-controlled, flexible-dose, trial of augmentation with OROS methylphenidate in Treatment Resistant Depression 
  • A randomized, double-blind, placebo-controlled, flexible-dose, trial of augmentation with oros methylphenidate in treatment resistant depression 
  • A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia. 
  • A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia. 
  • A recovery-oriented money management intervention. 
  • A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity 
  • A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. 
  • A repeat proton magnetic resonance spectroscopy study in social phobia. 
  • A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. 
  • A replicated molecular-genetic basis for subtyping antisocial behavior in ADHD 
  • A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. 
  • A research development workshop to stimulate outcome research in consultation-liaison psychiatry. 
  • A research strategy for investigating interactions between measured genes and measured environments 
  • A retrospective study exploring the effects of intramuscular aripiprazole on QTc change in agitated medically ill patients. 
  • A revised measure of occupational stress for firefighters: Psychometric properties and relationship to posttraumatic stress disorder, depression, and substance abuse 
  • A role for ΔFosB in calorie restriction-induced metabolic changes. 
  • A school-based post-Katrina therapeutic intervention. 
  • A screening questionnaire for mother-infant bonding disorders 
  • A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophrenia. 
  • A single high dose of cocaine induces differential sensitization to specific behaviors across adolescence. 
  • A spiritual problem? Primary care physicians' and psychiatrists' interpretations of medically unexplained symptoms. 
  • A statistical analysis of the classification of depression in a mixed community and clinical sample. 
  • A study of depressive typologies using grade of membership analysis. 
  • A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia. 
  • A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. 
  • A survey of health care practitioners' knowledge of the QT interval. 
  • A survey of medical toxicology training in psychiatry residency programs. 
  • A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus. 
  • A survey of stakeholder knowledge, experience, and opinions of advance directives for mental health in Virginia. 
  • A susceptibility gene for affective disorders and the response of the human amygdala. 
  • A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future. 
  • A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder. 
  • A systematic review of research on religion in four major psychiatric journals: 1991-1995. 
  • A systematic review of the association between biological markers and environmental stress risk factors for adolescent depression. 
  • A systematic review of treatments for refractory depression in older people. 
  • A taxometric investigation of dissociation in Vietnam veterans. 
  • A test of generalizability of cardiovascular reactivity using a controlled ambulatory procedure. 
  • A test of whether coping styles moderate the effect of PTSD symptoms on alcohol outcomes. 
  • A test-retest reliability study of child-reported psychiatric symptoms and diagnoses using the Child and Adolescent Psychiatric Assessment (CAPA-C). 
  • A thalamocorticostriatal dopamine network for psychostimulant-enhanced human cognitive flexibility. 
  • A three-component model for reengineering systems for the treatment of depression in primary care. 
  • A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder. 
  • A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. 
  • A typology of advance statements in mental health care. 
  • A visual guide to expected blood levels of long-acting injectable risperidone in clinical practice 
  • A volunteer community mental health clinic. 
  • A+KIDS, a web-based antipsychotic registry for North Carolina youths: an alternative to prior authorization. 
  • ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. 
  • ADDITIVE ASSOCIATION OF ANXIETY AND DEPRESSION WITH ALL-CAUSE MORTALITY IN INDIVIDUALS WITH CORONARY HEART DISEASE 
  • ADHD and manic symptoms: Diagnostic and treatment implications 
  • ADHD and nonsuicidal self-injury in male veterans with and without PTSD. 
  • ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge. 
  • ADHD, Smoking Withdrawal, and Resting State Functional Connectivity: Results of a fMRI Study With Methylphenidate Challenge 
  • ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence. 
  • ADRENERGIC GENE VARIANTS ARE ASSOCIATED WITH PLATELET AGGREGATION TO EPINEPHRINE 
  • ADVERSE CHILDHOOD EXPERIENCES AND POORER HEALTH IN MIDLIFE: INVESTIGATING PSYCHOSOCIAL MECHANISMS OF ACTION 
  • AGTR1 gene variation: association with depression and frontotemporal morphology. 
  • AKT1 and neurocognition in schizophrenia (vol 41, pg 169, 2007) 
  • AKT1 and neurocognition in schizophrenia. 
  • ALPRAZOLAM ATTENUATES STRESS-INDUCED HYPERGLYCEMIA 
  • ANXIETY, DEPRESSION, AND HEART RATE VARIABILITY 
  • APOE genotype and hippocampal volume change in geriatric depression. 
  • APPROXIMATING DIURNAL CORTISOL PROFILE MEMBERSHIP IN SMALLER SAMPLES 
  • ARE PEOPLE WITH GREATER CARDIOVASCULAR REACTIVITY SMARTER, HAPPIER, AND HEALTHIER? COUNTERINTUITIVE FINDINGS IN THE DUNEDIN AND MIDUS STUDIES 
  • AUTONOMIC BALANCE IN TYPE-A AND TYPE-B PERSONS - LARGER FOREARM VASOCONSTRICTION AND VAGAL REFLEX IN TYPE-BS DURING COLD FACE STIMULUS 
  • Abbreviating the Duke Social Support Index for use in chronically ill elderly individuals. 
  • Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms. 
  • Abnormal fronto-limbic engagement in incarcerated stimulant users during moral processing. 
  • Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia. 
  • Abnormalities in Inflammatory Lipid Levels in First Episode Schizophrenic Patients are Modulated by Risperidone 
  • Abnormalities in the response of plasma arginine vasopressin during hypertonic saline infusion in patients with eating disorders. 
  • About 7% of 4-year-olds in Norway meet criteria for a psychiatric diagnosis 
  • Absence of histological lesions in primate models of ECT and magnetic seizure therapy. 
  • Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues. 
  • Abuse and dependence on prescription opioids in adults: a mixture categorical and dimensional approach to diagnostic classification. 
  • Accelerated biological aging in schizophrenia 
  • Acceptability of second-step treatments to depressed outpatients: a STAR*D report. 
  • Acceptance and Commitment Therapy for Co-Occurring Posttraumatic Stress Disorder and Alcohol Use Disorders in Veterans: Pilot Treatment Outcomes. 
  • Acceptance-enhanced behavior therapy for trichotillomania: Randomized controlled trial rationale, method, and strategies for recruiting minority participants. 
  • Access to medical care among persons with psychotic and major affective disorders. 
  • Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation method. 
  • Accuracy of an intimate partner violence screening tool for female VHA patients: a replication and extension. 
  • Accuracy of proactive case finding for mental disorders by community informants in Nepal. 
  • Accurate awareness of heartbeat in hypochondriacal and non-hypochondriacal patients. 
  • Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression. 
  • Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy. 
  • Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. 
  • Acoustic startle and prepulse inhibition predict smoking lapse in posttraumatic stress disorder. 
  • Actigraphic-measured sleep disturbance predicts increased positive symptoms in adolescents at ultra high-risk for psychosis: A longitudinal study. 
  • Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. 
  • Actuarial prediction of psychotherapy retention among Iraq-Afghanistan veterans with posttraumatic stress disorder. 
  • Acupuncture: a promising treatment for depression during pregnancy. 
  • Acute 5-HT reuptake blockade potentiates human amygdala reactivity. 
  • Acute Stress in Children and Adolescents: Developing Autonomic, Endocrine, and Neural Responses 
  • Acute and chronic nicotine effects on working memory in aged rats. 
  • Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. 
  • Acute changes in cerebral blood flow associated with marijuana smoking. 
  • Acute changes in cranial blood flow after cocaine hydrochloride. 
  • Acute dystonic reaction with moderate-dose ziprasidone. 
  • Acute effects of trauma-focused research procedures on participant safety and distress. 
  • Acute psychotic disorder after gastric bypass surgery: differential diagnosis and treatment. 
  • Acute service delivery in a police-mental health program for children exposed to violence and trauma. 
  • Acute treatment with trimethyltin alters alcohol self-selection. 
  • Acute tryptophan depletion - converging evidence for decreasing central nervous serotonin synthesis in rodents and humans 
  • Acute tryptophan depletion - converging evidence for decreasing central nervous serotonin synthesis in rodents and humans. 
  • Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes. 
  • Adapting smoking cessation treatment according to initial response to precessation nicotine patch. 
  • Adaptive Activation of a Stress Response Pathway Improves Learning and Memory Through Gs and β-Arrestin-1-Regulated Lactate Metabolism. 
  • Added amantadine may diminish tardive dyskinesia in patients requiring continued neuroleptics [4] 
  • Adding a tricyclic antidepressant to a monoamine oxidase inhibitor. 
  • Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: A double blind, placebo controlled, parallel design clinical trial 
  • Addressing Incomplete Psychiatric Histories in Adult ADHD: Response to Agnew-Blais and Arseneault. 
  • Adenosine Regulation of Dopamine Release and Behavior in Adolescent Rats 
  • Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry. 
  • Adequacy of antidepressant treatment by psychiatric residents: the antidepressant treatment history form as a possible assessment tool. 
  • Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care. 
  • Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs. 
  • Adinazolam sustained-release treatment of panic disorder: a double-blind study. 
  • Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms. 
  • Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. 
  • Adjunctive use of olanzapine in mood disorders: five case reports. 
  • Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. 
  • Administrative update: utilization of services. I. Comparing use of public and private mental health services: the enduring barriers of race and age. 
  • Adolescent cannabis use and later psychosis 
  • Adolescent depression, cortisol and DHEA. 
  • Adolescent-onset nicotine self-administration modeled in female rats. 
  • Adolescents Who Self-Harm and Commit Violent Crime: Testing Early-Life Predictors of Dual Harm in a Longitudinal Cohort Study. 
  • Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up. 
  • Adrenal Gland Enlargement in Major Depression-Reply 
  • Adrenal gland enlargement in major depression [2] 
  • Adrenal gland enlargement in major depression. A computed tomographic study. 
  • Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome. 
  • Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome. 
  • Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity. 
  • Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity. 
  • Adrenocortical sensitivity to ACTH in humans. 
  • Adrenocortical sensitivity to low-dose ACTH administration in depressed patients. 
  • Adult criminal outcomes of juvenile justice involvement. 
  • Adult diagnostic and functional outcomes of DSM-5 disruptive mood dysregulation disorder. 
  • Adult onset of severe and pervasive antisocial behavior: A distinct syndrome? 
  • Adult outcomes of childhood bullying victimization. 
  • Adult vulnerability for psychiatric disorders: interactive effects of negative childhood experiences and recent stress. 
  • Advancements in treating intimate partner violence in veterans. 
  • Advances and emerging treatments in social phobia 
  • Advances in Pharmacotherapy of Late-Life Depression. 
  • Advances in opioid antagonist treatment for opioid addiction. 
  • Advances in pharmacotherapy for decline of memory and cognition in patients with Alzheimer's disease. 
  • Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder. 
  • Advancing research at the intersection of two systems. 
  • Advancing successful implementation of task-shifted mental health care in low-resource settings (BASIC): protocol for a stepped wedge cluster randomized trial. 
  • Advancing the boundaries of molecular imaging. 
  • Adverse childhood events are associated with obesity and disordered eating: results from a U.S. population-based survey of young adults. 
  • Adverse impact of coercive treatments on psychiatric inpatients' satisfaction with care. 
  • Adverse neurodevelopmental effects of dexamethasone modeled in PC12 cells: identifying the critical stages and concentration thresholds for the targeting of cell acquisition, differentiation and viability. 
  • Adverse race-related events as a risk factor for posttraumatic stress disorder in Asian American Vietnam veterans. 
  • Adverse-effect profile of kava. 
  • Advocacy through science: Reply to comments on Resick et al. (2012) 
  • Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. 
  • Aerobic exercise reduces depressive symptoms in patients with chronic heart failure 
  • Affective context interferes with cognitive control in unipolar depression: an fMRI investigation. 
  • Affective disorders in five United States communities. 
  • Affective states and nonsuicidal self-injury (NSSI): Results from an ecological momentary assessment study of veterans with NSSI disorder. 
  • African American and European American veterans' perspectives on receiving mental health treatment. 
  • Age and impaired subjective support. Predictors of depressive symptoms at one-year follow-up. 
  • Age and sex effects on brain morphology. 
  • Age dependent change of ventricular measures in schizophrenia: Cross-sectional analysis 
  • Age of first onset of bipolar disorder: demographic, family history, and psychosocial correlates. 
  • Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. 
  • Age-adjusted threshold values for reduced REM latency in unipolar depression using ROC analysis. 
  • Age-dependent reduction of amygdala volume in bipolar disorder. 
  • Aggression after traumatic brain injury: prevalence and correlates. 
  • Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder. 
  • Aging of the human corpus callosum: magnetic resonance imaging in normal volunteers. 
  • Aging-related diagnostic variations: need for diagnostic criteria appropriate for elderly psychiatric patients. 
  • Alcohol abuse and dependence in the rural South. 
  • Alcohol and drug dependence symptom items as brief screeners for substance use disorders: results from the Clinical Trials Network. 
  • Alcohol dependence and use of treatment services among women in the community. 
  • Alcohol pharmacodynamics in young-elderly adults contrasted with young and middle-aged subjects. 
  • Alcohol problems and posttraumatic stress disorder in female crime victims. 
  • Alcohol use disorders and the use of treatment services among college-age young adults. 
  • Algorithm for the treatment of panic disorder with agoraphobia. 
  • Algorithms For Treatment of Major Depressive Disorder: Efficacy and Cost-Effectiveness. 
  • Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review. 
  • Algorithms for optimizing the treatment of depression: making the right decision at the right time. 
  • All for One and One for All: Mental Disorders in One Dimension. 
  • Allan McLane Hamilton. 
  • Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits. 
  • Allostatic load in the association of depressive symptoms with incident coronary heart disease: The Jackson Heart Study. 
  • Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder. 
  • Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway. 
  • Alprazolam for endogenous depression. 
  • Alprazolam reduces stress hyperglycemia in ob/ob mice. 
  • Alprazolam vs amitriptyline in depressions with reduced REM latencies. 
  • Alprazolam-induced manic reaction. 
  • Alterations in the hypothalamic-pituitary-adrenal axis in a proposed animal model of depression with genetic muscarinic supersensitivity. 
  • Alterations in the neural circuitry for emotion and attention associated with posttraumatic stress symptomatology. 
  • Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. 
  • Altered Insula Activity during Visceral Interoception in Weight-Restored Patients with Anorexia Nervosa. 
  • Altered cocaine potency in the nucleus accumbens following 7-day withdrawal from intermittent but not continuous treatment: voltammetric assessment of dopamine uptake in the rat. 
  • Altered development of the dorsolateral prefrontal cortex in chromosome 22q11.2 deletion syndrome: an in vivo proton spectroscopy study. 
  • Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients. 
  • Altered fronto-amygdalar functional connectivity predicts response to cognitive behavioral therapy in pediatric obsessive-compulsive disorder. 
  • Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. 
  • Altered network connectivity predicts response to cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. 
  • Altered prefrontal dopaminergic function in chronic recreational ketamine users. 
  • Altered resting-state functional connectivity of basolateral and centromedial amygdala complexes in posttraumatic stress disorder. 
  • Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. 
  • Altered striatal functional connectivity in subjects with an at-risk mental state for psychosis. 
  • Alternative Perspectives on Police Encounters and Psychotic Experiences [Invited Commentary on DeVylder et al, "Psychotic Experiences in the Context of Police Victimization"]. 
  • Alternative therapy use by psychiatric outpatients. 
  • Alternatives to the Emergency Department: In Reply. 
  • Alzheimer's disease and the glutamate NMDA receptor. 
  • Alzheimer's disease: the importance of early diagnosis and appropriate management. 
  • Ambulatory Heart Rate Variability Monitoring: Comparisons Between the Empatica E4 Wristband and Holter Electrocardiogram. 
  • Ambulatory cardiovascular activity and hostility ratings in women with chronic posttraumatic stress disorder. 
  • Ambulatory monitoring and physical health report in Vietnam veterans with and without chronic posttraumatic stress disorder. 
  • American Christian Engagement With Mental Health and Mental Illness. 
  • Amitifadine, a triple reuptake inhibitor, reduces self-administration of the opiate remifentanil in rats. 
  • Amoxapine: A review of literature 
  • Amoxapine: Once versus divided daily doses in neurotic and endogenous depression 
  • Amplification of the Effects of Adolescent Binge Alcohol Exposure by Pretreatment With an Alpha-7 Nicotinic Receptor Positive Allosteric Modulator 
  • Amygdala Reward Reactivity Mediates the Association Between Preschool Stress Response and Depression Severity. 
  • Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder. 
  • Amygdala volume changes in posttraumatic stress disorder in a large case-controlled veterans group. 
  • Amygdala, Hippocampus, and Ventral Medial Prefrontal Cortex Volumes Differ in Maltreated Youth with and without Chronic Posttraumatic Stress Disorder. 
  • Amygdala-prefrontal cortex functional connectivity during threat-induced anxiety and goal distraction. 
  • Amygdalar volume and behavioral development in autism. 
  • Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells. 
  • Amyloid-associated depression: a prodromal depression of Alzheimer disease? 
  • An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. 
  • An Array of Serum Biomarkers May Predict Response to Transcranial Magnetic Stimulation in Major Depression Patients 
  • An Economic Evaluation of the Garrett Lee Smith Memorial Suicide Prevention Program. 
  • An Electrophysiological Biomarker That May Predict Treatment Response to ECT. 
  • An Inflammatory Pathway Links Atherosclerotic Cardiovascular Disease Risk to Neural Activity Evoked by the Cognitive Regulation of Emotion 
  • An Interprofessional Course on Substance Use Disorders for Health Professions Students. 
  • An Investigation of Treatment Engagement Among Returning Veterans With Problematic Anger. 
  • An MRI-based approach for the measurement of the dorsolateral prefrontal cortex in humans 
  • An RCT of Effects of Telephone Care Management on Treatment Adherence and Clinical Outcomes Among Veterans With PTSD. 
  • An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials. 
  • An abbreviated version of the brief assessment of cognition in schizophrenia (BACS) 
  • An adaptation of the modified mini-mental state examination: analysis of demographic influences and normative data: the cache county study. 
  • An additional recommendation on reporting depression [comment] 
  • An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine. 
  • An application of item response theory to fMRI data: prospects and pitfalls. 
  • An application of the revised CONSORT standards to FDA summary reports of recently approved antidepressants and antipsychotics. 
  • An assessment of the Newcastle Anxiety Depression Index. 
  • An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. 
  • An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology. 
  • An empirical analysis of cost outcomes of the Texas Medication Algorithm Project. 
  • An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder. 
  • An epigenetic mechanism links socioeconomic status to changes in depression-related brain function in high-risk adolescents. 
  • An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. 
  • An evaluation of two doses of isocarboxazid in depression. 
  • An evidence synthesis of care models to improve general medical outcomes for individuals with serious mental illness: a systematic review. 
  • An evidence-based medicine approach to combined treatment for ADHD in children and adolescents. 
  • An evidence-based medicine strategy for achieving remission in bipolar disorder. 
  • An examination of the association between altitude and suicide deaths, suicide attempts, and suicidal ideation among veterans at both the patient and geospatial level. 
  • An examination of the broader effects of warzone experiences on returning Iraq/Afghanistan veterans' psychiatric health. 
  • An experience-sampling study of depressive symptoms and their social context. 
  • An experimental investigation of emotional reactivity and delayed emotional recovery in borderline personality disorder: the role of shame. 
  • An exploration of comorbid depression among female victims of intimate partner violence with posttraumatic stress disorder. 
  • An inflammatory pathway links atherosclerotic cardiovascular disease risk to neural activity evoked by the cognitive regulation of emotion. 
  • An international comparison of two systems of community mental health care. 
  • An international survey of tardive dyskinesia 
  • An investigation of vago-regulatory and health-behavior accounts for increased inflammation in posttraumatic stress disorder. 
  • An involvement of dopamine in higher order choice mechanisms in the monkey 
  • An involvement of dopamine in higher order choice mechanisms in the monkey. 
  • An observational study of pharmacological treatment in primary care of children with ADHD in the United kingdom. 
  • An obsessional variant of capgras symptom: a case report. 
  • An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. 
  • An open study of the pharmacokinetics and the tolerability of raclopride extended release capsules in psychiatric patients 
  • An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants. 
  • An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression. 
  • An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features. 
  • An outpatient evaluation of phenelzine and imipramine. 
  • An overview of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. 
  • Analgesic efficacy of milnacipran in animal models of chronic pain 
  • Analysis of DNA Methylation in Young People: Limited Evidence for an Association Between Victimization Stress and Epigenetic Variation in Blood. 
  • Analysis of the RELN gene as a genetic risk factor for autism. 
  • Anatomic location and laterality of MRI signal hyperintensities in late-life depression. 
  • Anatomical variability predicts individual differences in ECT seizure threshold: a combined preclinical and computational modeling study 
  • Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats. 
  • Anger expression and ambulatory blood pressure: a comparison of state and trait measures. 
  • Anger mediates the relationship between posttraumatic stress disorder and suicidal ideation in veterans. 
  • Anger precedes and predicts nonsuicidal self-injury in veterans: Findings from an ecological momentary assessment study. 
  • Anger, impulsivity and wall/object punching in a sample of U.S. veterans with psychiatric disorders. 
  • Anger, social support, and suicide risk in U.S. military veterans. 
  • Angioedema occurring in patient prescribed iloperidone and haloperidol: a cross-sensitivity reaction to antipsychotics from different chemical classes. 
  • Angiotensin receptor gene polymorphisms and 2-year change in hyperintense lesion volume in men. 
  • Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): comparisons with electroconvulsive shock (ECS). 
  • Animal models provide insight into psychosomatic factors in diabetes. 
  • Ankyrin-G regulates forebrain connectivity and network synchronization via interaction with GABARAP. 
  • Antenatal thyroid correlates of postpartum depression. 
  • Anterior cingulate cortex gray matter volume mediates an association between 2D:4D ratio and trait aggression in women but not men. 
  • Anti-N-Methyl-d-Aspartate Receptor Encephalitis Presenting With Features of Kleine-Levin Syndrome and Demyelination. 
  • Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. 
  • Anticholinergic prophylaxis in young adults treated with neuroleptic drugs 
  • Anticipated Benefits of Care (ABC): psychometrics and predictive value in psychiatric disorders. 
  • Anticipating DSM-V: opportunities and challenges for cognition and psychosis. 
  • Anticipatory and residual effects of an active coping task on pre- and post-stress baselines. 
  • Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders. 
  • Antidepressant drug therapy in psychotic depression. 
  • Antidepressant effects of nicotine in an animal model of depression. 
  • Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. 
  • Antidepressant response to electroconvulsive therapy is sustained after catecholamine depletion. 
  • Antidepressant selection: Focus on nefazodone 
  • Antidepressant use by race. 
  • Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats. 
  • Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism. 
  • Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. 
  • Antineutrophil cytoplasmic antibodies associated with neurological vasculitic syndromes - Four cases 
  • Antipsychotic drug effects on brain morphology in first-episode psychosis. 
  • Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study 
  • Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. 
  • Antipsychotic medication use by Medicaid recipients with severe mental illness 
  • Antipsychotic medication use by Medicaid recipients: are there racial variations? 
  • Antipsychotic medications and sudden cardiac death. 
  • Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia 
  • Antipsychotic-induced weight gain and therapeutic response: a differential association. 
  • Antipsychotics and sudden death: is thioridazine the only bad actor? 
  • Antipsychotics and the risk of sudden cardiac death. 
  • Antisocial and related disorders in a southern community. An application of grade of membership analysis. 
  • Anxiety Disorders in Late Life. 
  • Anxiety and cerebral blood flow. 
  • Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments. 
  • Anxiety and vagal control of heart rate. 
  • Anxiety in medically ill older patients: a review and update. 
  • Anxiety in middle adulthood: effects of age and time on the 14-year course of panic disorder, social phobia and generalized anxiety disorder. 
  • Anxiety or irritability can lead to misdiagnosis of bipolar disorder: results from systematic consultations at the MGH Collaborative Care Initiative (CCI) Consultation Service 
  • Anxiety reduces baroreflex cardiac control in older adults with major depression. 
  • Anxiety sensitivity as a predictor of the clinical course of panic disorder: a 1-year follow-up study. 
  • Anxiety, depression, and heart rate variability. 
  • Anxiety-proneness and coronary heart disease. 
  • Anxiety-proneness and coronary heart disease. 
  • Apathy in neuropsychiatrie disorders 
  • Apolipoprotein E genotype and major depression in a community of older adults. The Cache County Study. 
  • Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects. 
  • Apolipoprotein E-epsilon 4 frequency in geriatric depression. 
  • Appetite regulatory hormones in women with anorexia nervosa: binge-eating/purging versus restricting type. 
  • Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging. 
  • Applying a stepped-care approach to the treatment of obesity. 
  • Approaches to the management of the acutely psychotic patient 
  • Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. 
  • Appropriateness of psychiatric advance directives facilitated by peer support specialists and clinicians on Assertive Community Treatment teams. 
  • Are Iraq and Afghanistan veterans using mental health services? New data from a national random-sample survey. 
  • Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis. 
  • Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models. 
  • Are changes in ADHD course reflected in differences in IQ and executive functioning from childhood to young adulthood? 
  • Are changes in positive mental health associated with increased likelihood of depression over a two year period? A test of the mental health promotion and protection hypotheses. 
  • Are children and adolescents with food allergies at increased risk for psychopathology? 
  • Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort. 
  • Are expectations for community mental health increasing among older adults in China? 
  • Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder? 
  • Are psychiatrists' characteristics related to how they care for depression in the medically ill? Results from a national case-vignette survey. 
  • Are smoking and alcohol misuse associated with subsequent hospitalizations for ambulatory care sensitive conditions? 
  • Arecoline reverses dexamethasone suppression of cortisol in normal males: a pilot study. 
  • Arguable assumptions, Questionable conclusions (reply to Munafo) 
  • Arguable assumptions, debatable conclusions. 
  • Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. 
  • Army Warrior Care Project (AWCP): Rationale and methods for a longitudinal study of behavioral health care in Army Warrior Transition Units using Military Health System data, FY2008-2015. 
  • Artificial Intelligence as a Transformative Force for Research and Practice in Neuropsychiatric Disorders: A Realistic Aspiration or a Magical Fantasy? 
  • Artificial intelligence and the future of psychiatry: Insights from a global physician survey. 
  • Ascending Digits Task as a Measure of Executive Function in Geriatric Depression 
  • Ascending digits task as a measure of executive function in geriatric depression. 
  • Assertive community treatment: an update of randomized trials. 
  • Assertive community treatment: facilitators and barriers to implementation in routine mental health settings. 
  • Assessing Functional Impairment and Social Adaptation for Child Mental Health Services Research: A Review of Measures 
  • Assessing and managing voilence risk in clinical practice 
  • Assessing anxious features in depressed outpatients. 
  • Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. 
  • Assessing depression symptoms in those with insomnia: an examination of the beck depression inventory second edition (BDI-II). 
  • Assessing diagnostic approaches to depression in medically ill older adults: how reliably can mental health professionals make judgments about the cause of symptoms? 
  • Assessing illicit drug use among adults with schizophrenia. 
  • Assessing insomnia severity in depression: comparison of depression rating scales and sleep diaries. 
  • Assessing instrumental activities of daily living (iADL) with a game-based assessment for individuals with schizophrenia. 
  • Assessing methylphenidate preference in ADHD patients using a choice procedure. 
  • Assessing outcomes for consumers in New York's assisted outpatient treatment program. 
  • Assessing patient beliefs in a clinical trial of Hypericum perforatum in major depression. 
  • Assessing risk of violent behavior among veterans with severe mental illness. 
  • Assessing the New York City involuntary outpatient commitment pilot program. 
  • Assessing the New York City involuntary outpatient treatment program. 
  • Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats. 
  • Assessing the practices and perceptions of dually-trained physicians: a pilot study. 
  • Assessing the preventive effects of cognitive therapy following relief of depression: A methodological innovation. 
  • Assessing the referral interface and communication between psychiatry and primary care 
  • Assessment and management of depression in older adults 
  • Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. 
  • Assessment of Myelin Compromise in Mild Traumatic Brain Injury with Quantitative Susceptibility Mapping 
  • Assessment of a new self-rating scale for post-traumatic stress disorder. 
  • Assessment of four stakeholder groups' preferences concerning outpatient commitment for persons with schizophrenia. 
  • Assessment of gene expression in peripheral blood using RNAseq before and after weight restoration in anorexia nervosa. 
  • Assessment of outcomes in autism clinical trials over the course of development. 
  • Assessment of safety and long-term outcomes of initial treatment with placebo in TADS. 
  • Assisted outpatient treatment in New York: regional differences in New York's assisted outpatient treatment program. 
  • Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. 
  • Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. 
  • Association between depression severity and amygdala reactivity during sad face viewing in depressed preschoolers: an fMRI study. 
  • Association between early life circumstances and depressive symptoms among Chinese older adults: Results from China health and retirement longitudinal study: Early life circumstances and depression. 
  • Association between frailty and cognitive function in older Chinese people: A moderated mediation of social relationships and depressive symptoms. 
  • Association between genetic and socioenvironmental risk for schizophrenia during upbringing in a UK longitudinal cohort. 
  • Association between genetic variation at the porphobilinogen deaminase gene and schizophrenia. 
  • Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. 
  • Association between tDCS computational modeling and clinical outcomes in depression: data from the ELECT-TDCS trial. 
  • Association between the self-reported duration and quality of sleep and cognitive function among middle-aged and older adults in China. 
  • Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. 
  • Association of Black Race With Physical and Chemical Restraint Use Among Patients Undergoing Emergency Psychiatric Evaluation. 
  • Association of DHEA, DHEAS, and cortisol with childhood trauma exposure and post-traumatic stress disorder. 
  • Association of Epidemiologic Factors and Genetic Variants Influencing Hypothalamic-Pituitary-Adrenocortical Axis Function With Postconcussive Symptoms After Minor Motor Vehicle Collision. 
  • Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort. 
  • Association of Obesity and Levels of Inflammatory Markers on Treatment Outcome with Adjunctive (6S)-5-methyl-5,6,7,8-tetrahydropteroyl-L-glutamic Acid (CH3-FH4) in MDD Patients Who are Inadequate Responders to SSRIs 
  • Association of adversity with psychopathology in early childhood: Dimensional and cumulative approaches. 
  • Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. 
  • Association of depression and survival in patients with chronic heart failure over 12 Years. 
  • Association of depressive and anxiety symptoms with 24-hour urinary catecholamines in individuals with untreated high blood pressure. 
  • Association of depressive symptoms with hippocampal volume in 1936 adults. 
  • Association of gene variants of the renin-angiotensin system with accelerated hippocampal volume loss and cognitive decline in old age. 
  • Association of maternal depression and home adversities with infant hypothalamic-pituitary-adrenal (HPA) axis biomarkers in rural Pakistan. 
  • Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. 
  • Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs. 
  • Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. 
  • Association of somatic symptoms with depression and anxiety in clinical patients of general hospitals in Guangzhou, China. 
  • Association of trauma exposure with psychiatric morbidity in military veterans who have served since September 11, 2001. 
  • Associations Between Sleep, Neurocognitive Performance, and ADHD Symptom Severity Among Adolescents 
  • Associations among disaster exposure, intimate relationship adjustment, and PTSD symptoms: can disaster exposure enhance a relationship? 
  • Associations among the NEO Personality Inventory, Revised and the serotonin transporter gene-linked polymorphic region in elders: effects of depression and gender. 
  • Associations between Childhood Adversity, C-Reactive Protein levels, and Psychotic Symptoms in Childhood: a Longitudinal Twin Cohort Study 
  • Associations between Purine Metabolites and Clinical Symptoms in Schizophrenia 
  • Associations between anger and suicidal ideation and attempts: A prospective study using the National Epidemiologic Survey on Alcohol and Related Conditions. 
  • Associations between depression and anxiety symptoms and retinal vessel caliber in adolescents and young adults. 
  • Associations between dimensions of religious commitment and mental health reported in the American Journal of Psychiatry and Archives of General Psychiatry: 1978-1989. 
  • Associations between functioning and PTSD symptom clusters in a dismantling trial of cognitive processing therapy in female interpersonal violence survivors. 
  • Associations between mental health and job loss among middle- and low-income veterans and civilians during the COVID-19 pandemic: An exploratory study. 
  • Associations between neuropsychiatric and health status outcomes in individuals with probable mTBI. 
  • Associations between positive emotional well-being and stress-induced myocardial ischemia: Well-being scores predict exercise-induced ischemia. 
  • Associations between the impact of terrorism and health perceptions of patients. 
  • Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality. 
  • Associations of depressive symptoms, trait hostility, and gender with C-reactive protein and interleukin-6 response after emotion recall. 
  • Associations of risk perception of COVID-19 with emotion and mental health during the pandemic. 
  • Astrocytic activation as evidence for brain damage. 
  • Asymmetry of rCBF in schizophrenia: relationship to AP-gradient and duration of illness. 
  • At the research front: cognitive therapy for depression. 
  • Atrocities exposure in Vietnam combat veterans with chronic posttraumatic stress disorder: relationship to combat exposure, symptom severity, guilt, and interpersonal violence. 
  • Attendance at religious services, interleukin-6, and other biological parameters of immune function in older adults. 
  • Attention and rewards in the control of psychophysiologic states 
  • Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome. 
  • Attention deficits in schizophrenia--preliminary evidence of dissociable transient and sustained deficits. 
  • Attention-deficit/hyperactivity disorder and nonsuicidal self-injury among veterans with complex psychiatric presentations. 
  • Attention-deficit/hyperactivity disorder and the explore/exploit trade-off. 
  • Attention-deficit/hyperactivity disorder: Part II. Treatment strategies 
  • Attentional and eye tracking deficits correlate with negative symptoms in schizophrenia. 
  • Attentional functioning in schizotypal personality disorder. 
  • Attentional markers of vulnerability to schizophrenia: performance of medicated and unmedicated patients and normals. 
  • Attenuation of Frontostriatal Connectivity During Reward Processing Predicts Response to Psychotherapy in Major Depressive Disorder. 
  • Attenuation of the effects of punishment by ethanol: comparisons with chlordiazepoxide. 
  • Attitudes toward borderline personality disorder: a survey of 706 mental health clinicians. 
  • Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. 
  • Atypical antidopaminergic properties of CI-686: a potential antipsychotic agent. 
  • Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis. 
  • Atypical antipsychotic drugs and diabetes mellitus in the USFDA adverse event reporting system (AERS) database in pediatric and adult patients 
  • Atypical antipsychotic drugs in treatment-refractory schizophrenia 
  • Atypical antipsychotics and pituitary neoplasms in the WHO database. 
  • Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. 
  • Atypical depression. 
  • Atypical depression: a comprehensive review. 
  • Atypical facial pain and trigeminal neuralgia: a comparison study. 
  • Atypical neuroleptic malignant syndrome caused by clozapine and venlafaxine: early brief treatment with dantrolene. 
  • Augmentation of ECT seizures with caffeine. 
  • Augmentation of sertraline antidepressant treatment with transcranial magnetic stimulation 
  • Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. 
  • Authors' reply 
  • Authors' reply. 
  • Authors' reply:. 
  • Autism and the serotonin transporter: the long and short of it. 
  • Autism in 1959: Joey the mechanical boy. 
  • Autistic disorder and chromosome 7: Evidence for a paternal effect. 
  • Autobiographical amnesia with ECT: an analysis of the roles of stimulus wave form, electrode placement, stimulus energy, and seizure length. 
  • Avoidant Restrictive Food Intake Disorder. 
  • Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. 
  • BAS and BIS in assessment of bipolar disorder 
  • BDNF Gene Polymorphism (Val66Met) Predicts Amygdala and Hippocampus Activation in Children Diagnosed with Anxiety as Preschoolers 
  • BDNF Val66Met and spontaneous dyskinesias in non-clinical psychosis. 
  • BIOBEHAVIORAL MEDIATORS OF SES EFFECTS ON CRP IN A NATIONALLY REPRESENTATIVE US SAMPLE 
  • BIOLOGICAL MECHANISMS OF CORONARY-PRONE BEHAVIOR IN MIDDLE-AGED MEN 
  • BIS and BAS interact with perceived parental affectionless control to predict personality disorder symptomatology. 
  • BLOOD PRESSURE 'NON-DIPPING' STATUS IS ASSOCIATED WITH GREATER OVERNIGHT EPINEPHRINE EXCRETION 
  • Back to school: review of school based interventions: comment on Rolfsness and Idsoe (2011). 
  • Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. 
  • Baclofen disrupts passive avoidance retention in rats. 
  • Bacterial infection early in life protects against stressor-induced depressive-like symptoms in adult rats. 
  • Baroreceptor sensitivity at rest and during stress in women with posttraumatic stress disorder or major depressive disorder. 
  • Barriers to and Facilitators of Mental Health Treatment Engagement Among Latina Adolescents. 
  • Barriers to employment for people with schizophrenia. 
  • Barriers to the use of Veterans Affairs health care services among female veterans who served in Iraq and Afghanistan. 
  • Baseline Cognitive Performance and Treatment Outcomes From Cognitive-Behavioral Therapies for Posttraumatic Stress Disorder: A Naturalistic Study. 
  • Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial. 
  • Baseline expression of alpha4beta2* nicotinic acetylcholine receptors predicts motivation to self-administer nicotine. 
  • Baseline neurocognitive assessment of 1364 patients with schizophrenia in the clinical antipsychotic trials for intervention effectiveness (CATIE) project 
  • Baseline neurocognitive deficits in the CATIE schizophrenia trial. 
  • Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial. 
  • Basic auditory processing deficits and their association with auditory emotion recognition in schizophrenia. 
  • Bayard Holmes (1852-1924) and Henry Cotton (1869-1933): Surgeon-psychiatrists and their tragic quest to cure schizophrenia. 
  • Behavior Change Counseling of Patients with Substance Use Disorders by Health Professions Students. 
  • Behavior and emotion modulation deficits in preschoolers at risk for bipolar disorder. 
  • Behavioral Health Care Quality Among Marketplace Insurers in 2019. 
  • Behavioral and cerebrovascular effects of caffeine in patients with anxiety disorders. 
  • Behavioral and emotional disturbances in the offspring of depressed parents with anger attacks. 
  • Behavioral and psychological approaches to the assessment and treatment of chronic pain. 
  • Behavioral approaches to Raynaud's disease. 
  • Behavioral assessment of the type A behavior pattern. 
  • Behavioral differences between two inbred strains of Fawn-Hooded rat: a model of serotonin dysfunction. 
  • Behavioral health integration model. 
  • Behavioral health mediators of the link between posttraumatic stress disorder and dyslipidemia. 
  • Behavioral health programs in fire service: Surveying access and preferences. 
  • Behavioral indications for serotonin receptor hypersensitivity in panic disorder. 
  • Behavioral markers of coping and psychiatric symptoms among sexually abused children. 
  • Behavioral medicine 
  • Behavioral neurology and neuropsychiatry fellowship training: the Johns Hopkins model. 
  • Behavioral observations at age 3 years predict adult psychiatric disorders. Longitudinal evidence from a birth cohort. 
  • Behavioral observations reflected on consultation requests from primary medical-surgical services: are they predictive of delirium diagnosis and outcomes? 
  • Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit. 
  • Behavioral toxicity with alprazolam 
  • Behavioural activation: history, evidence and promise 
  • Belief in life after death and mental health: findings from a national survey. 
  • Beliefs about God, psychiatric symptoms, and evolutionary psychiatry. 
  • Beliefs in karma and reincarnation among survivors of violent trauma--a community survey. 
  • Beliefs, mental health, and evolutionary threat assessment systems in the brain. 
  • Benefits of child-focused anxiety treatments for parents and family functioning. 
  • Benzodiazepine use and dependency risk in geriatric inpatients 
  • Benzodiazepine use and dependency risk in geriatric inpatients 
  • Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report. 
  • Benzodiazepines as antidepressants: does GABA play a role in depression? 
  • Best clinical practice: guidelines for managing major depression in primary medical care. 
  • Best practices: comparing medication treatments in mental health: drug class reviews and policy challenges. 
  • Beta-blockers and depression. 
  • Better, Faster, Safer: Exploring Biomarkers of Response to Transform Electroconvulsive Therapy. 
  • Beyond Thiamine: Treatment for Cognitive Impairment in Korsakoff's Syndrome. 
  • Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric disease. 
  • Bias in a protocol for a meta-analysis of 5-HTTLPR, stress, and depression. 
  • Biobehavioral Prognostic Factors in Chronic Obstructive Pulmonary Disease: Results From the INSPIRE-II Trial. 
  • Biobehavioral basis of coronary-prone behavior in middle-age men. Part II: Serum cholesterol, the Type A behavior pattern, and hostility as interactive modulators of physiological reactivity. 
  • Biobehavioral basis of coronary-prone behavior in middle-aged men. Part I: Evidence for chronic SNS activation in Type As. 
  • Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression. 
  • Biological and/or genetic factors in alcoholism. 
  • Biological annotation of genetic loci associated with intelligence in a meta-analysis of 87,740 individuals. 
  • Biological characterization of social phobia. 
  • Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls. 
  • Biological embedding of stress through inflammation processes in childhood. 
  • Biological rhythm disturbance in depression: temporal coherence of ultradian sleep EEG rhythms. 
  • Biological risk factors in late life depression. 
  • Biological therapies for posttraumatic stress disorder: an overview. 
  • Biological treatment of unipolar depressive disorders in the general practitioner's medical care: Guidelines of the World Federation of Societies of Biological Psychiatry (WFSBP) 
  • Biology of social phobia 
  • Biosocial implications growing from high‐risk research 
  • Bipolar Depression: Pregnancy, Postpartum, and Lactation. 
  • Bipolar Disorder and Crossover Design: Reply to Curtin Letter 
  • Bipolar disorder and crossover design. 
  • Bipolar disorder: Origin, recognition, and treatment 
  • Bl-1020, a new γ-aminobutyric acid-enhanced antipsychotic: results of 6-week, randomized, double-blind, controlled, efficacy and safety study. 
  • Blinding and bias in a hypnotic clinical trial. 
  • Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. 
  • Blood pressure during mental stress predicts left ventricular mass in men and women with high blood pressure 
  • Blood pressure reactivity and marital distress in employed women. 
  • Blunted Ventral Striatum Development in Adolescence Reflects Emotional Neglect and Predicts Depressive Symptoms. 
  • Blunted cortisol responses to stress signal social and behavioral problems among maltreated/bullied 12-year-old children. 
  • Blunted striatal response to monetary reward anticipation during smoking abstinence predicts lapse during a contingency-managed quit attempt. 
  • Body mass index and future schizophrenia in Israeli male adolescents. 
  • Body mass index, eating attitudes, and symptoms of depression and anxiety in pregnancy and the postpartum period. 
  • Book Review: The Rise and Fall of the Biopsychosocial Model: Reconciling Art and Science in Psychiatry 
  • Borderline Personality Disorder and the Effects of Instructed Emotional Avoidance or Acceptance in Daily Life. 
  • Borderline personality disorder and PTSD. 
  • Botanical medicines for anxiety: do they have a place? 
  • Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: a placebo-controlled double-blind trial. 
  • Brain Stimulation Therapies for Cliniciansby Edmund S. Higgins, M.D., and Mark S. George, M.D. Washington, D.C., American Psychiatric Publishing, Inc., 2009, 203 pp., $70.00. 
  • Brain Structure in Acutely Underweight and Partially Weight-Restored Individuals With Anorexia Nervosa: A Coordinated Analysis by the ENIGMA Eating Disorders Working Group. 
  • Brain activation during affective visual cues in schizophrenia: A pilot study using fMRI [3] 
  • Brain activation during decisions involving behavioral risk: Adolescents v. adults 
  • Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study. 
  • Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. 
  • Brain fluoxetine measurements using fluorine magnetic resonance spectroscopy in patients with social phobia. 
  • Brain imaging and psychiatric disorders 
  • Brain imaging correlates. 
  • Brain magnetic resonance imaging findings in ECT-induced delirium. 
  • Brain magnetic resonance spectroscopy: Role in assessing outcomes in Alzheimer's disease 
  • Brain mechanisms of social anxiety disorder: Comments 
  • Brain network functional connectivity and cognitive performance in major depressive disorder. 
  • Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. 
  • Brain stimulation in neurology and psychiatry: perspectives on an evolving field. 
  • Brain volumes in psychotic youth with schizophrenia and mood disorders. 
  • Brain-age in midlife is associated with accelerated biological aging and cognitive decline in a longitudinal birth cohort. 
  • Brain-derived neurotrophic factor (BDNF) Val66Met and adulthood chronic stress interact to affect depressive symptoms. 
  • Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism interacts with gender to influence cortisol responses to mental stress. 
  • Breast cancer patients have improved immune and neuroendocrine functions following massage therapy. 
  • Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment. 
  • Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients. 
  • Brief psychiatric rating scale expanded version: How do new items affect factor structure? 
  • Brief psychotherapy for depression: a systematic review and meta-analysis. 
  • Brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy (ECT) for major depression: efficacy, effectiveness, and cognitive effects. 
  • Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the research domain criteria (RDoC). 
  • British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. 
  • British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. 
  • Broken heart: depression in cardiovascular disease. 
  • Building Bridges Between Evidence and Policy in Mental Health Services Research: Introducing the Policy Review Article Type. 
  • Building a Community of Health Professionals to Establish a Shared Learning Experience in Psychiatry and Substance Use Disorders for Health Professions Students. 
  • Bulimia and depression. 
  • Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence. 
  • Bupropion HCL and sleep in patients with depression 
  • Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. 
  • Bupropion dosing recommendations. 
  • Bupropion extended release compared with escitalopram: Effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies 
  • Bupropion in chronic low back pain. 
  • Bupropion in the treatment of outpatients with asthma and major depressive disorder. 
  • Bupropion reinstates cocaine seeking behavior in rats 
  • Bupropion sustained release: a therapeutic overview. 
  • Bursts and the efficacy of selective serotonin reuptake inhibitors. 
  • C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. 
  • CARDIOVASCULAR LEVELS DURING ENVIRONMENTAL CHALLENGES IN HIGH AND LOW HOSTILE PATIENTS WITH A RECENT MYOCARDIAL-INFARCTION 
  • CARDIOVASCULAR REACTIVITY AND LEFT VENTRICULAR MASS IN HYPERTENSIVE MEN AND WOMEN 
  • CARDIOVASCULAR REACTIVITY AND THE EMOTIONAL SALIENCE OF LABORATORY STRESSORS 
  • CARDIOVASCULAR REACTIVITY ASSOCIATED WITH INDUCED ANGER AND DEPRESSIVE AFFECT 
  • CATECHOLAMINE RECEPTORS - MOLECULAR CHARACTERIZATION AND PHYSIOLOGICAL IMPLICATIONS 
  • CLOZAPINE DECREASES DRIVE TO SMOKE 
  • CMINDS does not have identical tests to the CATIE and MATRICS batteries. Commentary on O'Halloran et al. 
  • COGNITIVE DYSFUNCTION AND COMMUNITY FUNCTIONING IN SCHIZOPHRENIA: RESULTS FROM THE MATRICS PSYCHOMETRIC AND STANDARDIZATION STUDY (PASS) 
  • COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome. 
  • COVID-19 Epidemic Peer Support and Crisis Intervention Via Social Media. 
  • COVID-19-Related Impacts on Youth Mental Health. 
  • COVID-19-associated psychosis: A systematic review of case reports. 
  • CRITICAL ANALYSIS OF THE CURRENT TREATMENT GUIDELINES FOR COMPLEX PTSD IN ADULTS. 
  • CRP and Depression: A Test of Alternative Hypotheses 
  • CSF CRH in abstinent cocaine-dependent patients. 
  • CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression. 
  • CSF-5-HIAA, stress, and cytokine and adhesion molecule expression on blood monocytes 
  • Caffeine affects cardiovascular and neuroendocrine activation at work and home. 
  • Caffeine and cardiovascular responses to stress. 
  • Caffeine and cholesterol: interactions with hostility. 
  • Caffeine augmentation of ECT. 
  • Caffeine effects on cardiovascular and neuroendocrine responses to acute psychosocial stress and their relationship to level of habitual caffeine consumption. 
  • Caffeine raises blood pressure at work. 
  • Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial. 
  • Can IQ moderate the response to cognitive remediation in people with schizophrenia? 
  • Can We Use Brain Oscillations to Guide Treatment of MDD? 
  • Can a Framework Be Established for the Safe Use of Ketamine? 
  • Can a costly intervention be cost-effective? An analysis of violence prevention 
  • Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trial. 
  • Can food and addiction change the game? 
  • Can involuntary outpatient commitment reduce hospital recidivism?: Findings from a randomized trial with severely mentally ill individuals. 
  • Can mandated outpatient treatment prevent tragedies? 
  • Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. 
  • Can psychological features predict antidepressant response to rTMS? A Discovery-Replication approach. 
  • Can state and trait variables be disentangled? A methodological framework for psychiatric disorders. 
  • Can the digital revolution improve care for mood disorders patients? 
  • Can the panss cognitive factor be a valid surrogate for neurocognition in schizophrenia? 
  • Candidate gene polymorphisms and birth weight (BW) in the national longitudinal study of adolescent health (add health) 
  • Candidate neuroanatomic substrates of psychosis in old-aged depression. 
  • Cannabis use disorder and suicide attempts in Iraq/Afghanistan-era veterans. 
  • Cannabis use disorder, anger, and violence in Iraq/Afghanistan-era veterans. 
  • Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study. 
  • Cannabis use in adolescence and risk for adult psychosis: A birth cohort study 
  • Capability for suicide interacts with states of heightened arousal to predict death by suicide beyond the effects of depression and hopelessness. 
  • Carbon dioxide levels and cerebral blood flow. 
  • Carbon monoxide-related organic mood disorder successfully treated with ECT. 
  • Cardiovascular correlates of the psychotherapeutic process. 
  • Cardiovascular reactivity to laboratory stressors in maritally distressed women 
  • Cardiovascular response to unilateral electroconvulsive therapy. 
  • Cardiovascular responses in the laboratory and in the natural environment: is blood pressure reactivity to laboratory-induced mental stress related to ambulatory blood pressure during everyday life? 
  • Cardiovascular responses to an active coping challenge as predictors of blood pressure patterns 10 to 15 years later. 
  • Cardiovascular responses to behavioral stressors: laboratory-field generalization and inter-task consistency. 
  • Cardiovascular risks in relation to posttraumatic stress severity among young trauma-exposed women. 
  • Care-giver stress 
  • Career progress in online and blended learning environments. 
  • Career versus volunteer firefighters: Differences in perceived availability and barriers to behavioral health care. 
  • Caregiver burden and psychological distress in partners of veterans with chronic posttraumatic stress disorder. 
  • Caregiver strain and youth suicide attempt: Are they related? 
  • Caregivers as money managers for adults with severe mental illness: how treatment providers can help. 
  • Caregiving for persons with mental illness: the impact of outpatient commitment on caregiving strain. 
  • Caring for Families Separated by Changing Immigration Policies and Enforcement: A Cultural Psychiatry Perspective. 
  • Case finding and mental health services for children in the aftermath of the Oklahoma City bombing. 
  • Case report of phenothiazine-induced torsade de pointes 
  • Case report of treatment of severe mood disorder in an inpatient setting: when less is more. 
  • Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine. 
  • Case report: possible neuroleptic malignant syndrome associated with olanzapine. 
  • Case studies in neuropsychiatry II: Conversion pseudodementia 
  • Case-mix adjustment of adolescent mental health treatment outcomes. 
  • Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics. 
  • Catatonic coma with profound bradycardia. 
  • Catechol O-methyltransferase in red blood cells of schizophrenic, depressed, and normal human subjects. 
  • Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. 
  • Catechol-O-methyltransferase activity and classification of depression. 
  • Cause and effect in "alcoholic tremor". 
  • Cell-type specific transcriptional adaptations of nucleus accumbens interneurons to amphetamine. 
  • Cellular regulation of the benzodiazepine/GABA receptor: arachidonic acid, calcium, and cerebral ischemia. 
  • Central nervous system serotonin and clustering of hostility, psychosocial, metabolic, and cardiovascular endophenotypes in men. 
  • Central nervous system serotonin function and cardiovascular responses to stress. 
  • Cerebellar vermal volumes and behavioral correlates in children with autism spectrum disorder. 
  • Cerebellar volumes in pediatric maltreatment-related posttraumatic stress disorder. 
  • Cerebral blood flow changes during sodium-lactate-induced panic attacks. 
  • Cerebral blood flow changes induced by CO2 in anxiety. 
  • Cerebral blood flow in depression and mania 
  • Cerebral blood flow responses to CO2 and acetazolamide: the effect of anxiety. 
  • Cerebral blood flow responses to inhaled carbon dioxide in schizophrenia. 
  • Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. 
  • Cerebral ischemic symptoms in anxiety disorders. 
  • Cerebral vasodilation and vasoconstriction associated with acute anxiety. 
  • Cerebral white matter disease in late-onset paranoid psychosis. 
  • Cerebrospinal fluid DHEA levels are elevated in Alzheimer's disease, related to neuropathological disease stage, and correlated with brain DHEA levels 
  • Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants. 
  • Cerebrovascular changes in late life depression 
  • Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression. 
  • Certified psychiatric clinical nurse specialists. 
  • Challenges in Managing Insomnia in Older People. 
  • Challenges in the diagnosis and treatment of depression in autism spectrum disorders across the lifespan. 
  • Challenging assumptions from emotion dysregulation psychological treatments. 
  • Challenging the Hegemony of the Symptom: Reclaiming Context in PTSD and Moral Injury. 
  • Change in left ventricular ejection fraction during mental stress predicts 5-year clinical events in patients with coronary artery disease 
  • Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1. 
  • Changes in cerebral blood flow after diazepam evaluated with 3 measurement techniques 
  • Changes in cerebral blood flow and mental state after amphetamine challenge in schizophrenic patients. 
  • Changes in cerebral blood velocity after intravenous diazepam. 
  • Changes in children's behavior after a natural disaster. 
  • Changes in coping strategies, relationship to the perpetrator, and posttraumatic distress in female crime victims. 
  • Changes in depressive symptoms and glycemic control in diabetes mellitus. 
  • Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study. 
  • Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. 
  • Changes in guideline-recommended medication possession after implementing Kendra's law in New York. 
  • Changes in middle cerebral artery velocity after marijuana. 
  • Changes in religious beliefs following trauma. 
  • Changes in seizure threshold over the course of electroconvulsive therapy affect therapeutic response and are detected by ictal EEG ratings. 
  • Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care. 
  • Changing Rates of Mental Health Disorders Among Veterans Treated in the VHA During Troop Drawdown, 2007-2013. 
  • Changing face of pain: evolution of pain research in psychosomatic medicine. 
  • Changing how we think about insomnia 
  • Chaplains' Engagement with Suicidality among Their Service Users: Findings from the VA/DoD Integrated Mental Health Strategy. 
  • Characteristics of Representative Payeeship Involving Families of Beneficiaries With Psychiatric Disabilities 
  • Characteristics of antipsychotic medication prescribing on inpatient obstetric floors. 
  • Characteristics of insured and noninsured outpatients with depression in STAR(*)D. 
  • Characteristics of norepinephrine and clonidine displacement of [3H]yohimbine binding to platelet alpha2-adrenoreceptors in healthy volunteers. 
  • Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration. 
  • Characteristics of representative payeeship involving families of beneficiaries with psychiatric disabilities. 
  • Characteristics of schizophrenic and depressed patients excluded from clinical research. 
  • Characteristics of socially isolated patients with coronary artery disease who are at elevated risk for mortality. 
  • Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. 
  • Characteristics of third-party money management for persons with psychiatric disabilities. 
  • Characteristics of very poor outcome schizophrenia. 
  • Characterization of an inversion breakpoint in a multiplex autistic disorder family: Defining the candidate region on chromosome 7q. 
  • Characterizing anger-related affect in individuals with posttraumatic stress disorder using ecological momentary assessment. 
  • Characterizing the effects of sertraline in post-traumatic stress disorder. 
  • Characterizing the referral interface between psychiatry and primary care 
  • Chest pain self-management training for patients with coronary artery disease. 
  • Child mental health and maternal depression history in Pakistan. 
  • Child μ-opioid receptor gene variant influences parent-child relations. 
  • Child-, adolescent- and young adult-onset depressions: differential risk factors in development? 
  • Childhood Abuse and Cannabis Use Interact with the COMT Genotype to Predict Psychotic Symptoms in the General Population 
  • Childhood Bullying Victimization and Overweight in Young Adulthood: A Cohort Study. 
  • Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. 
  • Childhood Sexual Abuse and Fear of Abandonment Moderate the Relation of Intimate Partner Violence to Severity of Dissociation. 
  • Childhood and adolescent depression. I. Epidemiological and aetiological aspects. 
  • Childhood and adolescent depression. II: Research in clinical populations. 
  • Childhood and adolescent psychiatric disorders as predictors of young adult disorders. 
  • Childhood conduct problems and service costs: Understanding the expensive kids 
  • Childhood developmental risk factors for schizophrenia and other psychiatric disorders in the Dunedin birth cohort 
  • Childhood exposure to ambient air pollution and predicting individual risk of depression onset in UK adolescents. 
  • Childhood loneliness as a specific risk factor for adult psychiatric disorders. 
  • Childhood maltreatment and impact on clinical features of major depression in adults. 
  • Childhood maltreatment and impulsivity as predictors of interpersonal violence, self-injury and suicide attempts: A national study. 
  • Childhood maltreatment and poor functional outcomes at the transition to adulthood: a comparison of prospective informant- and retrospective self-reports of maltreatment. 
  • Childhood maltreatment and the risk of intimate partner violence: a nationally representative study. 
  • Childhood maltreatment, juvenile disorders and adult post-traumatic stress disorder: a prospective investigation. 
  • Childhood neuropsychological deficits associated with adult obsessive-compulsive disorder. 
  • Childhood origins of violent behaviour in adults with schizophreniform disorder. 
  • Childhood psychiatric disorders and young adult crime: a prospective, population-based study. 
  • Childhood psychotic symptoms share etiological and clinical features with adult schizophrenia: Results from a representative birth cohort. 
  • Childhood psychotic symptoms share etiological and clinical features with adult schizophrenia: Results from a representative borth cohort. 
  • Childhood risk factors associated with adult obsessive-compulsive symptoms and obsessive-compulsive disorder 
  • Childhood socioeconomic status and serotonin transporter gene polymorphism enhance cardiovascular reactivity to mental stress. 
  • Childhood somatic complaints predict generalized anxiety and depressive disorders during young adulthood in a community sample. 
  • Childhood trauma and children's emerging psychotic symptoms: A genetically sensitive longitudinal cohort study. 
  • Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome. 
  • Childhood traumatic stress and obesity in women: the intervening effects of PTSD and MDD. 
  • Children and evidence-based practice. 
  • Children of currently depressed mothers: a STAR*D ancillary study. 
  • Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. 
  • Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. 
  • Children with major depression show reduced rapid eye movement latencies. 
  • Children's response to terrorism: a critical review of the literature. 
  • Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. 
  • Cholesterol-lowering medication and relapse of depression. 
  • Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature. 
  • Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression. 
  • Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. 
  • Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response. 
  • Chronic low back pain and depression. 
  • Chronic neuroleptic effects on spatial reversal learning in monkeys. 
  • Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats. 
  • Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats. 
  • Chronic nicotine interactions with clozapine and risperidone and attentional function in rats. 
  • Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs. 
  • Chronic pain in psychiatric [correction of psychotic] patients. 
  • Chronic pain in psychiatric [correction of psychotic] patients. 
  • Chronic posttraumatic stress disorder and chronic pain in Vietnam combat veterans. 
  • Chronic stress and adaptation. 
  • Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment. 
  • Chronic underactivity of medial frontal cortical beta2-containing nicotinic receptors increases clozapine-induced working memory impairment in female rats. 
  • Chronic very low dose naltrexone administration attenuates opioid withdrawal expression. 
  • Chronicity and a low anteroposterior gradient of cerebral blood flow in schizophrenia. 
  • Chronobiologic parameter changes in patients with major depressive disorder and sleep disturbance treated with adjunctive brexpiprazole: An open-label, flexible-dose, exploratory substudy. 
  • Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. 
  • Cingulum bundle white matter lesions influence antidepressant response in late-life depression: a pilot study. 
  • Circadian Contrasts in Heart Rate Variability Associated With Posttraumatic Stress Disorder Symptoms in a Young Adult Cohort. 
  • Circadian rhythms in cognitive functioning among patients with schizophrenia: impact on signal detection in clinical trials of potential pro-cognitive therapies. 
  • Circuit-selective striatal synaptic dysfunction in the Sapap3 knockout mouse model of obsessive-compulsive disorder. 
  • Circulating natural killer cell phenotypes in men and women with major depression. Relation to cytotoxic activity and severity of depression. 
  • Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies. 
  • Citalopram and quality of life in lung transplant recipients. 
  • Classically conditioned enhancement of hyperinsulinemia in the ob/ob mouse. 
  • Classically conditioned hyperglycemia in the obese mouse. 
  • Classification of depression by grade of membership: a confirmation study. 
  • Classification of depressive disorders: A multiaxial approach 
  • Classification of trauma and stressor-related disorders in DSM-5. 
  • Classifying insomnia in a clinically useful way. 
  • Classifying psychophysiologic disorders: a new idea. 
  • Classifying psychosomatic disorders in DSM-III. 
  • Clinic Outcome Assessment of a Brief Course Neurofeedback for Childhood ADHD Symptoms. 
  • Clinical Care Update: The chronically mentally ill group treatment for individuals with schizophrenia 
  • Clinical Characteristics and Outcomes Associated With High-Dose Intravenous Thiamine Administration in Patients With Encephalopathy. 
  • Clinical Computing: Clinical Management Research Information System (CRIS). 
  • Clinical Decision Making About Psychopathy and Violence Risk Assessment in Public Sector Mental Health Settings 
  • Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression. 
  • Clinical Factors Associated with Successful Discharge from Assertive Community Treatment. 
  • Clinical Predictors of White Matter Disruption in Chronic Mild Traumatic Brain Injury among Post-9/11 Veterans 
  • Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry. 
  • Clinical advances in monoamine oxidase inhibitor therapies - Kennedy,SH 
  • Clinical and demographic factors associated with DSM-IV melancholic depression. 
  • Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. 
  • Clinical and phenomenological comparisons of late-onset and early-onset depression. 
  • Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients. 
  • Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries. 
  • Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline. 
  • Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings. 
  • Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. 
  • Clinical characteristics of outpatients with chronic major depression. 
  • Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. 
  • Clinical correlates of anxious depression among elderly patients with depression. 
  • Clinical correlates of cognitive decline in vascular dementia. 
  • Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. 
  • Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study. 
  • Clinical decision making and views about psychiatric advance directives. 
  • Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial. 
  • Clinical effectiveness study of a treatment to prepare for trauma-focused evidence-based psychotherapies at a veterans affairs specialty posttraumatic stress disorder clinic. 
  • Clinical experience with substance P receptor (NK1) antagonists in depression. 
  • Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa. 
  • Clinical features in depression in old age: A case for minor depression 
  • Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D. 
  • Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis. 
  • Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy. 
  • Clinical implications of spirituality to mental health: review of evidence and practical guidelines. 
  • Clinical needs assessment of middle and high school students following the 1995 Oklahoma City bombing. 
  • Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. 
  • Clinical practice guidelines. Good news, bad news, or no news? 
  • Clinical predictors of recurrence in depression. 
  • Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data. 
  • Clinical research challenges posed by difficult-to-treat depression. 
  • Clinical response to SSRIs relative to cognitive behavioral therapy in depression: a symptom-specific approach 
  • Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. 
  • Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease. 
  • Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far? 
  • Clinical use of nefazodone in major depression: a 6-year perspective. 
  • Clinical usefulness of clozapine [6] 
  • Clinical utility of the Primary Care--PTSD Screen among U.S. veterans who served since September 11, 2001. 
  • Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sample. 
  • Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report. 
  • Clinical, demographic and social characteristics of psychotic depression. 
  • Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression. 
  • Clinically relevant findings from STAR*D 
  • Clinician ratings vs. global ratings of symptom severity: a comparison of symptom measures in the bipolar disorder module, phase II, Texas Medication Algorithm Project. 
  • Clinician, parent, and child prediction of medication or placebo in double-blind depression study. 
  • Clinician-administered PTSD scale: a review of the first ten years of research. 
  • Clinicians' attitudes regarding barriers to the implementation of psychiatric advance directives. 
  • Clinicians' utilization of child mental health telephone consultation in primary care: findings from Massachusetts. 
  • Clozapine decreases smoking in patients with chronic schizophrenia. 
  • Clozapine effects on memory function are reversed by hippocampal damage 
  • Clozapine increases the neurosteroid pregnenolone in rat hippocampus, cerebral cortex, and serum: Relevance to superior efficacy? 
  • Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: Candidate mechanism for superior efficacy? 
  • Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT) 
  • Clozapine treatment in Russia: A review of clinical research 
  • Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder 
  • Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. 
  • Clues to the cognitive and perceptual origins of social isolation and psychosis in schizophrenia. 
  • Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. 
  • Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation. 
  • Cocaine self-administration reduces excitatory responses in the mouse nucleus accumbens shell. 
  • Coenzyme Q10: a review of its promise as a neuroprotectant. 
  • Cognition and schizophrenia: is there a role for cognitive assessments in diagnosis and treatment? 
  • Cognition and the concept of schizotaxia 
  • Cognition as a key to alliance, adherence, and functional outcomes 
  • Cognition as an outcome measure in schizophrenia. 
  • Cognition in schizophrenia: summary Nice Consultation Meeting 2012. 
  • Cognitive Aging: What Every Geriatric Psychiatrist Should Know. 
  • Cognitive Behavioral Strategies During Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder 
  • Cognitive Behavioral Strategies during Transcranial Magnetic Stimulation in Obsessive Compulsive Disorder and Concomitant Major Depressive Disorder: A Case Report 
  • Cognitive Control Across the Spectrum of Major Depressive Disorder 
  • Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial. 
  • Cognitive Neurostimulation of the Dopamine System 
  • Cognitive Processing Therapy for Posttraumatic Stress Disorder via Telehealth: Practical Considerations During the COVID-19 Pandemic. 
  • Cognitive Processing Therapy for Substance-Involved Sexual Assault: Does an Account Help or Hinder Recovery? 
  • Cognitive Subtyping in Schizophrenia: A Latent Profile Analysis. 
  • Cognitive and sedative effects of guanfacine extended release in children and adolescents aged 6 to 17 years with attention-deficit/hyperactivity disorder: Safety and sleep effects 
  • Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. 
  • Cognitive behavioral approaches to the treatment of pain 
  • Cognitive behavioral approaches to the treatment of pain. 
  • Cognitive behavioral therapy and cancer 
  • Cognitive behavioral therapy for chronic pain in veterans: Evidence for clinical effectiveness in a model program. 
  • Cognitive behavioral therapy for persons living with HIV in China: A randomized pilot trial. 
  • Cognitive behavioral treatment for young children with obsessive-compulsive disorder. 
  • Cognitive behavioural therapy (CBT) with exercise led to higher levels of continuous smoking cessation in women than did CBT without exercise: Commentary 
  • Cognitive behavioural treatments have long-term benefits in female rape survivors with post-traumatic stress disorder 
  • Cognitive burden of anticholinergic medications in psychotic disorders. 
  • Cognitive deficits following coronary artery bypass grafting: prevalence, prognosis, and therapeutic strategies. 
  • Cognitive deficits in patients with schizophrenia: effects and treatment. 
  • Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). 
  • Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. 
  • Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. 
  • Cognitive effects of nicotine. 
  • Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. 
  • Cognitive effects of quetiapine XR in patients with euthymic bipolar disorder. 
  • Cognitive enhancement in schizophrenia: Ending the therapeutic nihilism 
  • Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder. 
  • Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. 
  • Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease. 
  • Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. 
  • Cognitive impact of genetic variation of the serotonin transporter in primates is associated with differences in brain morphology rather than serotonin neurotransmission. 
  • Cognitive impairment as a target for pharmacological treatment in schizophrenia. 
  • Cognitive impairment in elderly depressed individuals with APOE epsilon 4 
  • Cognitive impairment in patients with bipolar disorder 
  • Cognitive impairment in schizophrenia and implications of atypical neuroleptic treatment 
  • Cognitive impairment in schizophrenia and implications of atypical neuroleptic treatment 
  • Cognitive improvement correlates with weight gain in schizophrenia subjects receiving quetiapine but not other antipsychotics: Data from the CATIE trial 
  • Cognitive performance in antidepressant-free recurrent major depressive disorder. 
  • Cognitive performance in first episode psychotic patients - A comparison of premorbid and morbid functioning 
  • Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. 
  • Cognitive therapy of depression and suicide. 
  • Cognitive therapy of depression: rationale, techniques, and efficacy. 
  • Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. 
  • Cognitive, Graphomotor, and Psychosocial Challenges in Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS) 
  • Cognitive-behavioral conjoint therapy for PTSD: Pilot results from a community sample. 
  • Cognitive-behavioral therapy for adolescent depression 
  • Cognitive-behavioral therapy for adolescent depression: Processes of cognitive change. 
  • Collaborative care for late-life depression 
  • Collaborative mental health and primary care for bipolar disorder. 
  • Combat exposure, posttraumatic stress disorder, and head injuries differentially relate to alterations in cortical thickness in military Veterans. 
  • Combination Treatment With Varenicline and Bupropion in an Adaptive Smoking Cessation Paradigm 
  • Combination pharmacotherapy in alcoholism: a novel treatment approach. 
  • Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study. 
  • Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm. 
  • Combined Agonist-Antagonist Treatment for Nicotine and Other Drug Dependencies. 
  • Combined PTSD and depressive symptoms interact with post-deployment social support to predict suicidal ideation in Operation Enduring Freedom and Operation Iraqi Freedom veterans. 
  • Combined Residency Programs in Psychiatry. 
  • Combined catecholamine and indoleamine depletion following response to ECT. 
  • Combined ecological momentary assessment and global positioning system tracking to assess smoking behavior: a proof of concept study. 
  • Combining antidepressant medications: a good idea? 
  • Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. 
  • Commentary: Sir Arthur Mitchell--pioneer of psychiatric epidemiology and of community care. 
  • Commentary: psychiatric advance directives and recovery-oriented care. 
  • Comments on "Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder". 
  • Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies. 
  • Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder. 
  • Common sense, insight, and neuropsychological test performance in schizophrenia patients. 
  • Common-variant associations with fragile X syndrome. 
  • Communication to the editor: Response to Bass 
  • Community integration of formerly homeless men and women with severe mental illness after hospital discharge. 
  • Comorbid HIV encephalopathy and cocaine use as a risk factor for new-onset seizure disorders. 
  • Comorbid disorders in patients with bipolar disorder and concomitant substance dependence. 
  • Comorbid posttraumatic stress disorder is associated with suicidality in male veterans with schizophrenia or schizoaffective disorder. 
  • Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. 
  • Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people. 
  • Comorbidity and depression treatment. 
  • Comorbidity and quality of life in adults with hair pulling disorder. 
  • Comorbidity between abuse of an adult and DSM-III-R mental disorders: evidence from an epidemiological study. 
  • Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. 
  • Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. 
  • Comorbidity of depression with other medical diseases in the elderly. 
  • Comorbidity of late life depression: an opportunity for research on mechanisms and treatment. 
  • Comparable dopamine 2 receptor occupancy [10] (multiple letters) 
  • Comparative diagnostic criteria for melancholia and endogenous depression. 
  • Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: A randomized, double-blind trial of olanzapine versus low doses of haloperidol (American Journal of Psychiatry (2004) 161, (985-995)) 
  • Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. 
  • Comparative effectiveness of dual-action versus single-action antidepressants for the treatment of depression in people living with HIV/AIDS. 
  • Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. 
  • Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol (American Journal of Psychiatry (2003) 160, (1396-1404)) 
  • Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. 
  • Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: initial lessons from the treatment for adolescents with depression study. 
  • Comparative mortality risks of antipsychotic medications in community-dwelling older adults. 
  • Comparing Use of Public and Private Mental Health Services: The Enduring Barriers of Race and Age 
  • Comparing neighborhoods of adults with serious mental illness and of the general population: research implications. 
  • Comparing pharmacological treatments for cocaine dependence: Incorporation of methods for enhancing generalizability in meta-analytic studies. 
  • Comparing psychosocial functioning, suicide risk, and nonsuicidal self-injury between veterans with probable posttraumatic stress disorder and alcohol use disorder. 
  • Comparing the Effects of an Index Course of Magnetic Seizure Therapy and Electroconvulsive Therapy on Quality of Life 
  • Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. 
  • Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy. 
  • Comparison between clinician-rated and self-reported depressive symptoms in Italian psychiatric patients. 
  • Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine. 
  • Comparison of Antipsychotics for Metabolic Problems (CAMP): A NIMH schizophrenia trials network study 
  • Comparison of Golgi stains of human and non-human primates 
  • Comparison of Premenstrual Symptoms in Black and White Community Samples 
  • Comparison of academic and nonacademic sites in multi-center clinical trials. 
  • Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. 
  • Comparison of brain nicotine uptake from electronic cigarettes and combustible cigarettes. 
  • Comparison of electric field strength and spatial distribution of electroconvulsive therapy and magnetic seizure therapy in a realistic human head model. 
  • Comparison of lifetime psychiatric diagnoses in Premenstrual Syndrome Clinic and community samples. 
  • Comparison of major and minor depression in older medical inpatients with chronic heart and pulmonary disease. 
  • Comparison of outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE study. 
  • Comparison of post-disaster psychiatric disorders after terrorist bombings in Nairobi and Oklahoma City. 
  • Comparison of quality of life measures in a depressed population. 
  • Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. 
  • Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. 
  • Comparison of the delta EEG in the first and second non-REM periods in depressed adults and normal controls. 
  • Comparison of the effects of cognitive therapy and pharmacotherapy on hopelessness and self-concept. 
  • Comparison of the posttraumatic stress disorder scale versus the clinician-administered posttraumatic stress disorder scale in domestic violence survivors. 
  • Comparison of treatment options for depression in heart failure: A network meta-analysis. 
  • Comparison of urinary-free cortisol in depressed and nondepressed patients with malignancy. 
  • Competent adolescents from different socioeconomic and ethnic contexts. 
  • Completeness of response and quality of life in mood and anxiety disorders. 
  • Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome. 
  • Complex PTSD in victims exposed to sexual and physical abuse: results from the DSM-IV Field Trial for Posttraumatic Stress Disorder. 
  • Components and correlates of family burden in schizophrenia. 
  • Components of Type A, hostility, and anger-in: relationship to angiographic findings. 
  • Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS). 
  • Computerized cognitive training and functional recovery in major depressive disorder: A meta-analysis. 
  • Computerizing the Texas Medication Algorithm Project. 
  • Concealed medicines for people with schizophrenia: a U.S. perspective. 
  • Concept of interpersonal distance in borderline personality disorder (Reply) 
  • Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD. 
  • Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. 
  • Conceptualizing comorbid PTSD and depression among treatment-seeking, active duty military service members. 
  • Concerns about data reporting and interpretation in "Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial". 
  • Concerns about measuring "spirituality" in research. 
  • Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality. 
  • Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. 
  • Conclusions inconsistent with results with amphetamines and divalproex. 
  • Conclusions. Bipolar disorder: Origin, recognition, and treatment 
  • Concordance of genetic variation that increases risk for anxiety disorders and posttraumatic stress disorders and that influences their underlying neurocircuitry. 
  • Conditioned Food Avoidance in Adolescence: A Contributor to Eating Disorders? 
  • Conduct problems subtypes in males predict differential adult health burden 
  • Confirmatory factor analysis: an introduction for psychosomatic medicine researchers. 
  • Conflict and mental health: a cross-sectional epidemiological study in Nepal. 
  • Conflict of interest-- an issue for every psychiatrist. 
  • Confusion about outpatient commitment. 
  • Congenital neuroblastoma in a bot born to a woman with bipolar disorder treated with carbamazepine during pregnancy 
  • Connecting Mentally Ill Detainees in Large Urban Jails with Community Care. 
  • Connectivity Analysis of Eeg in Depressed Patients Receiving Electroconvulsive Therapy and Magnetic Seizure Therapy 
  • Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. 
  • Consensus criteria for traumatic grief. A preliminary empirical test. 
  • Consensus guidelines in the treatment of major depressive disorder. 
  • Consensus statement on depression, anxiety, and cardiovascular disease. 
  • Consensus statement on depression, anxiety, and functional gastrointestinal disorders. 
  • Consensus statement on depression, anxiety, and oncology. 
  • Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety. 
  • Considering PTSD for DSM-5. 
  • Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB). 
  • Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer’s Disease-Neuropsychological Assessment Battery (CERAD-NAB) 
  • Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. 
  • Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research. 
  • Constant current vs constant voltage ECT devices. 
  • Constitutional Implications of Firearm Restrictions for Veterans with Fiduciaries 
  • Consumer perceptions of involuntary outpatient commitment. 
  • Consumer views of representative payee use of disability funds to leverage treatment adherence. 
  • Consumer, provider, and informal caregiver opinions on psychiatric advance directives. 
  • Consumers who call the Anxiety Disorders Association of America: characteristics and satisfaction. 
  • Consumers' perceptions of the fairness and effectiveness of mandated community treatment and related pressures. 
  • Contemporary management of comorbid anxiety and depression in geriatric patients. 
  • Contextual predictors of mental health service use among children open to child welfare. 
  • Continuation of clozapine during chemotherapy: a case report and review of literature. 
  • Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. 
  • Continuation treatment of panic disorder with high-potency benzodiazepines. 
  • Continuing medication and hospitalization outcomes after assisted outpatient treatment in New York. 
  • Continuity and stability of preschool depression from childhood through adolescence and following the onset of puberty. 
  • Continuity of antipsychotic medication management for Medicaid patients with schizophrenia. 
  • Continuity of medication management in Medicaid patients with chronic comorbid conditions: An examination by mental health status. 
  • Contribution of job strain, job status and marital status to laboratory and ambulatory blood pressure in patients with mild hypertension. 
  • Controlled comparison of electrophysiological sleep in families of probands with unipolar depression. 
  • Controlling Stimulation Strength and Focality in Electroconvulsive Therapy via Current Amplitude and Electrode Size and Spacing: Comparison With Magnetic Seizure Therapy. 
  • Controlling stimulation strength and focality in electroconvulsive therapy via current amplitude and electrode size and spacing: comparison with magnetic seizure therapy. 
  • Controversies in community-based psychiatric epidemiology: let the data speak for themselves. 
  • Convergent Evidence for Predispositional Effects of Brain Gray Matter Volume on Alcohol Consumption. 
  • Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity 
  • Converting positive and negative symptom scores between PANSS and SAPS/SANS. 
  • Convulsive therapy: 50 years later. 
  • Convulsive threshold differences in right unilateral and bilateral ECT. 
  • Coordination of Brain-Wide Activity Dynamics by Dopaminergic Neurons. 
  • Coping and quality of life in patients awaiting lung transplantation. 
  • Coping as a mediator in the relationships of spiritual well-being to mental health in black women with type 2 diabetes. 
  • Coping styles in heart failure patients with depressive symptoms. 
  • Coping with arthritis pain: The role of daily spiritual experiences and religious and spiritual coping 
  • Coping with genetic testing for breast cancer susceptibility. 
  • Correction to: Amitifadine, a triple reuptake inhibitor, reduces self-administration of the opiate remifentanil in rats. 
  • Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS). 
  • Correction to: The History of Coordinated Specialty Care for Early Intervention in Psychosis in the United States: A Review of Effectiveness, Implementation, and Fidelity. 
  • Correction: Altered network connectivity predicts response to cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. 
  • Correction: Ankyrin-G regulates forebrain connectivity and network synchronization via interaction with GABARAP. 
  • Correction: Common-variant associations with fragile X syndrome. 
  • Correlates and Prevalence of Aggression at Six Months and One Year After First-Time Traumatic Brain Injury. 
  • Correlates and clinical associations of military sexual assault in Gulf War era U.S. veterans: Findings from a national sample. 
  • Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report. 
  • Correlates of Future Violence in People Being Treated for Schizophrenia. 
  • Correlates of anger and hostility in Iraq and Afghanistan war veterans. 
  • Correlates of postpartum common mental disorders: results from a population-based study in Amhara region, Ethiopia. 
  • Correlates of remission in primary care patients treated for minor depression. 
  • Correlates of suicidal ideation among an elderly depressed sample. 
  • Corrigendum to "Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism interacts with gender to influence cortisol responses to mental stress" [Psychoneuroendocrinology 79 (2017) (May) 13-19]. 
  • Corrigendum to "Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]". 
  • Corrigendum to "Neuroendocrine biomarkers of prolonged exposure treatment response in military-related PTSD" [Psychoneuroendocrinology (2020) Article 104749]. 
  • Corrigendum to "Socioeconomic status moderates associations between CNS serotonin and expression of beta2-integrins CD11b and CD11c" [J. Psychiatr Res. (2010) 44:373-377]. 
  • Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. 
  • Cortical activity differs during nicotine deprivation versus satiation in heavy smokers. 
  • Cortical and subcortical white matter abnormalities in adults with remitted first-episode mania revealed by Tract-Based Spatial Statistics. 
  • Cortical excitability in cocaine-dependent patients: a replication and extension of TMS findings. 
  • Cortical excitability in cocaine-dependent subjects; Preliminary data 
  • Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia. 
  • Cortical stimulation in conscious rats controls joint inflammation. 
  • Cortical thickness predicts remission of depression with antidepressants in patients with late-life depression and cognitive impairment. 
  • Cortical thinning in preschoolers with maladaptive guilt. 
  • Cortical volume abnormalities in posttraumatic stress disorder: an ENIGMA-psychiatric genomics consortium PTSD workgroup mega-analysis. 
  • Cortical white matter microstructural abnormalities in bipolar disorder. 
  • Corticocortical Evoked Potentials and Patient Response Reveal Networks Underlying Depression 
  • Corticolimbic brain anomalies are associated with cognitive subtypes in psychosis: A longitudinal study. 
  • Cortisol and development of depression in adolescence and young adulthood - a systematic review and meta-analysis. 
  • Cortisol levels and responses to mammography screening in breast cancer survivors: a pilot study. 
  • Cortisol, estradiol, and androgens in acutely ill paranoid schizophrenics. 
  • Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia. 
  • Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression. 
  • Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders. 
  • Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. 
  • Cost-effectiveness of improving primary care treatment of late-life depression. 
  • Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. 
  • Cost-effectiveness of treatments for adolescent depression: results from TADS. 
  • Cost-sharing requirements and access to mental health care among medicare enrollees with schizophrenia. 
  • Costs of criminal justice involvement among persons with serious mental illness in connecticut. 
  • Countertransference in the expectant father. 
  • Couples training, pharmacotherapy, and behavior therapy in the treatment of obesity. 
  • Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. 
  • Course of suicide ideation and predictors of change in depressed older adults. 
  • Covariate analysis of late-onset Alzheimer disease refines the chromosome 12 locus. 
  • Covariation of psychological attributes and incident coronary heart disease in U.S. Air Force veterans of the Vietnam war. 
  • Cranial electrostimulation for headache: meta-analysis. 
  • Creating a Practice-Based Implementation Network: Facilitating Practice Change Across Health Care Systems. 
  • Criminal justice system involvement among people with schizophrenia. 
  • Criminal victimization of persons with severe mental illness. 
  • Crisis treatment of a preadolescent who accidentally killed his twin. 
  • Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems. 
  • Cross-cultural gene- environment interactions in depression, post-traumatic stress disorder, and the cortisol awakening response: FKBP5 polymorphisms and childhood trauma in South Asia. 
  • Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. 
  • Cross-reaction to maprotiline. 
  • Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia 
  • Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. 
  • Crossing the secular divide: government and faith-based organizations as partners in health. 
  • Cultivating Freud's Garden in France 
  • Culture and Social Structure in Comprehensive Case Formulation. 
  • Cumulative Effects of Neighborhood Social Adversity and Personal Crime Victimization on Adolescent Psychotic Experiences. 
  • Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. 
  • Current and future treatments for cognitive deficits in dementia. 
  • Current concepts in schizophrenia: International symposia report new standards for assessment and treatment. Part I: Pathophysiology research prompts assessment updates 
  • Current state of psychiatry in Saudi Arabia. 
  • Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice. 
  • Current, emerging, and newly available insomnia medications. 
  • Cynicism and paranoid alienation in the Cook and Medley HO Scale. 
  • Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia. 
  • D-amphetamine challenge effects on Wisconsin Card Sort Test. Performance in schizotypal personality disorder. 
  • D-amphetamine in obsessive-compulsive disorder 
  • DEFICIENT VISUAL ODDBALL STIMULUS PROCESSING PREDICTS PSYCHOSIS ONSET: RESULTS FROM THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY 
  • DELIRIUM AND TRICYCLIC ANTIDEPRESSANTS - REPLY 
  • DEPRESSION PREDICTS LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE INDIVIDUALS 
  • DEVELOPMENT OF AN INTERVIEW-BASED "CO-PRIMARY'' MEASURE OF COGNITION 
  • DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli. 
  • DHEA metabolism to the neurosteroid androsterone: a possible mechanism of DHEA's antidepressant action. 
  • DIFFERENCES IN THE PREVALENCE OF SCREEN-DETECTED DEPRESSION AFTER ACUTE CORONARY SYNDROME ACROSS 4 HEALTH SYSTEMS IN THE UNITED STATES: FINDINGS FROM THE CODIACS-QOL TRIAL 
  • DIFFERENTIAL-EFFECTS OF ANTAGONISTIC AND NEUROTIC HOSTILITY ON CARDIOVASCULAR-RESPONSES IN WOMEN 
  • DIFFERENTIATING VOLITION FROM HEDONIA USING A MONITARY REWARD TASK DURING FMRI 
  • DNA methylation signatures of aggression and closely related constructs: A meta-analysis of epigenome-wide studies across the lifespan. 
  • DNA methylation signatures of childhood trauma predict psychiatric disorders and other adverse outcomes 17 years after exposure. 
  • DOPAMINE D2 RECEPTOR OCCUPANCY AND COGNITION IN SCHIZOPHRENIA: ANALYSIS OF THE CATIE DATA 
  • DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues. 
  • DSM melancholic features are unreliable predictors of ECT response: a CORE publication. 
  • DSM-5 posttraumatic stress disorder: factor structure and rates of diagnosis. 
  • DSM-V PTSD diagnostic criteria for children and adolescents: a developmental perspective and recommendations. 
  • DSM-V: should PTSD be in a class of its own? 
  • DURATION OF HYPERTENSION BLUNTS CEREBROVASCULAR REACTIVITY IN TREATMENT-RESISTANT HYPERTENSIVES 
  • Daily Left Prefrontal TMS for Major Depression: A Sham-Controlled Multi-Site Randomized Trial (NIH Optimization of TMS for Depression Study, OPT-TMS) 
  • Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. 
  • Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. 
  • Daily ratings of premenstrual symptoms, II: Differentiating women with severe symptoms from women with normal menstrual cycles 
  • Daily ratings of premenstrual symptoms, I: Awareness effects 
  • Dasotraline as a Novel DAT/NET Inhibitor for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-concept Trial in Adults 
  • Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults. 
  • Dasotraline for the treatment of attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled, proof-of-concept trial in adults 
  • Datapoints: Effects of changing from five to ten preauthorized outpatient sessions. 
  • Datapoints: Use of medications and counseling for depression by Asian and multiple-race adolescents aged 12-17 years. 
  • Davidson Trauma Scale (DTS): normative scores in the general population and effect sizes in placebo-controlled SSRI trials. 
  • Daytime spikes in dopaminergic activity drive rapid mood-cycling in mice. 
  • Daytime spikes in dopaminergic activity drive rapid mood-cycling in mice. 
  • Debate on late luteal phase dysphoric disorder. 
  • Decision model for the acute treatment of mania. 
  • Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial. 
  • Decisional competence to complete psychiatric advance directives 
  • Decreased Resting-State Activity in the Precuneus Is Associated With Depressive Episodes in Recurrent Depression. 
  • Decreased alcohol consumption by verapamil in alcohol preferring rats. 
  • Deep Transcranial Magnetic Stimulation Combined With Brief Exposure for Posttraumatic Stress Disorder: A Prospective Multisite Randomized Trial. 
  • Deep-vein thrombosis with antipsychotic drugs. 
  • Deficit in the GABAergic neuroactive steroid allopregnanolone in Alzheimer's dementia and relevance to neuropathological disease stage: Investigations in temporal cortex 
  • Deficits in Auditory Predictive Coding in Individuals With the Psychosis Risk Syndrome: Prediction of Conversion to Psychosis 
  • Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders. 
  • Defining a cognitive function decrement in schizophrenia 
  • Defining a cognitive function decrement in schizophrenia. 
  • Defining an appropriate management strategy for social anxiety disorder. 
  • Defining the role of baclofen for the treatment of alcohol dependence: a systematic review of the evidence. 
  • Definitions, measurements, and management in insomnia 
  • Delayed onset of neuroleptic malignant syndrome after discontinuation of thioridazine. 
  • Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates (vol 58, pg 199, 2001) 
  • Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. 
  • Deliberate self-harm and suicidal ideation among male Iraq/Afghanistan-era veterans seeking treatment for PTSD. 
  • Delirium: diagnosis, neuropathogenesis, and treatment. 
  • Delirium: where do we stand? 
  • Delta sleep EEG in depressed adolescent females and healthy controls. 
  • Delta-9-Tetrahydrocannabinol Exposure Alters Sperm Methylation Profiles: Concurrent Results From Humans and Rats 
  • Demographics, family history, premorbid functioning, developmental characteristics, and course of patients with deteriorated affective disorder. 
  • Dentate gyrus volume deficit in schizophrenia. 
  • Depersonalization after marijuana smoking. 
  • Depressed mood is a factor in glycemic control in type 1 diabetes. 
  • Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up. 
  • Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial. 
  • Depression Suppresses Treatment Response for Traumatic Loss-Related Posttraumatic Stress Disorder in Active Duty Military Personnel. 
  • Depression among military spouses: Demographic, military, and service member psychological health risk factors. 
  • Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. 
  • Depression and Cardiovascular Disorders in the Elderly. 
  • Depression and anxiety disorder among older male inmates at a federal correctional facility. 
  • Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. 
  • Depression and benign intracranial hypertension. 
  • Depression and cardiovascular disease: mechanisms of interaction. 
  • Depression and cognitive impairment in older adults 
  • Depression and five year survival following acute myocardial infarction: a prospective study. 
  • Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. 
  • Depression and health-related quality of life. 
  • Depression and heart disease: evidence of a link, and its therapeutic implications. 
  • Depression and ischemic heart disease: overview of the evidence and treatment implications. 
  • Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. 
  • Depression and level of functioning in patients with rheumatoid arthritis. 
  • Depression as a psychopathological disorder in chronic low back pain patients. 
  • Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment 
  • Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. 
  • Depression awareness training and the clergy. 
  • Depression in diabetes and obesity: racial/ethnic/gender issues in older adults. 
  • Depression in early-onset Alzheimer's disease: clinical and neuroendocrine correlates. 
  • Depression in elderly is associated with blood vessels pathology in lateral orbitofrontal cortex 
  • Depression in hospitalized older patients with congestive heart failure. 
  • Depression in late life 
  • Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. 
  • Depression in radiation oncology patients: a preliminary evaluation. 
  • Depression in the elderly. Myths and misconceptions. 
  • Depression in the elderly: A timely update 
  • Depression in the medically ill: a common and serious disorder. 
  • Depression increases in women during early to late menopause but decreases after menopause. 
  • Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D. 
  • Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders. 
  • Depression spectrum disease with and without depression in first-degree relatives. 
  • Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. 
  • Depression, IV: STAR*D treatment trial for depression. 
  • Depression, Immunosuppressant Levels, and Clinical Outcomes in Postlung Transplant Recipients. 
  • Depression, heart rate variability, and acute myocardial infarction 
  • Depression, smoking abstinence and HPA function in women smokers. 
  • Depression, suicidal ideation, and associated factors: a cross-sectional study in rural Haiti. 
  • Depressive Symptoms, Exercise Capacity, and Clinical Outcomes After Lung Transplantation. 
  • Depressive comorbidity in children and adolescents: empirical, theoretical, and methodological issues. 
  • Depressive disorders: treatment patterns and costs of treatment in the private sector of the United States. 
  • Depressive illness and placebo response 
  • Depressive state- and disease-related alterations in neural responses to affective and executive challenges in geriatric depression. 
  • Depressive symptomatology and hypertension-associated morbidity and mortality in older adults. 
  • Depressive symptoms and associated factors in systemic lupus erythematosus. 
  • Depressive symptoms and depressive diagnoses in a community population. Use of a new procedure for analysis of psychiatric classification. 
  • Depressive symptoms and mental stress-induced myocardial ischemia in patients with coronary heart disease. 
  • Depressive symptoms and mild cognitive impairment in the elderly: an ominous combination. 
  • Depressive symptoms and survival of patients with coronary artery disease. 
  • Depressive symptoms associated with physical health problems in midlife women: A longitudinal study. 
  • Depressive symptoms in the elderly: association with total white blood cell count. 
  • Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. 
  • Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder. 
  • Design and field procedures in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). 
  • Desipramine toxicity with terbinafine. 
  • Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response. 
  • Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. 
  • Detection and treatment of major depression in older medically ill hospitalized patients. 
  • Detection of dementia in the elderly using telephone screening of cognitive status 
  • Detection of depression in low resource settings: validation of the Patient Health Questionnaire (PHQ-9) and cultural concepts of distress in Nepal. 
  • Detection of illicit substance use among persons with schizophrenia by radioimmunoassay of hair. 
  • Detection of risk for future depression among adolescents: Stakeholder views of acceptability and feasibility in the United Kingdom. 
  • Determinants of Implementing Evidence-Based Trauma-Focused Interventions for Children and Youth: A Systematic Review. 
  • Determinants of care seeking for mental health problems in rural Haiti: culture, cost, or competency. 
  • Determinants of resting regional cerebral blood flow in normal subjects 
  • Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors. 
  • Determining the Culprit: Stress, Fat, or Carbohydrates. 
  • Determining when impairment constitutes incapacity for informed consent in schizophrenia research. 
  • Developing Quality Indicators for Family Support Services in Community Team-Based Mental Health Care 
  • Developing a screening index for community studies of somatization disorder. 
  • Developing and validating a perinatal depression screening tool in Kenya blending Western criteria with local idioms: A mixed methods study. 
  • Developing nicotinic therapy for cognitive impairment of schizophrenia and aging-related dementia 
  • Developing quality indicators for family support services in community team-based mental health care. 
  • Development and natural history of mood disorders. 
  • Development and neural bases of face recognition in autism. 
  • Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function. 
  • Development of a brief self-report measure of the type A (coronary prone) behavior pattern. 
  • Development of a computer-based behavioral assessment of checking behavior in obsessive-compulsive disorder. 
  • Development of a computerized assessment of clinician adherence to a treatment guideline for patients with bipolar disorder. 
  • Development of a criteria set and a structured interview for disorders of extreme stress (SIDES). 
  • Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). 
  • Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects. 
  • Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents 
  • Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents: factor composition and structure across development 
  • Development of an organic affective syndrome during a hyperbaric diving experiment. 
  • Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder. 
  • Developmental change in amygdala reactivity during adolescence: effects of family history of depression and stressful life events. 
  • Developmental programming of brain and behavior by perinatal diet: focus on inflammatory mechanisms. 
  • Deviation from expected cognitive ability across psychotic disorders. 
  • Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. 
  • Dexamethasone suppression test and onset of poststroke depression in patients with ischemic infarction. 
  • Dexamethasone suppression test identifies a subset of elderly depressed patients with reduced platelet serotonin transport and resistance to imipramine inhibition of transport. 
  • Dexamethasone suppression test status does not predict differential response to nortriptyline versus amitriptyline. 
  • Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research. 
  • Dextroamphetamine modulates the response of the human amygdala. 
  • Dextroamphetamine-induced changes in regional cerebral blood flow 
  • Diagnosed mental disorder in children and use of health services in four organized health care settings. 
  • Diagnosing and Treating Insomnia in Adults and Older Adults. 
  • Diagnosing depression in patients with medical illness. 
  • Diagnosis and management of memory loss and cognitive disorders among elderly persons. 
  • Diagnosis and neuroanatomical correlates of depression in brain-damaged patients. Implications for a neurology of depression. 
  • Diagnosis and treatment of depression in late life: the NIH Consensus Development Conference Statement. 
  • Diagnosis of Alzheimer's disease in epidemiologic studies by staged review of clinical data 
  • Diagnosis of major depression in cancer patients according to four sets of criteria. 
  • Diagnosis, epidemiology, and clinical course of geriatric depression 
  • Diagnostic Correlates of Nonsuicidal Self-Injury Disorder among Veterans with Psychiatric Disorders. 
  • Diagnostic issues in chronic schizophrenia: kraepelinian schizophrenia, undifferentiated schizophrenia, and state-independent negative symptoms. 
  • Diagnostic significance of vegetative symptoms in depression. 
  • Diagnostic utility of the Quick Inventory of Depressive Symptomatology (QIDS-C16 and QIDS-SR16) in the elderly. 
  • Diagnostic utility of the dexamethasone suppression test. 
  • Dialectical behavior therapy for borderline personality disorder 
  • Dialectical behavior therapy for patients dually diagnosed with borderline personality disorder and substance use disorders 
  • Dialectical behavior therapy: Efficacy, mechanisms, and application 
  • Dialectical behavior therapy: current status, recent developments, and future directions. 
  • Diazepam for catatonia 
  • Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. 
  • Differences in Seizure Expression Between Magnetic Seizure Therapy and Electroconvulsive Shock. 
  • Differences in brain volumes among males and female hormone-therapy users and nonusers. 
  • Differences in early childhood risk factors for juvenile-onset and adult-onset depression. 
  • Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. 
  • Differences in psychiatric symptoms and barriers to mental health care between volunteer and career firefighters. 
  • Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients 
  • Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. 
  • Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats. 
  • Differential characteristics of young and midlife adult users of psychotherapy, psychotropic medications, or both: information from a population representative sample in São Paulo, Brazil. 
  • Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder. 
  • Differential effects of cognitive therapy and pharmacotherapy on depressive symptoms. 
  • Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. 
  • Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression. 
  • Differential efficacies of the nicotinic α4β2 desensitizing agents in reducing nicotine self-administration in female rats. 
  • Differential patterns of initial and sustained responses in amygdala and cortical regions to emotional stimuli in schizophrenia patients and healthy participants. 
  • Differential psychological effects of cognitive-behavioral stress management among breast cancer patients with high and low initial cancer-specific distress. 
  • Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin. 
  • Differential response to SSRI versus Placebo and distinct neural signatures among data-driven subgroups of patients with major depressive disorder. 
  • Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder. 
  • Differential sensitivity to dexamethasone suppression in an animal model of the DST. 
  • Differential service utilization associated with trauma-informed integrated treatment for women with co-occurring disorders. 
  • Differential therapeutic response by history during treatment with neuroleptic threshold haloperidol doses. 
  • Differentiation of Reward Dependent Behavior Circuitry from Reward Anticipation with fMRI-Guided TMS 
  • Differentiation of depression from chronic pain with the dexamethasone suppression test and DSM-III. 
  • Difficult-to-treat depression: A clinical and research roadmap for when remission is elusive. 
  • Diffusion Tensor Imaging of OEF/OIF Veterans with and without Exposure to Primary Blast Forces 
  • Diffusion tensor imaging: background, potential, and utility in psychiatric research. 
  • Digital Intervention for Cognitive Deficits in Major Depression: A Randomized Controlled Trial to Assess Efficacy and Safety in Adults. 
  • Digital period analysis of EEG in depression: periodicity, coherence, and interhemispheric relationships during sleep. 
  • Digital period analysis of sleep EEG in depression. 
  • Dimensional brain-behavior relationships in children with attention-deficit/hyperactivity disorder. 
  • Dimensional diagnosis and the medical student's grasp of psychiatry. 
  • Diminished Structural Brain Integrity in Long-term Cannabis Users Reflects a History of Polysubstance Use. 
  • Disclosure of editors' financial relationships 
  • Discontinuation of clonazepam in the treatment of social phobia. 
  • Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. 
  • Discriminative tryptophan pathway in first-episode neuroleptic-naive patients with schizophrenia 
  • Discussing Out-of-Pocket Expenses During Clinical Appointments: An Observational Study of Patient-Psychiatrist Interactions. 
  • Disengagement of visual attention in infancy is associated with emerging autism in toddlerhood. 
  • Disorder- and Treatment-Specific Therapeutic Competence Scales for Posttraumatic Stress Disorder Intervention: Development and Psychometric Properties. 
  • Disorders of extreme stress: The empirical foundation of a complex adaptation to trauma. 
  • Disputing psychiatry's redefinition. 
  • Disrupted network cross talk, hippocampal dysfunction and hallucinations in schizophrenia. 
  • Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study. 
  • Disrupted task related activation to action selection and conflict resolution in patients with schizophrenia 
  • Disruption of component processes of spatial working memory by electroconvulsive shock but not magnetic seizure therapy. 
  • Disruption of rat forebrain development by glucocorticoids: critical perinatal periods for effects on neural cell acquisition and on cell signaling cascades mediating noradrenergic and cholinergic neurotransmitter/neurotrophic responses. 
  • Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors. 
  • Disseminating the partnership: The Pew Memorial Trust State-University Collaboration Project 
  • Dissemination of evidence-based mental health interventions: importance to the trauma field. 
  • Dissemination of evidence-based psychological treatments for posttraumatic stress disorder in the Veterans Health Administration. 
  • Dissemination to community-based practices 
  • Dissociated effects of anticipating smoking versus monetary reward in the caudate as a function of smoking abstinence. 
  • Dissociation, affect dysregulation and somatization: The complexity of adaptation to trauma 
  • Dissociation, somatization, and affect dysregulation: the complexity of adaptation of trauma. 
  • Distinct Trauma Types in Military Service Members Seeking Treatment for Posttraumatic Stress Disorder. 
  • Distinguishing functional from syndromal recovery: implications for clinical care and research. 
  • Distress and affective dysregulation in patients with borderline personality disorder: a psychophysiological ambulatory monitoring study. 
  • Distress associated with cancer as measured by the illness distress scale. 
  • Distress tolerance to auditory feedback and functional connectivity with the auditory cortex. 
  • Distribution of Leonhard's subtypes of chronic schizophrenia in two cultures 
  • Diurnal dynamic range as index of dysregulation of system dynamics. A cortisol examplar using data from the Study of Midlife in the United States. 
  • Diurnal mood variation in outpatients with major depressive disorder. 
  • Diurnal mood variation in outpatients with major depressive disorder: implications for DSM-V from an analysis of the Sequenced Treatment Alternatives to Relieve Depression Study data. 
  • Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. 
  • Divergence of an association between depressive symptoms and a dopamine polygenic score in Caucasians and Asians. 
  • Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression. 
  • Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. 
  • Divergent responses of the amygdala and ventral striatum predict stress-related problem drinking in young adults: possible differential markers of affective and impulsive pathways of risk for alcohol use disorder. 
  • Do adolescent offspring of women with PTSD experience higher levels of chronic and episodic stress? 
  • Do anticonvulsants hinder clozapine treatment? 
  • Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial. 
  • Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial. 
  • Do benzodiazepines have a role in the prevention or treatment of coronary heart disease and other major medical disorders? 
  • Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients? 
  • Do dehydroepiandrosterone, progesterone, and testosterone influence women's depression and anxiety levels? Evidence from hair-based hormonal measures of 2105 rural Indian women. 
  • Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model. 
  • Do novel antipsychotics improve cognition? A report of a meta-analysis 
  • Do people turn to religion in times of stress?: an examination of change in religiousness among elderly, medically ill patients. 
  • Do repeated courses of ECT cause brain damage detectable by MRI? (I: Reply) 
  • Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. 
  • Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium. 
  • Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression? 
  • Does age make a difference in the effects of physical health and social support on the outcome of a major depressive episode? 
  • Does autonoetic agnosia underlie specific psychotic symptoms in schizophrenia? 
  • Does body mass index moderate the association between posttraumatic stress disorder symptoms and suicidal ideation in Iraq/Afghanistan veterans? 
  • Does change in ECT electrode placement help temporomandibular joint pain? 
  • Does cognitive-behavioral therapy for PTSD improve perceived health and sleep impairment? 
  • Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report. 
  • Does family history indicate a more serious form of illness? The case for depression, anxiety, alcohol dependence and drug dependence 
  • Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities? 
  • Does learned resourcefulness predict response to cognitive therapy in depressed outpatients? 
  • Does military sexual trauma moderate the impact of critical warzone experiences? 
  • Does multimodal treatment of ADHD decrease other diagnoses? 
  • Does physiologic response to loud tones change following cognitive-behavioral treatment for posttraumatic stress disorder? 
  • Does prenatal nicotine exposure sensitize the brain to nicotine-induced neurotoxicity in adolescence? 
  • Does pretreatment anxiety predict response to either bupropion SR or sertraline? 
  • Does pretreatment insomnia or anxiety predict acute response to bupropion SR? 
  • Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project. 
  • Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. 
  • Does sigma receptor antagonism predict clinical antipsychotic efficacy? 
  • Does social support buffer functional decline in elderly patients with unipolar depression? 
  • Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial. 
  • Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report. 
  • Does the pretreatment polysomnogram predict response to cognitive therapy in depressed outpatients? A preliminary report. 
  • Does writing about suicidal thoughts and feelings reduce them? 
  • Domestic violence increases risk of psychiatric disorder in women but not in men: A longitudinal cohort study 
  • Domestic violence is followed by increased risk of psychiatric disorder among women, but not men 
  • Dominance rank causally affects personality and glucocorticoid regulation in female rhesus macaques. 
  • Don't Blame the Tools: Clinical Neuroscience and the Quest to Link Brain With Behavior. 
  • Don't give up on GWAS. 
  • Donepezil for Down's syndrome. 
  • Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial. 
  • Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data. 
  • Dopamine efflux during withdrawal from continuous or intermittent cocaine. 
  • Dopamine's Role in ADHD Symptoms: Beyond an Attention Deficit 
  • Dopamine-modulated aversive emotion processing fails in alcohol-dependent patients. 
  • Dopaminergic correlates of attentional performance in unmedicated schizophrenic patients 
  • Dopaminergic modulation of reward discounting in healthy rats: a systematic review and meta-analysis. 
  • Dopaminergic role in cannabis-induced psychosis? Genetic and imaging evidence 
  • Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. 
  • Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Results of a two-year controlled study 
  • Dose response relationship between plasma ACTH and cortisol after the infusion of ACTH1-24. 
  • Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia. 
  • Dosing recommendations and prescribing patterns for depressed medically ill hospitalized older patients. 
  • Double depression: A distinctive subtype of unipolar depression - Discussion 
  • Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. 
  • Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. 
  • Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression. 
  • Downregulation of TOMM40 expression in the blood of Alzheimer disease subjects compared with matched controls. 
  • Dr Barber and colleagues reply 
  • Dr Kantrowitz and Colleagues Reply. 
  • Dr McClintock and Colleagues Reply. 
  • Dr McClintock and Colleagues Reply. 
  • Dr. Ahearn and Colleagues Reply 
  • Dr. Dwork and Colleagues Reply 
  • Dr. Keefe and colleagues reply 
  • Dr. Lieberman and Colleagues Reply 
  • Dr. Lieberman and Colleagues reply [17] 
  • Dr. McClintock and Colleagues reply 
  • Dr. McGrath and colleagues reply [2] 
  • Dr. Nejtek and colleagues reply 
  • Dr. Perrone-Bizzozero and W. Michael Bullock reply 
  • Dr. Rosenheck and Colleagues Reply 
  • Dr. Rosenheck and colleagues reply [2] 
  • Dr. Rush replies 
  • Dr. Schneider and Colleagues Reply 
  • Dr. Swanson and colleagues reply [4] 
  • Dr. Trivedi and colleagues reply [2] 
  • Dreams of flying in narcoleptic patients. 
  • Drinking and Smoking History and Antidepressant Plasma Levels 
  • Drinking to Cope with Posttraumatic Stress: A Nationally Representative Study of Men with and without Military Combat Experience. 
  • Driving Access and Quality: A Shift to Value-Based Behavioral Health Care. 
  • Dropouts versus completers among chronically depressed outpatients. 
  • Drs. Blazer and Wu Reply. 
  • Drug and alcohol trajectories among adults with schizophrenia: data from the CATIE study. 
  • Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. 
  • Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder. 
  • Drug therapy of post-traumatic stress disorder. 
  • Drugs and psychotherapy in the treatment of depressions 
  • Drugs of the psychopharmacological revolution in clinical psychiatry. 
  • Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial. 
  • Durability of acute response to TMS in the treatment of major depression: Relapse during a continuation pharmacotherapy extension study 
  • Durability of antidepressant response to vagus nerve stimulation (VNS). 
  • Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. 
  • Duration of untreated psychosis and the pathway to care in KwaZulu-Natal, South Africa. 
  • Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression. 
  • Dynamic Resting-State Functional Connectivity in Major Depression. 
  • Dynamically Timed Stimulation of Corticolimbic Circuitry Activates a Stress-Compensatory Pathway. 
  • Dysfunctional attitudes in depressed patients before and after clinical treatment and in normal control subjects. 
  • Dysthymia in community and clinical samples of older adults. 
  • Dystonia, neuroleptic dose, and anticholinergic drugs. 
  • E-cigarette prevalence and correlates of use among adolescents versus adults: A review and comparison 
  • E-cigarette prevalence and correlates of use among adolescents versus adults: a review and comparison. 
  • ECT and TMS: past, present, and future. 
  • ECT and seizure threshold: effects of stimulus wave form and electrode placement. 
  • ECT failure rate among specific devices - Drs. Krystal and Weiner reply 
  • ECT failure rate among specific devices. 
  • ECT in bipolar and unipolar depression: differences in speed of response. 
  • ECT in the treatment of status epilepticus. 
  • ECT instrumentation 
  • ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. 
  • ECT stimulus intensity: are present ECT devices too limited? 
  • ECT use in unipolar and bipolar depression. 
  • ECT-induced amnesia and postictal EEG suppression. 
  • ECT-induced delirium and further ECT: a case report. 
  • ECT-induced delirium in depressed patients with Parkinson's disease. 
  • ECT-induced status epilepticus and further ECT: a case report. 
  • EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial. 
  • EEG correlates of the response to ECT 
  • EEG correlates of the response to ECT: a possible antidepressant role of brain-derived neurotrophic factor. 
  • EEG effects of ECT: implications for rTMS. 
  • EEG evidence of more "intense" seizure activity with bilateral ECT. 
  • EFFECT OF CENTRAL NERVOUS SYSTEM SEROTONIN FUNCTION ON INFLAMMATION, ADIPOSITY AND INSULIN SENSITIVITY 
  • EFFECT OF FAMILY HISTORY OF HYPERTENSION ON CARDIOVASCULAR-RESPONSES TO INTRAVENOUS INFUSIONS OF ISOPROTERENOL (ISO) OR NOREPINEPHRINE (NE) 
  • EFFECT OF THE APOE ε4 ALLELE AND COMBAT EXPOSURE ON PTSD AMONG IRAQ/AFGHANISTAN-ERA VETERANS. 
  • EFFECTS OF COGNITIVE REMEDIATION ON NEGATIVE SYMPTOMS DIMENSIONS: EXPLORING THE ROLE OF WORKING MEMORY 
  • EFFECTS OF RELIGIOUS VERSUS STANDARD COGNITIVE-BEHAVIORAL THERAPY ON OPTIMISM IN PERSONS WITH MAJOR DEPRESSION AND CHRONIC MEDICAL ILLNESS. 
  • EFFICACY AND TOLERABILITY OF ADJUNCTIVE ARMODAFINIL IN PATIENTS WITH SCHIZOPHRENIA 
  • EIGHT-MONTH STABILITY OF PLASMA EPINEPHRINE AND CORTISOL IN FASTED ADULTS AT BASELINE AND IN RESPONSE TO A GLUCOSE BOLUS 
  • ELECTRICAL DOSAGE, STIMULUS PARAMETERS, AND ELECTRODE PLACEMENT 
  • EMDR for treatment of PTSD. 
  • ENIGMA-DTI: Translating reproducible white matter deficits into personalized vulnerability metrics in cross-diagnostic psychiatric research. 
  • EPINEPHRINE, CORTISOL AND NON-ESTERIFIED FATTY ACID LEVELS DURING AN INTRAVENOUS GLUCOSE TOLERANCE TEST ARE ASSOCIATED WITH THE ACUTE INSULIN RESPONSE (AIR), AN EARLY RISK MARKER FOR TYPE 2 DIABETES 
  • ERICH3: vesicular association and antidepressant treatment response. 
  • EURODEP Consortium and late-life depression. 
  • EVALUATING POTENTIAL IATROGENIC SUICIDE RISK IN TRAUMA-FOCUSED GROUP COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF PTSD IN ACTIVE DUTY MILITARY PERSONNEL. 
  • EVALUATION OF THE EFFECTS OF AL-108 ON NEUROCOGNITION IN SCHIZOPHRENIA: INITIAL TURNS STUDY RESULTS 
  • EXAMINING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) INATTENTION SYMPTOMS AS ANTECEDENTS OF PSYCHOSIS RISK IN 22Q11.2 DELETION SYNDROME (22Q11.2DS) 
  • EXERCISE TRAINING AND MAJOR DEPRESSION 
  • Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial. 
  • Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report. 
  • Early and late side effects of phenelzine. 
  • Early childhood factors associated with the development of post-traumatic stress disorder: results from a longitudinal birth cohort. 
  • Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats. 
  • Early environmental exposures and adult psychiatric disorder: Epstein-Barr virus antibodies as a biomarker of stressor exposure 
  • Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial. 
  • Early pharmacological treatment of autism: a rationale for developmental treatment. 
  • Early physical and sexual abuse associated with an adverse course of bipolar illness. 
  • Early physical and sexual abuse associated with an adverse course of bipolar illness. 
  • Early recognition of Alzheimer's disease: what is consensual? What is controversial? What is practical? 
  • Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. 
  • Early-life exposure to famine and late-life depression: Does leukocyte telomere length mediate the association? 
  • Ease of marital communication and depressive symptom severity among men and women in rural Uganda: cross-sectional, whole-population study. 
  • Easing the burden of social anxiety disorder. 
  • Ecological momentary assessment (EMA) of mental health outcomes in veterans and servicemembers: A scoping review. 
  • Economic grand rounds: Can states implement involuntary outpatient commitment within existing state budgets? 
  • Economic outcomes of depression screening after acute coronary syndromes: The CODIACS-QoL randomized clinical trial. 
  • Edgar Allan Poe's ''William Wilson'' and Capgras syndrome (Reply) 
  • Editorial: A recap and farewell from the editor 
  • Editorial: Exploring psychobiological, psychosocial, and cultural aspects of patient care: The International Journal of Psychiatry in Medicine in the 21st century 
  • Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats. 
  • Effect of Bupropion SR on the Quality of Life of Elderly Depressed Patients With Comorbid Medical Disorders. 
  • Effect of ECT treatment number on the ictal EEG. 
  • Effect of Electroconvulsive Shock and Magnetic Seizure on Gene Expression Profiles in the Prefrontal Cortex of the Rhesus Monkey 
  • Effect of Experimental Manipulation of the Orbitofrontal Cortex on Short-Term Markers of Compulsive Behavior: A Theta Burst Stimulation Study. 
  • Effect of Extended Release Bupropion on Unilateral Ultrabrief Electroconvulsive Therapy Seizure Parameters in Major Depressive Disorder. 
  • Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats. 
  • Effect of Supplementary Motor Area Modulation on Motor Cortex Excitability in Obsessive-Compulsive Disorder: Relations to Clinical Improvement 
  • Effect of a lay counselor delivered integrated maternal mental health and early childhood development group-based intervention in Siaya County, Kenya: A quasi-experimental longitudinal study. 
  • Effect of a paraprofessional home-visiting intervention on American Indian teen mothers’ and infants’ behavioral risks: a randomized controlled trial. 
  • Effect of age at onset on the course of major depressive disorder. 
  • Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study. 
  • Effect of bromocriptine on affect and libido in hyperprolactinemia. 
  • Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression. 
  • Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study. 
  • Effect of chronic stress associated with unemployment on salivary cortisol: overall cortisol levels, diurnal rhythm, and acute stress reactivity. 
  • Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial. 
  • Effect of electroconvulsive shock and magnetic seizure on gene expression profiles in the prefrontal cortex of the rhesus monkey 
  • Effect of electroconvulsive shock and magnetic seizure on gene expression profiles in the prefrontal cortex of the rhesus monkey 
  • Effect of gamma interferon on the hypothalamic-pituitary-adrenal system. 
  • Effect of genetic variation in the nicotinic receptor genes on risk for posttraumatic stress disorder. 
  • Effect of kava extract on vagal cardiac control in generalized anxiety disorder: preliminary findings. 
  • Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study. 
  • Effect of nitrous oxide on cerebral blood velocity while reclining and standing. 
  • Effect of olanzapine versus placebo on the neuropsychological status of prodromal subjects 
  • Effect of olanzapine versus placebo on the neuropsychological status of prodromal subjects 
  • Effect of patients' reasons for refusing treatment on implementing psychiatric advance directives. 
  • Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain. 
  • Effect of sex on ethanol consumption and conditioned taste aversion in adolescent and adult rats. 
  • Effect of structured interviews on evaluation time in pediatric community mental health settings. 
  • Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. 
  • Effectiveness of Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression 
  • Effectiveness of a brain-computer interface based programme for the treatment of ADHD: a pilot study. 
  • Effectiveness of a telephone-delivered psycho-behavioural intervention on depression in elderly with chronic heart failure: rationale and design of a randomized controlled trial. 
  • Effectiveness of antiepileptic drugs for the treatment of bipolar disorder: findings from a systematic review. 
  • Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: Primary efficacy and safety outcomes of the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial 
  • Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment. 
  • Effectiveness of atypical antipsychotics for substance use in schizophrenia patients. 
  • Effectiveness of chromium in atypical depression: a placebo-controlled trial. 
  • Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. 
  • Effectiveness of disease management programs in depression: a systematic review. 
  • Effectiveness of involuntary outpatient commitment - Dr. Swartz and colleagues reply 
  • Effectiveness of involuntary outpatient commitment. 
  • Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence. 
  • Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study. 
  • Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study 
  • Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. 
  • Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. 
  • Effectiveness of paroxetine and problem solving treatment for PC patients with minor depression or dysthymia 
  • Effectiveness of paroxetine and problem solving treatment for primary care patients age 18-59 with minor depression or dysthymia 
  • Effectiveness of paroxetine and problem-solving treatment for elders with minor depression or dysthymia 
  • Effectiveness of paroxetine and problem-solving treatment for younger adults with minor depression or dysthymia 
  • Effectiveness of psychological treatments for depression and alcohol use disorder delivered by community-based counsellors: two pragmatic randomised controlled trials within primary healthcare in Nepal. 
  • Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. 
  • Effectiveness of switching from antipsychotic polypharmacy to monotherapy. 
  • Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial. 
  • Effectiveness study of venlafaxine-XR combined with aripiprazole for chronic or recurrent major depressive disorder 
  • Effectiveness trials in mood disorders 
  • Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. 
  • Effects of 24 hour smoking abstinence on sustained and event-related brain activity during continuous working memory: Preliminary results of an fMRI study 
  • Effects of 5HTTLPR on cardiovascular response to an emotional stressor. 
  • Effects of AZD3480, a neuronal nicotinic acetylcholine receptor agonist, and donepezil on dizocilpine-induced attentional impairment in rats. 
  • Effects of Acute Course Electroconvulsive Therapy on Global Cognitive Function in Elderly Adults with Depression 
  • Effects of ECT on brain structure: a pilot prospective magnetic resonance imaging study. 
  • Effects of ECT on diabetes mellitus. An attempt to account for conflicting data. 
  • Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial. 
  • Effects of Guanfacine Extended Release in Children Aged 6 to 12 Years with Oppositional Symptoms and a Diagnosis of Attention-Deficit/Hyperactivity Disorder 
  • Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. 
  • Effects of LifeSkills training on medical students' performance in dealing with complex clinical cases. 
  • Effects of Maternal Prenatal Stress: Mechanisms, Implications, and Novel Therapeutic Interventions. 
  • Effects of Mindfulness-Based Stress Reduction on Experimental Pain Sensitivity and Cortisol Responses in Women With Early Life Abuse: A Randomized Controlled Trial. 
  • Effects of Schizophrenia Polygenic Risk Scores on Brain Activity and Performance During Working Memory Subprocesses in Healthy Young Adults. 
  • Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients. 
  • Effects of a right unilateral ultrabrief pulse electroconvulsive therapy course on health related quality of life in elderly depressed patients. 
  • Effects of aerobic exercise on white matter hyperintensities: An exploratory analysis. 
  • Effects of aerobic exercise training on hemodynamic responses during psychosocial stress in normotensive and borderline hypertensive type A men: a preliminary report. 
  • Effects of age and gender on the relationship between anxiety and coronary artery disease. 
  • Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. 
  • Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers 
  • Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. 
  • Effects of antidepressants on sleep: Focus on nefazodone 
  • Effects of antipsychotic medication on psychiatric service utilization and cost. 
  • Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. 
  • Effects of antipsychotic medications on sleep in schizophrenia. 
  • Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. 
  • Effects of bright light on responsiveness to a muscarinic agonist in rats selectively bred for endogenously increased cholinergic function. 
  • Effects of chronic sazetidine-A, a selective α4β2 neuronal nicotinic acetylcholine receptors desensitizing agent on pharmacologically-induced impaired attention in rats. 
  • Effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia. 
  • Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. 
  • Effects of cognitive remediation on negative symptoms dimensions: exploring the role of working memory. 
  • Effects of concomitant risperidone and lithium treatment [1] 
  • Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: A randomized clinical trial. 
  • Effects of coping on health outcome among women with gastrointestinal disorders. 
  • Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. 
  • Effects of depression on QT interval variability after myocardial infarction. 
  • Effects of early life stress on depression, cognitive performance and brain morphology. 
  • Effects of electroconvulsive shock and magnetic seizure therapy on mossy fiber sprouting and cellular proliferation in the primate hippocampus 
  • Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy. 
  • Effects of electroconvulsive therapy on plasma vasopressin and oxytocin. 
  • Effects of exercise and weight loss on blood pressure during daily life 
  • Effects of exercise and weight loss on depressive symptoms among men and women with hypertension. 
  • Effects of exercise on the Type A (coronary prone) behavior pattern. 
  • Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics. 
  • Effects of fluoxetine on the polysomnogram in outpatients with major depression. 
  • Effects of four normalizing methods on data analytic results in functional brain imaging. 
  • Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials. 
  • Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. 
  • Effects of heart disease on depression treatment: results from the COMED study. 
  • Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats. 
  • Effects of involuntary outpatient commitment and depot antipsychotics on treatment adherence in persons with severe mental illness. 
  • Effects of legal mechanisms on perceived coercion and treatment adherence among persons with severe mental illness. 
  • Effects of marijuana on performance of a computerized cognitive-neuromotor test battery. 
  • Effects of medical illness and somatic symptoms on treatment of depression in a family medicine residency practice. 
  • Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats. 
  • Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens 
  • Effects of nicotine on novelty detection and memory recognition performance: double-blind, placebo-controlled studies of smokers and nonsmokers. 
  • Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. 
  • Effects of paroxetine and venlafaxine XR on heart rate variability in depression. 
  • Effects of perceived racism and anger inhibition on ambulatory blood pressure in African Americans. 
  • Effects of periadolescent versus adult cocaine exposure on cocaine conditioned place preference and motor sensitization in mice. 
  • Effects of postnatal parental smoking on parent and teacher ratings of ADHD and oppositional symptoms. 
  • Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathy. 
  • Effects of prenatal nicotine exposure on primate brain development and attempted amelioration with supplemental choline or vitamin C: neurotransmitter receptors, cell signaling and cell development biomarkers in fetal brain regions of rhesus monkeys. 
  • Effects of propranolol on cardiovascular and neuroendocrine responses to mental arithmetic in type A men. 
  • Effects of psychotherapy on brain function: Brain imaging studies indicate changes 
  • Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial. 
  • Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats. 
  • Effects of sertraline augmentation of rTMS treatment in major depression on tms motor cortex excitability measures 
  • Effects of single and repeated alcohol withdrawal on kindling. 
  • Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. 
  • Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder. 
  • Effects of smoking on the acoustic startle response and prepulse inhibition in smokers with and without posttraumatic stress disorder. 
  • Effects of social support and resilient coping on violent behavior in military veterans. 
  • Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial. 
  • Effects of time-limited vs unlimited compensation on pain behavior and treatment outcome in low back pain patients. 
  • Effects of tobacco smoke constituents, anabasine and anatabine, on memory and attention in female rats. 
  • Effects of transdermal nicotine on lateralized identification and memory interference. 
  • Effects of treatment with a cyclic peptide that targets PDZ domain of PSD-95: Peptide administration to the ventral tegmental area inhibits opiate-induced motor sensitization in C57BL/6 mice 
  • Effects of vagus nerve stimulation on cortical excitability in patients with major depression 
  • Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale. 
  • Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice. 
  • Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression 
  • Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study. 
  • Efficacy and acceptability of transcranial direct current stimulation (tDCS) for major depressive disorder: An individual patient data meta-analysis. 
  • Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. 
  • Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. 
  • Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. 
  • Efficacy and safety of ketamine in patients with complex regional pain syndrome: a systematic review. 
  • Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature. 
  • Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder 
  • Efficacy and safety of lisdexamfetamine dimesylate in adults with executive dysfunction and partial or full remission of major depressive disorder 
  • Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. 
  • Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. 
  • Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. 
  • Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial. 
  • Efficacy of ECT in the treatment of depression: Wave form and electrode placement considerations 
  • Efficacy of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy (ECT): Data from Phase I of the PRIDE Study 
  • Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation [3] 
  • Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. 
  • Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies. 
  • Efficacy of olanzapine in social anxiety disorder: a pilot study. 
  • Efficacy of path-oriented psychological self-help interventions to improve mental health of empty-nest older adults in the Community of China. 
  • Efficacy of risperidone on positive features of schizophrenia. 
  • Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. 
  • Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. 
  • Efficacy of treatments for major depression. 
  • Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials. 
  • Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. 
  • Efficiency of outpatient ECT. 
  • Efficiency of the BACS and CATIE neuropsychological batteries in assessing cognition and antipsychotic treatment related change in cognition during the CAFE clinical trial 
  • Efficient trial designs to reduce placebo requirements. 
  • Eighty-five per cent of what? Discrepancies in the weight cut-off for anorexia nervosa substantially affect the prevalence of underweight. 
  • Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. 
  • Electric Field Characteristics of Low-Field Synchronized Transcranial Magnetic Stimulation (sTMS) 
  • ElectroConvulsive therapy Cognitive Assessment (ECCA) tool: A new instrument to monitor cognitive function in patients undergoing ECT. 
  • Electrocardiogram Characteristics and Their Association With Psychotropic Drugs Among Patients With Schizophrenia. 
  • Electroconvulsive Therapy and All-Cause Mortality in Texas, 1998-2013. 
  • Electroconvulsive therapy (ECT) for moderate-severity major depression among the elderly: Data from the pride study. 
  • Electroconvulsive therapy as an alternative to deep brain stimulation for medication-refractory Tourette syndrome 
  • Electroconvulsive therapy device classification: response to FDA advisory panel hearing and recommendations. 
  • Electroconvulsive therapy does not change serum CK, LD, or LD isoenzymes. 
  • Electroconvulsive therapy for severe major depressive disorder after orthotopic liver transplantation. 
  • Electroconvulsive therapy in the United States. 
  • Electroconvulsive therapy in the United States: how often is it used? 
  • Electroconvulsive therapy in the presence of brain tumor. Case reports and an evaluation of risk. 
  • Electroconvulsive therapy increases angiogenesis and neurogenesis in the monkey hippocampus 
  • Electroconvulsive therapy of depression in patients with white matter hyperintensity. 
  • Electroconvulsive therapy stimulus parameters: rethinking dosage. 
  • Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes. 
  • Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain. 
  • Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity. 
  • Electronic source materials in clinical research: acceptability and validity of symptom self-rating in major depressive disorder. 
  • Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. 
  • Elevated gray and white matter densities in cocaine abstainers compared to current users 
  • Elevated hematocrit in patients with schizophrenia. 
  • Elevated inflammation levels in depressed adults with a history of childhood maltreatment (vol 65, pg 409, 2008) 
  • Elevated inflammation levels in depressed adults with a history of childhood maltreatment. 
  • Elevated motor threshold in drug-free, cocaine-dependent patients assessed with transcranial magnetic stimulation. 
  • Elevated plasma A beta(1-42) in geriatric depression 
  • Elevated plasma concentrations of alpha 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients. 
  • Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. 
  • Eliciting recovery narratives in global mental health: Benefits and potential harms in service user participation. 
  • Elucidation of The Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons. 
  • Embedded Temporal Patterns in the Feedback Signal Differentially Predict VTA Neurofeedback-Mediated Learning to Self-Regulate Motivation 
  • Emergence of anxiety-like behaviours in depressive-like Cpe(fat/fat) mice. 
  • Emergency Department Boarding: Nowhere Else to Go. 
  • Emergency Psychiatry Experience, Resident Burnout, and Future Plans to Treat Publicly Funded Patients. 
  • Emotion recognition and social/role dysfunction in non-clinical psychosis. 
  • Emotion suppression in borderline personality disorder: an experience sampling study. 
  • Emotion: The science of sentiment 
  • Emotional antecedents of hot flashes during daily life. 
  • Emotional consequences of victimization and discrimination in "special populations" of women. 
  • Emotional distress and quality of life in caregivers of patients awaiting lung transplant. 
  • Emotional learning during dissociative states in borderline personality disorder. 
  • Emotional reactions to pain predict psychological distress in adult patients with Sickle Cell Disease (SCD). 
  • Emotional responses to interpersonal rejection. 
  • Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. 
  • Empirical assessment of the factorial structure of clinical symptoms in schizophrenic patients: formal thought disorder. 
  • Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale. 
  • Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia. 
  • Endocrine Factors in Depression 
  • Endocrine activity in air traffic controllers at work. I. Characterization of cortisol and growth hormone levels during the day. 
  • Endocrine activity in air traffic controllers at work. II. Biological, psychological and work correlates. 
  • Endocrine activity in air traffic controllers at work. III. Relationship to physical and psychiatric morbidity. 
  • Endothelial function and cardiovascular hemodynamics during stress 
  • Endothelial function and hemodynamic responses during mental stress. 
  • Endurance of Neural Response to Rewards Predicts Post-Treatment Depression Severity 
  • Enduring behavioral effects of early exposure to methylphenidate in rats. 
  • Enduring effects of adolescent drug exposure. 
  • Engaging Depressed Patients: An Essential Step in Optimizing Care. 
  • Enhanced affective aggression in genetically bred hypercholinergic rats. 
  • Enhanced behavioral response to repeated-dose cocaine in adolescent rats. 
  • Enhanced cortisol suppression following dexamethasone administration in domestic violence survivors. 
  • Enhanced endocannabinoids promote fear plasticity 
  • Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. 
  • Enhancement of rTMS Neuromodulatory Effects with Novel Waveforms Demonstrated via Controllable Pulse Parameter TMS (cTMS) 
  • Enhancing "Usual Practice" Treatment Foster Care: Findings From a Randomized Trial on Improving Youths' Outcomes 
  • Enhancing "usual practice" treatment foster care: findings from a randomized trial on improving youths' outcomes. 
  • Enhancing Cognitive Restructuring with Concurrent Repetitive Transcranial Magnetic Stimulation: A Transdiagnostic Randomized Controlled Trial. 
  • Enhancing Discovery of Genetic Variants for Posttraumatic Stress Disorder Through Integration of Quantitative Phenotypes and Trauma Exposure Information. 
  • Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design. 
  • Enhancing cognitive restructuring with concurrent fMRI-guided neurostimulation for emotional dysregulation-A randomized controlled trial. 
  • Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants. 
  • Enrolling research subjects from clinical practice: ethical and procedural issues in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. 
  • Ensuring Quality in Psychological Support (WHO EQUIP): developing a competent global workforce. 
  • Epidemiologic data and planning mental health services. A tale of two surveys. 
  • Epidemiology of child traumatic stress. 
  • Epidemiology of dysphoria and depression in an elderly population. 
  • Epidemiology of persecutory ideation in an elderly population in the community. 
  • Epidemiology of recurrent major and minor depression with a seasonal pattern. The National Comorbidity Survey. 
  • Epigenome-Wide Association of PTSD from Heterogeneous Cohorts with a Common Multi-Site Analysis Pipeline 
  • Epigenome-wide Association Study of Attention-Deficit/Hyperactivity Disorder Symptoms in Adults. 
  • Epstein-Barr virus antibodies in whole blood spots: a minimally invasive method for assessing an aspect of cell-mediated immunity. 
  • Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis - ERRATUM. 
  • Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis. 
  • Errata 
  • Erratum 
  • Erratum 
  • Erratum 
  • Erratum to "Project among African-Americans to explore risks for schizophrenia (PAARTNERS): Recruitment and assessment methods" [Schizophrenia Research 87 (1-3) (2006) 32-44] (DOI:10.1016/j.schres.2006.06.027) 
  • Erratum to: DHEA metabolism to the neurosteroid androsterone: a possible mechanism of DHEA's antidepressant action. 
  • Erratum: AKT1 and neurocognition in schizophrenia (Australian and New Zealand Journal of Psychiatry (2007) 41 (169-177)) 
  • Erratum: Comparison of post-disaster psychiatric disorders after terrorist bombings in Nairobi and Oklahoma City (British Journal of Psychiatry 186 (487-493)) 
  • Erratum: Correction of Authorship. 
  • Erratum: Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates (Archives of General Psychiatry (February 2001) 58 (199-200)) 
  • Erratum: Enhanced behavioral response to related-dose cocaine in adolescent rats (Psychopharmacology (2005) 183 (218-225) DOI: doi.org/10.1007/s00213-005- 0159-4) 
  • Erratum: Focal electrically administered seizure therapy: A novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction (Neuropsychopharmacology (2009) 34 (2002-2010) DOI: 10.1038/npp.2009.12) 
  • Erratum: Full and partial PTSD among earthquake survivors in rural Taiwan (Journal of Psychiatric Research (2005) 38 (313-322) DOI: 10.1016/j.jpsychires. 2003.08.005) 
  • Erratum: Hierarchical temporal processing deficit model of reality distortion and psychoses (Molecular Psychiatry (2011) 16, (129-144) DOI: 10.1038/mp.2010.63) 
  • Erratum: Modafinil for atypical depression: Effects of open-label and double-blind discontinuation treatment (Journal of Clinical Psychopharmacology (August 2006) 26, (373-378)) 
  • Erratum: Modafinil for atypical depression: Effects of open-label and double-blind discontinuation treatment (Journal of Clinical Psychopharmacology (August 2006) 26, (373-378)) 
  • Erratum: Novelty seeking and stereotypic activation of behavior in mice with disruption of the DatI gene (Neuropsychopharmacology (April 27, 2005), DOI:10.1038/sj.npp.1300724) 
  • Erratum: Predictors of response to monoamine oxidase inhibitors: Do they exist? (Eur Arch Psychiatry Clin Neurosci (1992) 241: 181-186) 
  • Erratum: Rates of depressive and anxiety disorders in a residential mother-infant unit for unsettled infants (Australian and New Zealand Journal of Psychiatry (2007) 41 (836-842)) 
  • Erratum: Remission of maternal depression and child symptoms among single mothers - A STAR*-child report (Social Psychiatry and Psychiatric Epidemiology (2007) vol. 42 (12) (962-971) 10.1007/s00127-007-0262-4) 
  • Erratum: Smoking withdrawal is associated with increases in brain activation during decision making and reward anticipation: A preliminary study 
  • Erratum: The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evalution in patients with chronic major depression (Biological Psychiatry 54 (573-583)) 
  • Erratum: The Cost of Assisted Outpatient Treatment: Can It Save States Money? (American Journal of Psychiatry) 
  • Erratum: VNS therapy in treatment-resistant depression: Clinical evidence and putative neurobiological mechanisms (Neuropsychopharmacology (2006) 31 (1345-1355) DOI: 10.1038/sj.npp.1301082) 
  • Erratum: alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder. 
  • Escitalopram in clinical practice: results of an open-label trial in a naturalistic setting. 
  • Escitalopram in specific phobia: results of a placebo-controlled pilot trial. 
  • Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study. 
  • Escitalopram treatment of trichotillomania. 
  • Establishing a methodology to examine the effects of war-zone PTSD on the family: the family foundations study. 
  • Establishing the Brief Assessment of Cognition - Short form. 
  • Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder. 
  • Estimating between- and within-individual variation in cortisol levels using multilevel models. 
  • Estimating prevalence of serious emotional disturbance in schools using a brief screening scale. 
  • Estimating suicidality as an outcome measure in clinical trials of suicide in schizophrenia. 
  • Estimating the prevalence of borderline personality disorder in the community 
  • Estimation of D2-like receptor occupancy by dopamine in the putamen of hemiparkinsonian Monkeys. 
  • Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. 
  • Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. 
  • Ethanol Withdrawal in Adolescent and Adult Rat 
  • Ethanol Withdrawal in Adolescent and Adult Rats 
  • Ethnic/racial differences in weight-related concerns and behaviors among adolescent girls and boys: findings from Project EAT. 
  • Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort. 
  • Etiological paradigms of depression: The relationship between perceived causes, empowerment, treatment preferences, and stigma 
  • Evaluating Suicide Risk Using the Reasons for Dying-Reasons for Living (RFD-RFL) Index in a Military Psychiatric Inpatient Setting. 
  • Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults. 
  • Evaluating medicinal herbs. 
  • Evaluating the Effectiveness of Community and Hospital Medical Record Integration on Management of Behavioral Health in the Emergency Department. 
  • Evaluation and modification of exercise patterns in the natural environment. 
  • Evaluation of Clinical Biofeedback 
  • Evaluation of Community-Based Cessation Programs: How Do Smokers with Behavioral Health Conditions Fare? 
  • Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure. 
  • Evaluation of Proactive Community Case Detection to Increase Help Seeking for Mental Health Care: A Pragmatic Randomized Controlled Trial. 
  • Evaluation of a district mental healthcare plan in a low-resource setting in Nepal: outcomes at community, facility and individual levels 
  • Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial. 
  • Evaluation of cognitive function in bipolar disorder using the Brief Assessment of Cognition in Affective Disorders (BAC-A). 
  • Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia 
  • Evaluation of outcome in brief psychotherapy 
  • Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. 
  • Evaluation of the Effects of Severe Depression on Global Cognitive Function and Memory. 
  • Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. 
  • Evaluation of the central nervous system risks of ECT 
  • Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow. 
  • Eveningness chronotype preference among individuals at clinical high risk for psychosis. 
  • Evidence for a menstrual-linked artifact in determining rates of depression 
  • Evidence for altered cerebellar vermis neuronal integrity in schizophrenia. 
  • Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. 
  • Evidence for genetic linkage of autism to chromosomes 7 and 4 
  • Evidence for impaired cortical inhibition in patients with unipolar major depression 
  • Evidence for impaired cortical inhibition in patients with unipolar major depression. 
  • Evidence for multiple loci from a genome scan of autism kindreds. 
  • Evidence for the diagnostic criteria of delirium: an update. 
  • Evidence for the segregation of a major gene for human plasma GABA levels. 
  • Evidence for the treatment of borderline personality disorder. 
  • Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index. 
  • Evidence of CNIH3 involvement in opioid dependence. 
  • Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. 
  • Evidence of causal effect of major depression on alcohol dependence: findings from the psychiatric genomics consortium. 
  • Evidence of early retinal microvascular changes in patients with type 2 diabetes and depression. 
  • Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome. 
  • Evidence of white matter tract disruption in MRI hyperintensities. 
  • Evidence report on: Treatment of depression - Newer pharmacotherapies 
  • Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk. 
  • Evidence-based decision-making in psychopharmacology. 
  • Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. 
  • Evidence-based mental health use of anticonvulsants during pregnancy. 
  • Evidence-based mental health. 
  • Evidence-based practice in child and adolescent mental health services. 
  • Evidence-based practice: how to evaluate what you read. 
  • Evidence-based treatment of psychiatric disorders with comorbid medical illnesses: the need for large simple clinical trials. 
  • Evolving approaches to management of osteoarthritis 
  • Examination of Treatment Effects on Hazardous Drinking Among Service Members With Posttraumatic Stress Disorder. 
  • Examination of the indirect effects of combat exposure on suicidal behavior in veterans. 
  • Examining DSM criteria for trichotillomania in a dimensional framework: implications for DSM-5 and diagnostic practice. 
  • Examining suicide assessment measures for research use: Using item response theory to optimize psychometric assessment for research on suicidal ideation in major depressive disorder. 
  • Examining the Crux of Autonomic Dysfunction in Posttraumatic Stress Disorder: Whether Chronic or Situational Distress Underlies Elevated Heart Rate and Attenuated Heart Rate Variability. 
  • Examining the Overlap Between Moral Injury and PTSD in US Veterans and Active Duty Military. 
  • Examining the Unanticipated Adverse Consequences of Youth Suicide Prevention Strategies: A Literature Review with Recommendations for Prevention Programs. 
  • Examining the effects of initial smoking abstinence on response to smoking-related stimuli and response inhibition in a human laboratory model. 
  • Examining the relationship between adjunctive psychotherapy use and antipsychotic persistence and hospitalization. 
  • Examining the relationship between negative affect and posttraumatic stress disorder symptoms among smokers using ecological momentary assessment. 
  • Exclusion criteria of DSM-III. A study of co-occurrence of hierarchy-free syndromes. 
  • Executive control, ERP and pro-inflammatory activity in emotionally exhausted middle-aged employees. Comparison between subclinical burnout and mild to moderate depression. 
  • Exercise Prescription Practices to Improve Mental Health. 
  • Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study. 
  • Exercise and pharmacotherapy in the treatment of major depressive disorder. 
  • Exercise therapy for the prevention and treatment of depression 
  • Exercise training in healthy type A middle-aged men: effects on behavioral and cardiovascular responses. 
  • Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. 
  • Expanded studies of the pharmacokinetics and clinical effects of multidose sublingual triazolam in healthy volunteers. 
  • Experiences of VA vocational and education training and assistance services: Facilitators and barriers reported by veterans with disabilities. 
  • Experiences of health care costs among people with employer-sponsored insurance and bipolar disorder. 
  • Experiential Sampling in the Study of Multiple Personality Disorder 
  • Experiential avoidance is associated with medical and mental health diagnoses in a national sample of deployed Gulf War veterans. 
  • Experimental therapeutics and biological psychiatry 
  • Explained and unexplained medical symptoms in generalized anxiety and panic disorder: relationship to the somatoform disorders. 
  • Explaining rare acts of violence: the limits of evidence from population research. 
  • Explanatory models and mental health treatment: is vodou an obstacle to psychiatric treatment in rural Haiti? 
  • Exploration of NO₂ and PM_2.5 air pollution and mental health problems using high-resolution data in London-based children from a UK longitudinal cohort study. 
  • Exploration of the resilience construct in posttraumatic stress disorder severity and functional correlates in military combat veterans who have served since September 11, 2001. 
  • Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis. 
  • Exploratory investigation of biomarker candidates for suicide in schizophrenia and bipolar disorder. 
  • Exploring common changes after acute mental stress and acute tryptophan depletion: Resting-state fMRI studies. 
  • Exploring the Impact of Religion and Spirituality on Mental Health and Coping in a Group of Canadian Psychiatric Outpatients. 
  • Exploring the relationship between posttraumatic stress disorder symptoms and momentary heart rate variability. 
  • Exploring the role of age as a moderator of cognitive remediation for people with schizophrenia. 
  • Exploring the role of anger in nonsuicidal self-injury in veterans. 
  • Exposure to Smoking Context Potentiates Habitual Motor Response 
  • Exposure to violence during childhood is associated with telomere erosion from 5 to 10 years of age: a longitudinal study. 
  • Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study. 
  • Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. 
  • Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials. 
  • Extrapyramidal side-effects of antipsychotics in a randomised trial. 
  • Eye movement impairment and schizotypal psychopathology. 
  • Eye tracking impairment in clinically identified patients with schizotypal personality disorder. 
  • Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia. 
  • Eye-tracking, attention and amphetamine challenge 
  • F113. Hippocampal Connectivity Insulates High-Risk Adolescents From the Relationship Between Stress and Depressive Symptoms 
  • F14. Neurostimulation Enhanced Cognitive Restructuring: A Proof of Concept Study 
  • F2. White Matter Lesions are Common in Midlife and Associated With Cognitive Decline 
  • FACS analysis of neuronal-glial interactions in the nucleus accumbens following morphine administration. 
  • FDA considers classification of ECT. 
  • FINDING THE SITES OF GLUTAMATE CIRCUITRY ABNORMALITY IN SCHIZOPHRENIA WITH PROTON MRS 
  • FRONTAL CORTEX GABA, OSCILLATIONS, AND WORKING MEMORY IN SCHIZOPHRENIA 
  • Facets of openness predict mortality in patients with cardiac disease. 
  • Facial expressions and EEG in infants of intrusive and withdrawn mothers with depressive symptoms. 
  • Facial expressions of emotion reveal neuroendocrine and cardiovascular stress responses. 
  • Facial expressions of emotion reveal neuroendocrine and cardiovascular stress responses. 
  • Facilitated Psychiatric Advance Directives: A Randomized Trial of an Intervention to Foster Advance Treatment Planning Among Persons with Severe Mental Illness 
  • Facilitated psychiatric advance directives: a randomized trial of an intervention to foster advance treatment planning among persons with severe mental illness. 
  • Facilitation of Psychiatric Advance Directives by Peers and Clinicians on Assertive Community Treatment Teams. 
  • Factor Structure and Psychometric Properties of the Peritraumatic and Posttraumatic Emotions Questionnaires Among Active Duty Military Personnel With Posttraumatic Stress Disorder. 
  • Factor Structure of the Hamilton Depression Rating Scale During Electroconvulsive Therapy and Magnetic Seizure Therapy in the Treatment of Major Depression 
  • Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets. 
  • Factor structure of cognitive performance and functional capacity in schizophrenia: Evidence for differences across functional capacity measures. 
  • Factor structure of the positive and negative syndrome scale (PANSS) in people at ultra high risk (UHR) for psychosis. 
  • Factorial invariance of posttraumatic stress disorder symptoms across three veteran samples. 
  • Factors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, Brazil. 
  • Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. 
  • Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report. 
  • Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. 
  • Factors that differentiate early vs. later onset of major depression disorder. 
  • Failure of glucagon-like peptide-1 to induce panic attacks or anxiety in patients with panic disorder. 
  • Failure of isocarboxazid and haloperidol to alleviate delusional depression in a pilot study. 
  • Failures in learning-dependent predictive perception as the key cognitive vulnerability to psychosis in schizophrenia. 
  • Familial influence and childhood trauma in female alcoholism. 
  • Familial leukoencephalopathy in bipolar disorder. 
  • Familial psychiatric illness in chronic posttraumatic stress disorder. 
  • Familial schizophrenia and treatment response. 
  • Family history of completed suicide and characteristics of major depressive disorder: A STAR*D (sequenced treatment alternatives to relieve depression) study 
  • Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study. 
  • Family history of depression and therapeutic outcome: findings from STAR*D. 
  • Family history of hypertension influences neurobehavioral function in hypertensive patients. 
  • Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study. 
  • Family history of psychiatric disorder and low self-confidence: predictors of depressive symptoms at 12-month follow-up. 
  • Fast feedback regulation of ACTH by cortisol. 
  • Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. 
  • Fear Learning Circuitry in PTSD is Biased Toward Generalization of Conditioned Response 
  • Fear and anxiety from principle to practice: implications for when to treat youth with anxiety disorders. 
  • Feasibility and effectiveness of cognitive-behavioral therapy for posttraumatic stress disorder in preschool children: two case reports. 
  • Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. 
  • Feasibility of client reports to measure treatment outcome in schizophrenia. 
  • Feedback to physicians plus telephone care management improved outcomes in primary care patients with depression: Commentary 
  • Female gender is associated with impaired quality of life 1 year after coronary artery bypass surgery. 
  • Fetal brain development of twins assessed in utero by ultrasound: implications for schizophrenia. 
  • Fetal brain development of twins assessedIn utero by ultrasound 
  • Financial Stressors During the Great Recession and Subsequent Risk of Early Mortality. 
  • Fink M. Electroconvulsive Therapy 
  • First- and second-generation antipsychotics. 
  • First-line pharmacotherapy approaches for generalized anxiety disorder. 
  • Fish oil, blood vessels, and depression. 
  • Five-year follow-up of the myocaridal ischemia intervention trial: Clinical outcomes and economic analysis 
  • Fixed versus seizure threshold-based dosing of right unilateral ECT. 
  • Flexible dosing schedules for continuation electroconvulsive therapy. 
  • Flexible system criteria in chronic schizophrenia 
  • Flexible treatment strategies in chronic disease: clinical and research implications. 
  • Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. 
  • Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders. 
  • Fluoxetine Alleviates Behavioral Depression while Decreasing Acetylcholine Release in the Nucleus Accumbens Shell 
  • Fluoxetine and oculomotor activity during sleep in depressed patients. 
  • Fluoxetine in child and adolescent depression: acute and maintenance treatment. 
  • Fluoxetine in post-traumatic stress disorder 
  • Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. 
  • Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. 
  • Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. 
  • Fluoxetine versus trazodone in the treatment of outpatients with major depression. 
  • Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. 
  • Fluvoxamine in civilians with posttraumatic stress disorder. 
  • Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder. 
  • Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. 
  • Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. 
  • Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder. 
  • Fluxetine, comprehensive cognitive behavioral therapy (CCBT) and placebo in generalized social phobia 
  • Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study. 
  • Focal brain dysfunction in a 41-year old man with familial alternating hemiplegia. 
  • Focal brain stimulation with repetitive transcranial magnetic stimulation (rTMS): implications for the neural circuitry of depression. 
  • Focal electrically administered seizure therapy: a novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction. 
  • Focal prefrontal seizures induced by bilateral ECT. 
  • Focality of Neural Stimulation with Magnetic Seizure Therapy (MST) and Electroconvulsive Therapy (ECT) in Humans and Non-Human Primates 
  • Focus on social anxiety disorder: Introduction 
  • Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment. 
  • Foreword. After the tsunami: mental health challenges to the community for today and tomorrow. 
  • Forms of atypical depression and their response to antidepressant drugs. 
  • Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. 
  • Free triiodothyronine (T3) and thyroxine (T4) in a group of unipolar depressed patients and normal subjects. 
  • Frequency-Dependent Effects of rTMS on Neurogenesis, Synaptic Plasticity, and Behavior 
  • From Circuits to the Clinic: Bridging Systems Neuroscience with the Practice of Psychiatry through Neuromodulation 
  • From Good Habit to Bad: Corticostriatal Synaptic and Circuit Mechanisms in Habit and Compulsion 
  • From scientific knowledge to the clinical practice of psychopharmacology: can the gap be bridged? 
  • Front line workers' attitudes towards psychiatric advance directives. 
  • Frontal Cortex GABA and Glutamate-Glutamine Levels in Schizophrenia Measured with Magnetic Resonance Spectroscopy 
  • Frontal functioning and plasma HVA in the relatives of schizophrenic patients 
  • Frontiers in TMS technology development: Controllable pulse shape TMS (cTMS) and magnetic seizure therapy (MST) at 100 Hz 
  • Frontomedial electrode placement with low current amplitude: a case report 
  • Frontoparietal attentional network activation differs between smokers and nonsmokers during affective cognition. 
  • Full and partial PTSD among earthquake survivors in rural Taiwan. 
  • Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies. 
  • Functional MRI assessment of atypical and conventional antipsychotic effects on cognitive function in schizophrenia patients 
  • Functional brain activation to emotionally valenced faces in school-aged children with a history of preschool-onset major depression. 
  • Functional changes in the activity of brain regions underlying emotion processing in the elderly. 
  • Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. 
  • Functional correlates of military sexual assault in male veterans. 
  • Functional disability, depression, and suicidal ideation in older prisoners. 
  • Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing 
  • Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing. 
  • Functional impairment and utilization of services associated with posttraumatic stress in the community. 
  • Functional magnetic resonance imaging guided transcranial magnetic stimulation in obsessive-compulsive disorder. 
  • Functional neuroimaging of emotionally intense autobiographical memories in post-traumatic stress disorder. 
  • Functional neuroimaging of social and executive processes in individuals with autism 
  • Functional organization of activation patterns in children: whole brain fMRI imaging during three different cognitive tasks. 
  • Functional outcomes and characteristics of olanzapine cognitive super-responders 
  • Functional outcomes in schizophrenia. 
  • Functional status in depressed patients: the relationship to disease severity and disease resolution. 
  • Functioning and interpersonal relationships as predictors of response in treatment-resistant depression. 
  • Funeral mania in recurrent bipolar affective disorders: Reports of three cases 
  • Funeral mania in recurrent bipolar affective disorders: reports of three cases. 
  • Further discussion of EMDR for treatment of PTSD. 
  • Further evidence for a role of the ADRB2 gene in risk for posttraumatic stress disorder. 
  • Further genetic characterization of the fawn-hooded (FH/Wjd) rat, an animal model of comorbid depression and alcoholism. 
  • Further psychometric assessment of the TOP-8: a brief interview-based measure of PTSD. 
  • Further selection of rat lines differing in 5-HT-1A receptor sensitivity: behavioral and functional correlates. 
  • Further studies on platelet serotonin transporter binding in depression. 
  • Future directions in primary care/mental health research 
  • GABA AND GLUTAMATE DYSFUNCTION IN SCHIZOPHRENIA: DISTINGUISHING MEDICATION EFFECTS FROM NEUROBIOLOGY 
  • GABA AND GLUTAMATE-GLUTAMINE LEVELS IN THE FRONTAL CORTEX IN SCHIZOPHRENIA: A MAGNETIC RESONANCE SPECTROSCOPY STUDY 
  • GABA, genes and depression 
  • GENDER AND FAMILY HISTORY (FH) OF CARDIOVASCULAR (CV) DISEASE MODULATE THE EXPRESSION OF CV AND NEUROENDOCRINE (NE) HYPERREACTIVITY TO BEHAVIORAL CHALLENGES AMONG TYPE-A PERSONS 
  • GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder. 
  • GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium. 
  • GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium. 
  • Gabapentin in the treatment of mental illness: the echo chamber of the case series. 
  • Galantamine for treatment-resistant schizophrenia [3] 
  • Gamma Oscillations and Excitation/Inhibition Imbalance: Parallel Effects of NMDA Receptor Antagonism and the Psychosis Risk Syndrome 
  • Gas exchange and exercise capacity affect neurocognitive performance in patients with lung disease. 
  • Gender difference in cocaine-induced HPA axis activation. 
  • Gender differences in antidepressant and activating-drug effects on self-perceptions 
  • Gender differences in associations between DSM-5 posttraumatic stress disorder symptom clusters and functional impairment in war veterans. 
  • Gender differences in blood pressure control during a variety of behavioral stressors. 
  • Gender differences in depression: findings from the STAR*D study. 
  • Gender differences in hepatitis C infection and risks among persons with severe mental illness. 
  • Gender differences in posttraumatic stress symptoms among OEF/OIF veterans: an item response theory analysis. 
  • Gender, concurrent estrogen use and cognition in Alzheimer's disease 
  • Gender, depressive subtypes, and gender-age effects on antidepressant response: Hormonal hypotheses 
  • Gender, hostility & lymphocyte CD62L 
  • Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention. 
  • Gene-educational attainment interactions in a multi-ancestry genome-wide meta-analysis identify novel blood pressure loci. 
  • Gene-environment interactions in psychiatry: joining forces with neuroscience. 
  • General Anxiety Disorder-7 Questionnaire as a marker of low socioeconomic status and inequity. 
  • General and specific cognitive deficits in bipolar depression: the Brief Assessment of Cognition in Affective Disorders (BAC-A) 
  • General aspects of the history of psychiatry 
  • General medical and specialty mental health service use for major depression. 
  • General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. 
  • Generalizability of Pharmacologic and Psychotherapy Clinical Trial Results for Posttraumatic Stress Disorder to Community Samples. 
  • Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis. 
  • Generalized anxiety disorder and depression: childhood risk factors in a birth cohort followed to age 32. 
  • Generalized anxiety disorder and panic disorder in the elderly: a review. 
  • Generalized anxiety disorder: acute and chronic treatment. 
  • Generalized anxiety disorder: nature and course. 
  • Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. 
  • Generalized social anxiety disorder and avoidant personality disorder: structural analysis and treatment outcome. 
  • Genetic Moderation of Stress Effects on Corticolimbic Circuitry. 
  • Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. 
  • Genetic and hormonal sensitivity to threat: testing a serotonin transporter genotype × testosterone interaction. 
  • Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. 
  • Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. 
  • Genetic correlates of insight in schizophrenia. 
  • Genetic deletion of Rgs12 in mice affects serotonin transporter expression and function in vivo and ex vivo. 
  • Genetic influences on eight psychiatric disorders based on family data of 4 408 646 full and half-siblings, and genetic data of 333 748 cases and controls - CORRIGENDUM. 
  • Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. 
  • Genetic polymorphisms in the dopamine system predict heterogeneity in intelligence and adult prognosis among children with attention-deficit hyperactivity disorder: Evidence from two birth cohorts 
  • Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. 
  • Genetic variants in 5-HTTLPR, BDNF, HTR1A, COMT, and FKBP5 and risk for treated depression after cancer diagnosis. 
  • Genetic variants in SLC9A9 are associated with measures of attention-deficit/hyperactivity disorder symptoms in families. 
  • Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB. 
  • Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB. 
  • Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. 
  • Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. 
  • Genetic vulnerability to affective psychopathology in childhood: a combined voxel-based morphometry and functional magnetic resonance imaging study. 
  • Genetics and the future of clinical psychiatry. 
  • Genetics of the human circadian clock and sleep homeostat. 
  • Geniculocalcarine hyperintensities on brain magnetic resonance imaging associated with visual hallucinations in the elderly. 
  • Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts. 
  • Genome-Wide Association of Neuroimaging Phenotypes in PTSD at Multiple Sites 
  • Genome-scale technologies foster advances in neurological and behavioral research 
  • Genome-wide DNA methylation profiling in monozygotic twins discordant for psychotic symptoms at age 12 
  • Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders. 
  • Genome-wide association study identifies a novel locus for cannabis dependence. 
  • Genome-wide association study of bipolar I disorder in the Han Chinese population. 
  • Genome-wide association study of obsessive-compulsive disorder. 
  • Genome-wide association study of posttraumatic stress disorder in a cohort of Iraq-Afghanistan era veterans. 
  • Genome-wide association study of suicide attempts in mood disorder patients. 
  • Genome-wide meta-analysis of macronutrient intake of 91,114 European ancestry participants from the cohorts for heart and aging research in genomic epidemiology consortium. 
  • Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. 
  • Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. 
  • Genomic Approaches to Posttraumatic Stress Disorder: The Psychiatric Genomic Consortium Initiative. 
  • Genomic screen for Autistic Disorder. 
  • Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression. 
  • Genotypic Differences in Angiotensin Receptor Genes in Late-Life Depression 
  • Geotemporal analysis of perinatal care changes and maternal mental health: an example from the COVID-19 pandemic. 
  • Gepirone extended-release in the treatment of adult outpatients with major depressive disorder: a double-blind, randomized, placebo-controlled, parallel-group study. 
  • Geriatric Psychiatry 
  • Geriatric Psychiatry. 
  • Geriatric depression and cognitive impairment. 
  • Geriatric depression: Further evidence for the 'vascular depression' hypothesis 
  • Geriatric psychiatry matures: Advantages and problems as the psychiatry of old age grows older 
  • Geriatric syndromes: An introduction 
  • Gestational and postnatal tobacco smoke exposure as predictor of ADHD, comorbid ODD/CD, and treatment response in the MTA 
  • Gestational dexamethasone treatment elicits sex-dependent alterations in locomotor activity, reward-based memory and hippocampal cholinergic function in adolescent and adult rats. 
  • Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse. 
  • Global Mental Health: Five Areas for Value-Driven Training Innovation. 
  • Glutamatergic dysfunction in OCD. 
  • Good news in the battle against military suicide. 
  • Graph Theoretical Analysis of Peritreatment Resting EEG in Depressed Patients Receiving Electroconvulsive Therapy and Magnetic Seizure Therapy 
  • Gray and white matter brain chemistry in young children with autism. 
  • Greater MRI lesion volumes in elderly depressed subjects than in control subjects. 
  • Group cognitive processing therapy delivered to veterans via telehealth: a pilot cohort. 
  • Growth hormone response to baclofen: a comparison of 10-mg and 20-mg doses in healthy men. 
  • Growth hormone-releasing factor stimulation test in depression. 
  • Guanfacine and secondary mania in children. 
  • Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus. 
  • Guideline series commentary [4] (multiple letters) 
  • Guideline-concordant antidepressant use among patients with major depressive disorder. 
  • Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic. 
  • Guidelines for treatment of PTSD. 
  • Guidelines on nicotine dose selection for in vivo research. 
  • Guns, Mental Illness, and the Law: Introduction to This Issue. 
  • HIGH SCORES ON THE COOK AND MEDLEY HOSTILITY (HO) SCALE PREDICT INCREASED CARDIOVASCULAR-RESPONSES TO HARASSMENT 
  • HIGH WORK DEMANDS AND DEPRESSION: THE MODERATING ROLE OF THE SEROTONIN TRANSPORTER GENE (5-HTT) AND WORK CONTROL 
  • HOSTILITY IS ASSOCIATED WITH LYMPHOCYTE BETA2 ADRENERGIC-RECEPTOR ADENYLATE-CYCLASE ACTIVITY 
  • Haase hermeneutics, or, the exegesis of the neuroleptic threshold. 
  • Habitual anger-coping styles: I. Effect on mean blood pressure and risk for essential hypertension. 
  • Haloperidol increases smoking in patients with schizophrenia. 
  • Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes. 
  • Handbook of Clinical Child Neuropsychology, 3rd ed 
  • Handbook of Spirituality and Worldview in Clinical Practice 
  • Handbook of the Sociology of Mental Health 
  • Harnessing the microbiota to treat neurological diseases
. 
  • Hazardous alcohol use and receipt of risk-reduction counseling among U.S. veterans of the wars in Iraq and Afghanistan. 
  • Head computed tomography interpretation in trauma: a primer. 
  • Head injury and combat-related posttraumatic stress disorder. 
  • Head injury in early adulthood and the lifetime risk of depression. 
  • Health care infrastructure post-Katrina: disaster planning to return health care workers to their home communities. 
  • Health reform in the private sector: initiatives of the American Managed Behavioral Healthcare Association. 
  • Health status, somatization, and severity of posttraumatic stress disorder in Vietnam combat veterans with posttraumatic stress disorder. 
  • Health-related quality of life in depression: a STAR*D report. 
  • Healthcare barriers among severely mentally ill homeless adults: evidence from the five-site health and risk study. 
  • Hearing Loss: The Silent Risk for Psychiatric Disorders in Late Life. 
  • Hearing loss and psychiatric disorders: a review. 
  • Heart rate turbulence, depression, and survival after acute myocardial infarction. 
  • Heightened connectivity between the ventral striatum and medial prefrontal cortex as a biomarker for stress-related psychopathology: understanding interactive effects of early and more recent stress. 
  • Hematocrit and anxiety 
  • Hemodynamic mechanisms of mental stress-induced ischemia 
  • Hepatitis C and depressive symptoms: psychological and social factors matter more than liver injury. 
  • Heritability of functioning in families with schizophrenia in relation to neurocognition. 
  • Heterogeneity in the response pattern of organ systems to stress: Mediators and mechanisms 
  • Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications. 
  • Heterogeneity of tardive dyskinesia. A multivariate analysis. 
  • Hierarchical temporal processing deficit model of reality distortion and psychoses. 
  • High dose magnetic seizure therapy (HD-MST) increases mossy fiber sprouting but not cellular proliferation in the primate dentate gyrus 
  • High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. 
  • High users of outpatient mental health services, I: Definition and characteristics. 
  • High-Deductible Health Plans Paired With Health Savings Accounts Increased Medication Cost Burden Among Individuals With Bipolar Disorder. 
  • High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. 
  • High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial. 
  • High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study. 
  • High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. 
  • High-frequency prefrontal repetitive transcranial magnetic stimulation for the negative symptoms of schizophrenia: a case series. 
  • High-frequency repetitive TMS for suicidal ideation in adolescents with depression. 
  • Higher levels of CSF homovanillic acid in recently abstinent cocaine-dependent patients. 
  • Hippocampal abnormalities in depression. 
  • Hippocampal and Insular Response to Smoking-Related Environments: Neuroimaging Evidence for Drug-Context Effects in Nicotine Dependence. 
  • Hippocampal and striatal gray matter volume are associated with a smoking cessation treatment outcome: results of an exploratory voxel-based morphometric analysis. 
  • Hippocampal cellular proliferation and cognitive outcome following magnetic seizure therapy and electroconvulsive shock 
  • Hippocampal plasticity following ECT: Towards a theory of antidepressant action 
  • Hippocampal plasticity following chronic repetitive transcranial magnetic stimulation. 
  • Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. 
  • Hippocampal volume and volume asymmetry prospectively predict PTSD symptom emergence among Iraq-deployed soldiers. 
  • Hippocampal volume in geriatric depression. 
  • Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. 
  • Hippocampal volumes and depression subtypes. 
  • Hispanic ethnicity, language, and depression: physician-patient communication and patient use of alternative treatments. 
  • History of depression and survival after acute myocardial infarction. 
  • History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study. 
  • History of depressive and/or anxiety disorders as a predictor of treatment response: a post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia. 
  • History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release. 
  • Homeopathic and psychiatric perspectives on grief. 
  • Homeopathic treatments in psychiatry: a systematic review of randomized placebo-controlled studies. 
  • Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naive Patients with Schizophrenia 
  • Homoclites revisited: the search for identification in hospitalized young adult patients. 
  • Hospital stressors experienced by elderly medical inpatients: developing a Hospital Stress Index. 
  • Hospitalized schizophrenic patient views about seclusion. 
  • Hostility and adrenergic receptor responsiveness: evidence of reduced beta-receptor responsiveness in high hostile men. 
  • Hostility and fasting glucose in African American women. 
  • Hostility and functional health status in women veterans with and without posttraumatic stress disorder: a preliminary study. 
  • Hostility and heart disease: Williams et al. (1980). 
  • Hostility and minimal model of glucose kinetics in African American women. 
  • Hostility and platelet reactivity in individuals without a history of cardiovascular disease events. 
  • Hostility and risk for disease 
  • Hostility as a predictor of survival in patients with coronary artery disease. 
  • Hostility is related to blunted beta-adrenergic receptor responsiveness among middle-aged women. 
  • Hostility, CHD incidence, and total mortality: a 25-year follow-up study of 255 physicians. 
  • Hostility, coronary risk, and alpha-adrenergic to beta-adrenergic receptor density ratio - Response 
  • Hostility, coronary risk, and alpha-adrenergic to beta-adrenergic receptor density ratio. 
  • Hostility, social support, and adrenergic receptor responsiveness among African-American and white men and women. 
  • Household responsibilities, income, and ambulatory blood pressure among working men and women. 
  • How Do Astrocytes Shape Synaptic Circuits? 
  • How Does Electroconvulsive Therapy Work? 
  • How changes in physical activity relate to fatigue interference, mood, and quality of life during treatment for non-metastatic breast cancer. 
  • How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. 
  • How competent are non-specialists trained to integrate mental health services in primary care? Global health perspectives from Uganda, Liberia, and Nepal. 
  • How do mental health courts work? 
  • How does deep brain stimulation work? 
  • How etiological explanations for depression impact perceptions of stigma, treatment effectiveness, and controllability of depression. 
  • How is recovery from social anxiety disorder defined?: Comments 
  • How kids are different: Child and adolescent services under managed care 
  • How mental health providers see managed care. 
  • How much does love really hurt? Psychopathology and romantic relationships: A meta-analysis 
  • How much haldol D does Larry really need? [5] 
  • How objective is medical practice? 
  • How primary care physicians treat psychiatric disorders: a national survey of family practitioners. 
  • How reviews covered the unfolding scientific story of gabapentin for bipolar disorder. 
  • How should DSM-V criteria for schizophrenia include cognitive impairment? 
  • How should we construct psychiatric family history scores? A comparison of alternative approaches from the Dunedin Family Health History Study. 
  • How should we implement psychiatric advance directives? Views of consumers, caregivers, mental health providers and researchers. 
  • How should we teach psychopharmacology to residents? Results of the initial experience with the ASCP model curriculum 
  • How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS. 
  • How the circadian rhythm affects sleep, wakefulness, and overall health: background for understanding shift work disorder. 
  • How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south. 
  • How well does cognitive-behavioral therapy treat symptoms of complex PTSD? An examination of child sexual abuse survivors within a clinical trial. 
  • Human choline transporter gene variation is associated with corticolimbic reactivity and autonomic-cholinergic function. 
  • Human plasma B-endorphin through the menstrual cycle 
  • Human resource issues in rural mental health services. 
  • Humanistic Stories About the Workplace and Resident Wellness: a Missing Connection? 
  • Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist. 
  • Hypercortisolemia and hippocampal changes in depression. 
  • Hypercortisolism associated with social subordinance or social isolation among wild baboons. 
  • Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial. 
  • Hyperhidrosis in social anxiety disorder. 
  • Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review. 
  • Hyperintense lesions on magnetic resonance images in bipolar disorder. 
  • Hypertension affects neurobehavioral functioning. 
  • Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA. 
  • Hypochondriacal patients' beliefs about good health. 
  • Hypogyrification and its association with cognitive impairment in children with 22q11.2 deletion Syndrome: A preliminary report. 
  • Hypomania following withdrawal of trazodone. 
  • Hypothalamic-pituitary-adrenal axis dysfunction in non-clinical psychosis. 
  • Hypothalamic-pituitary-adrenal axis genetic variation and early stress moderates amygdala function. 
  • Hysterectomy and loss of fertility: implications for women's mental health. 
  • Hysterical psychosis and epilepsy: differential diagnosis. 
  • IN MEMORIAM Marc Caron 1946-2022. 
  • INCREASED DEPRESSION AND ANXIETY ARE ASSOCIATED WITH LOWER LIPIDS 
  • INTRAVASCULAR FOOD REWARD 
  • IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness. 
  • IV nicotine self-administration in rats using a consummatory operant licking response: sensitivity to serotonergic, glutaminergic and histaminergic drugs. 
  • Ictal EEG Correlates of Neurocognitive Outcome in Electroconvulsive Therapy and Magnetic Seizure Therapy 
  • Ictal Theta Power as an Electroconvulsive Therapy Safety Biomarker: A Pilot Study. 
  • Identification of borderline personality disorder with the NIMH Diagnostic Interview Schedule. 
  • Identification of patients with recent-onset psychosis in KwaZulu Natal, South Africa: a pilot study with traditional health practitioners and diagnostic instruments. 
  • Identifying adolescents at risk for depression: Assessment of a global prediction model in the Great Smoky Mountains Study. 
  • Identifying and Referring Youths at Risk for Suicide Following Participation in School-Based Gatekeeper Training. 
  • Identifying clinical competencies that support rehabilitation and empowerment in individuals with severe mental illness. 
  • Identifying core curricular components for behavioral health training in internal medicine residency: Qualitative interviews with residents, faculty, and behavioral health clinicians. 
  • Identifying depressed older adults in primary care: a secondary analysis of a multisite randomized controlled trial. 
  • Identifying depression in primary care: a literature synthesis of case-finding instruments. 
  • Identifying illness: pitfalls and discoveries. 
  • Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics. 
  • Identifying patterns of symptom change during a randomized controlled trial of cognitive processing therapy for military-related posttraumatic stress disorder. 
  • Identifying physicians most likely to benefit from depression education 
  • Identifying priorities for patient-centered outcomes research for serious mental illness. 
  • Identifying risk factors and detection strategies for adolescent depression in diverse global settings: A Delphi consensus study. 
  • Identifying risk for attrition during treatment for depression. 
  • Illness behavior as a predictor of pain and overt behavior patterns in chronic low back pain patients. 
  • Images in psychiatry 
  • Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential. 
  • Imaging and genetics advances in understanding geriatric depression. 
  • Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. 
  • Imaging genetics offers new predictive markers of individual differences in behavior and risk for psychiatric diseases 
  • Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. 
  • Imaging in acquired immune deficiency syndrome dementia complex (AIDS dementia complex): a review. 
  • Immediate postictal effects of ECT on cerebral perfusion 
  • Immigrant youth face barriers accessing mental health services in outpatient settings 
  • Immune function, cortisol, and cognitive decline & dementia in an aging latino population. 
  • Impact of Daily Caffeine on Actigraphically-Measured Sleep Duration Among Adolescents With and Without Attention-Deficit/Hyperactivity Disorder 
  • Impact of High-Deductible Health Plans on Medication Use Among Individuals With Bipolar Disorder. 
  • Impact of Narrative Expressive Writing on Heart Rate, Heart Rate Variability, and Blood Pressure After Marital Separation. 
  • Impact of Racial Discrimination and Hostility on Adrenergic Receptor Responsiveness in African American Adults. 
  • Impact of an Alcohol Withdrawal Treatment Pathway on Hospital Length of Stay: A Retrospective Observational Study Comparing Pre and Post Pathway Implementation. 
  • Impact of antipsychotic medication on family burden in schizophrenia: longitudinal results of CATIE trial. 
  • Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1. 
  • Impact of childhood maltreatment on outcomes of antidepressant medication in chronic and/or recurrent depression. 
  • Impact of depressive symptoms on the treatment of generalized social anxiety disorder. 
  • Impact of early intervention on psychopathology, crime, and well-being at age 25. 
  • Impact of generalized social anxiety disorder in managed care. 
  • Impact of integrated district level mental health care on clinical and functioning outcomes of people with depression and alcohol use disorder in Nepal: a non-randomised controlled study. 
  • Impact of late-life depression on the social network. 
  • Impact of neuroleptic medications on continuous performance test measures in schizophrenia. 
  • Impact of outpatient commitment on victimization of people with severe mental illness. 
  • Impact of patients' psychiatric hospitalization on caregivers: a systematic review. 
  • Impact of physician names on missed appointments in psychiatry resident clinics: A pilot study 
  • Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders. 
  • Impact of psychiatric advance directive facilitation on mental health consumers: empowerment, treatment attitudes and the role of peer support specialists. 
  • Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS). 
  • Impact of psychological stress on the associations between apolipoprotein E variants and metabolic traits: findings in an American sample of caregivers and controls. 
  • Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia. 
  • Impact of short access nicotine self-administration on expression of α4β2* nicotinic acetylcholine receptors in non-human primates. 
  • Impact of sleep complaints and depression outcomes among participants in the standard medical intervention and long-term exercise study of exercise and pharmacotherapy for depression. 
  • Impact of sleep quality on amygdala reactivity, negative affect, and perceived stress. 
  • Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. 
  • Impact of structured clinical interviews on physicians' practices in community mental health settings. 
  • Impacting late life depression: integrating a depression intervention into primary care. 
  • Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder. 
  • Impaired cortical inhibition in patients with unipolar major depression: evidence from transcranial magnetic stimulation of the motor cortex 
  • Impaired cortical inhibition in patients with unipolar major depression: evidence from transcranial magnetic stimulation of the motor cortex 
  • Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia. 
  • Impaired plasmalogens in patients with schizophrenia. 
  • Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report. 
  • Implementation considerations for multisite clinical trials with cognitive neuroscience tasks. 
  • Implementation of multifamily group treatment for veterans with traumatic brain injury. 
  • Implementation of the Texas Medication Algorithm Project patient and family education program. 
  • Implementing Integrated Mental Health and Chaplain Care in a National Quality Improvement Initiative. 
  • Implementing Psychiatric Advance Directives: The Transmitter and Receiver Problem and the Neglected Right to Be Deemed Incapable. 
  • Implementing a disease management intervention for depression in primary care: a random work sampling study. 
  • Implementing evidence-based practices for persons with severe mental illnesses. 
  • Implementing guidelines and systems of care: Experiences with the Texas Medication Algorithm Project (TMAP) 
  • Implementing practice guidelines for depression: applying a new framework to an old problem. 
  • Implications of health care reform for rural mental health services. 
  • Improved attention is associated with reductions in frontal lobe lactate levels in first episode psychosis 
  • Improved attention is associated with reductions in frontal lobe lactate levels in first episode psychosis 
  • Improvement in Depression Ratings after the First Electroconvulsive Therapy (ECT): Preliminary Data from Phase I of the PRIDE Study 
  • Improvement of anger at one week predicts the effects of sertraline and placebo in PTSD. 
  • Improving Depression Outcome by Patient-Centered Medical Management. 
  • Improving care for late-life depression: Results from a randomized controlled trial with 1,801 depressed older adults (presented in cooperation with the IMPACT Project Investigators) 
  • Improving depression outcomes in older adults with comorbid medical illness. 
  • Improving detection and treatment of mental disorders in community settings: development, validation and evaluation of community informant detection tool in Nepal 
  • Improving mental health and substance abuse services for adolescents 
  • Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. 
  • Improving the chance of recovery from the short- and long-term consequences of depression. 
  • Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. 
  • Improving understanding of research consent disclosures among persons with mental illness 
  • Impulsivity and neuroendocrine response to buspirone in bulimia nervosa. 
  • Impulsivity, Apathy, and Executive Dysfunction in a Patient With Multiple Potential Etiologies 
  • In Reply 
  • In rape trauma PTSD, patient characteristics indicate which trauma-focused treatment they are most likely to complete. 
  • In reply [4] 
  • In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. 
  • In vivo quantitation of basal ganglia and thalamic degenerative changes in two temporal lobectomy patients with affective disorder. 
  • In-office, in-home, and telehealth cognitive processing therapy for posttraumatic stress disorder in veterans: a randomized clinical trial. 
  • Incidence of mental health hospitalizations, treated self-harm, and emergency room visits following new anxiety disorder diagnoses in privately insured U.S. children. 
  • Incident stressful and traumatic life events and human immunodeficiency virus sexual transmission risk behaviors in a longitudinal, multisite cohort study. 
  • Income and Employment of People Living With Combined HIV/AIDS, Chronic Mental Illness, and Substance Abuse Disorders 
  • Income and attrition in the treatment of depression: a STAR*D report. 
  • Income inequality and depression: a systematic review and meta-analysis of the association and a scoping review of mechanisms. 
  • Increase in untreated cases of psychiatric disorders during the transition to adulthood. 
  • Increase in work productivity of depressed individuals with improvement in depressive symptom severity. 
  • Increased Activation in Precuneus and Parahippocampus When Smokers View Tobacco Retail Outlets: Results of a GPS plus fMRI 'Community Neuroscience' Study 
  • Increased Functional Connectivity in an Insula-Based Network is Associated with Improved Smoking Cessation Outcomes. 
  • Increased Metabotropic Glutamate Receptor 5 Signaling Underlies Obsessive-Compulsive Disorder-like Behavioral and Striatal Circuit Abnormalities in Mice. 
  • Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. 
  • Increased health burden associated with comorbid depression in older Brazilians with diabetes. 
  • Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression. 
  • Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients. 
  • Increased perception of post-ischemic paresthesias in depressed subjects. 
  • Increased pituitary volume in ...psychosis study. 
  • Increased risk for schizophrenia in siblings of patients with schizotypal personality disorder 
  • Increased subjective and reinforcing effects of initial nicotine exposure in young adults with attention deficit hyperactivity disorder (ADHD) compared to matched peers: results from an experimental model of first-time tobacco use. 
  • Increasing Access to State Psychiatric Hospital Beds: Exploring Supply-Side Solutions. 
  • Increasing memory load modulates regional brain activity in older adults as measured by fMRI. 
  • Increasing sensitivity of early detection of psychosis with cognitive measures 
  • Incubating the research independence of a medical scientist training program graduate: a case study. 
  • Independent Effects of Lps and Social Isolation on Forced Swim Behavior in Female Mice 
  • Independent research by early investigators: an underutilized option. 
  • Indicators of pretreatment suicidal ideation in adults with major depressive disorder. 
  • Indigenous perspectives on depression in rural regions of India and the United States. 
  • Indirect effects of dissociation on the relationship between lifetime PTSD symptoms and condomless sex among men who have sex with men with a history of childhood sexual abuse. 
  • Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. 
  • Individual differences in the diurnal cycle of cortisol. 
  • Individual differences in typical reappraisal use predict amygdala and prefrontal responses. 
  • Individualized Low Amplitude Seizure Therapy (iLAST) - Magnetic and Electric Approaches to Enhance Focality and Safety for Depression Treatment 
  • Individualized Low-Amplitude Seizure Therapy: Minimizing Current for Electroconvulsive Therapy and Magnetic Seizure Therapy. 
  • Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study. 
  • Inflammation, Glutamate, and Glia in Depression:A Literature Review 
  • Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. 
  • Influence of Criminal Justice Involvement and Psychiatric Diagnoses on Treatment Costs Among Adults With Serious Mental Illness. 
  • Influence of L-triiodothyronine on memory following repeated electroconvulsive shock in rats: implications for human electroconvulsive therapy. 
  • Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey. 
  • Influence of gender on the clinical presentation of generalized anxiety disorder, and response to treatment with Pregabalin 
  • Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. 
  • Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. 
  • Informant-rated cognitive symptoms in normal aging, mild cognitive impairment, and dementia. Initial development of an informant-rated screen (Brief Cognitive Scale) for mild cognitive impairment and dementia. 
  • Information processing for decision making in depressed women. A study of subjective expected utilities. 
  • Information-processing markers of vulnerability to schizophrenia: Performance of patients with schizotypal and nonschizotypal personality disorders 
  • Informed Consent for Electroconvulsive Therapy--Finding Balance. 
  • Informed consent for research in Borderline Personality Disorder. 
  • Informing Federal Policy on Firearm Restrictions for Veterans with Fiduciaries: Risk Indicators in the Post-Deployment Mental Health Study. 
  • Informing the Complex Association Between Depression Symptom Severity and Neurocognitive Function in Geriatric Major Depressive Disorder 
  • Inhibition of GH in maternal separation may be mediated through altered serotonergic activity at 5-HT2A and 5-HT2C receptors. 
  • Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine. 
  • Inhibitory control in children with attention-deficit/hyperactivity disorder: event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. 
  • Initial Response to Intranasal Nicotine Young Adults With and Without Attention Deficit Hyperactivity Disorder 
  • Initial treatment decisions by level of care for youth in the CHAMPUS Tidewater Demonstration 
  • Inpatient and outpatient patterns of psychotropic drug prescribing by nonpsychiatrist physicians. 
  • Insight and the clinical outcome of schizophrenic patients 
  • Insight and treatment outcome in obsessive-compulsive disorder. 
  • Insight in first-episode psychosis. 
  • Insight in schizophrenia and mania. 
  • Insight in schizophrenia. Its relationship to acute psychopathology 
  • Insight is greater in mixed than in pure manic episodes of bipolar I disorder. 
  • Insights into the Roles of the Methyl-DNA Binding Protein MeCP2 in Addictive-like Behaviors 
  • Insomnia and heart disease: a review of epidemiologic studies. 
  • Insomnia in patients with depression: a STAR*D report. 
  • Insomnia is frequent in schizophrenia and associated with night eating and obesity. 
  • Insomnia: A health care (gap that is growing) 
  • Institutional rearing and psychiatric disorders in Romanian preschool children. 
  • Insured and non-insured depressed outpatients: how do they compare? 
  • Integrated genetic and genomic approach in the SingaporeTranslational and Clinical Research in Psychosis Study: an overview. 
  • Integrating Stakeholder Engagement With Claims-Based Research on Health Insurance Design and Bipolar Disorder. 
  • Integrating therapies for anxiety disorders 
  • Intellectual and behavioral functioning in schizophrenia patients and their unaffected siblings: A population based historical prospective cohort study 
  • Intellectual, neurocognitive, and academic achievement in abstinent adolescents with cannabis use disorder. 
  • Interaction between Antidepressants and Perphenazine in Psychiatric Inpatients 
  • Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. 
  • Interaction of oxytocin level and past depression may predict postpartum depressive symptom severity. 
  • Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions. 
  • Interactive associations of depression and sleep apnea with adverse clinical outcomes after acute myocardial infarction. 
  • Interest among veterans in spiritually-oriented therapy for inner conflict/moral injury in the setting of PTSD. 
  • Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. 
  • Internal consistency, test-retest reliability, and predictive validity for a Likert-based version of the Sources of occupational stress-14 (SOOS-14) scale. 
  • Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder. 
  • International advances in the treatment of social phobia. 
  • International consensus statement on major depressive disorder. 
  • Internet-delivered computerized cognitive & affective remediation training for the treatment of acute and chronic posttraumatic stress disorder: Two randomized clinical trials 
  • Interpersonal and self-reported hostility among combat veterans with and without posttraumatic stress disorder. 
  • Interpersonal trauma and posttraumatic stress disorder in patients with severe mental illness: demographic, clinical, and health correlates. 
  • Interpersonal trauma, war zone exposure, and posttraumatic stress disorder among veterans with schizophrenia. 
  • Interrelationships of psychiatric symptom severity, medical comorbidity, and functioning in schizophrenia. 
  • Interventions for suicidal youth: a review of the literature and developmental considerations. 
  • Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 
  • Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms. 
  • Intimate partner violence and new-onset depression: a longitudinal study of women's childhood and adult histories of abuse. 
  • Intracranial and extracranial blood flow during acute anxiety. 
  • Intractable seizures, compulsions, and coprolalia: a pediatric case study. 
  • Intravenous Ketamine Relieves Pain and Depression After Traumatic Suicide Attempts: A Case Series. 
  • Introduction - Chronic major depression: A review and update 
  • Introduction - Pathophysiology of depression: The emerging role of substance P 
  • Introduction to the CATIE special section. 
  • Introduction to the special section on CATIE baseline data: practical clinical trials in psychiatry: studies of schizophrenia from the CATIE network. 
  • Introduction to the special section on assisted outpatient treatment in New York State. 
  • Introduction. Social phobia in review: 1993 
  • Introduction: Beyond SSRIs 
  • Introduction: Definitions, measurements, and management in insomnia. 
  • Introduction: Recognizing treatment-resistant depression 
  • Introduction: Violence and Mental Illness. 
  • Investigating patterns of neural response associated with childhood abuse v. childhood neglect. 
  • Investigating patterns of neural response associated with childhood abuse v. childhood neglect - Corrigendum. 
  • Investigation of potential gene-gene interactions between APOE and RELN contributing to autism risk. 
  • Involuntary Outpatient Commitment and the Elusive Pursuit of Violence Prevention. 
  • Involuntary out-patient commitment and reduction of violent behaviour in persons with severe mental illness. 
  • Involuntary outpatient commitment and homelessness in persons with severe mental illness. 
  • Involuntary outpatient commitment, community treatment orders, and assisted outpatient treatment: what's in the data? 
  • Ipsilateral subcortical atrophy associated with temporal lobectomy. 
  • Irreducible Mind: Toward a Psychology for the 21st Century 
  • Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder. 
  • Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study. 
  • Is Cumulative Exposure to Suicide Attempts and Deaths a Risk Factor for Suicidal Behavior Among Firefighters? A Preliminary Study. 
  • Is cognitive improvement with antipsychotic treatment pseudospecific? 
  • Is cognitive improvement with antipsychotic treatment pseudospecific? 
  • Is depression a disorder of electrical brain networks? 
  • Is depression associated with immune activation? 
  • Is depression associated with microvascular disease in patients with type 2 diabetes? 
  • Is domestic violence followed by an increased risk of psychiatric disorders among women but not among men? A longitudinal cohort study. 
  • Is military sexual trauma associated with trading sex among women veterans seeking outpatient mental health care? 
  • Is obstructive sleep apnea associated with ADHD? 
  • Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report. 
  • Is the idle mind a Devil's workshop? 
  • Is there a definition of remission in late-life depression that predicts later relapse? 
  • Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder. 
  • Is treatment for alcoholism effective in persons on methadone maintenance? 
  • Isn't It About Time to Employ Measurement-Based Care in Practice? 
  • Isocarboxazid. Efficacy and tolerance. 
  • Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia. 
  • Issues in the treatment of major depression: Selection, efficacy, and safety 
  • It is time to take a stand for medical research and against terrorism targeting medical scientists. 
  • Itemized clinician ratings versus global ratings of symptom severity in patients with schizophrenia. 
  • JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats. 
  • Jhum-jhum: Depression, somatization and comorbidity in Nepal 
  • John Henryism and the health of African-Americans. 
  • John Henryism, Gender and Self-Reported among Roma/Gypsies in Serbia 
  • John Henryism, Gender and Self-reported Health Among Roma/Gypsies in Serbia. 
  • Joint effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration. 
  • Julia Rush's diary: coping with loss in the early nineteenth century. 
  • Juvenile mental health histories of adults with anxiety disorders. 
  • Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials. 
  • Kava in generalized anxiety disorder: three placebo-controlled trials. 
  • Ketamine ("Ketalar"): a safer anaesthetic for ECT. 
  • Ketamine for treatment-resistant depression: ready or not for clinical use? 
  • Ketamine up-regulates a cluster of intronic miRNAs within the serotonin receptor 2C gene by inhibiting glycogen synthase kinase-3. 
  • Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review. 
  • Key lessons learned from the INDIGO global network on mental health related stigma and discrimination. 
  • Key updates in the clinical application of electroconvulsive therapy. 
  • Knowledge and attitudes about depression among non-generalists and generalists. 
  • Kraepelinian schizophrenia: A replication in an independent sample 
  • Kraepelinian schizophrenia: a subgroup of schizophrenia? 
  • L-dopa challenge and relapse in schizophrenia. 
  • L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. 
  • L-serine predicts self-reported pain in female OEF/OIF veterans 
  • LONGITUDINAL SUBSTANCE USE TRAJECTORIES FOR PERSONS WITH SCHIZOPHRENIA 
  • Laboratory and clinical tests of spatial working memory 
  • Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study. 
  • Lack of association between autism and SLC25A12. 
  • Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [¹⁸ F]fallypride PET. 
  • Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. 
  • Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias 
  • Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias 
  • Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. 
  • Lack of relapse with tryptophan depletion following successful treatment with ECT. 
  • Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. 
  • Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study. 
  • Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability. 
  • Lasting effects of developmental dexamethasone treatment on neural cell number and size, synaptic activity, and cell signaling: critical periods of vulnerability, dose-effect relationships, regional targets, and sex selectivity. 
  • Late luteal phase dysphoric disorder. 
  • Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25. 
  • Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. 
  • Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction. 
  • Latent class analysis of discordance between results of drug use assessments in the CATIE data. 
  • Latent class analysis of the feared situations of social anxiety disorder: A population-based study 
  • Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). 
  • Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). 
  • Latent subtypes of depression in a community sample of older adults: can depression clusters predict future depression trajectories? 
  • Lateralized Effects of Prefrontal Transcranial Magnetic Stimulation on Emotional Working Memory 
  • Law & psychiatry: Gun laws and mental illness: how sensible are the current restrictions? 
  • Law Enforcement and Clinician Partnerships: Training of Trainers for CIT Teams in Liberia, West Africa. 
  • Leading indicators of community-based violent events among adults with mental illness. 
  • Learning and memory in combat veterans with posttraumatic stress disorder. 
  • Learning and recall in subjects at genetic risk for Alzheimer's disease. 
  • Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder. 
  • Left orbital frontal cortex volume and performance on the benton visual retention test in older depressives and controls. 
  • Leighton's theory of sentiments: explorations and speculations on barriers to interpersonal forgiveness. 
  • Leonhard's classification of the chronic schizophrenias 
  • Lesions of the Orbitofrontal Cortex Reduce Risk-taking in Rats 
  • Less dropout from prolonged exposure sessions prescribed at least twice weekly: A meta-analysis and systematic review of randomized controlled trials. 
  • Lessons from SADHART, ENRICHD, and other trials. 
  • Letter to the Editor: Posttraumatic stress disorder has genetic overlap with cardiometabolic traits. 
  • Letter to the editor: Critique of Bahorik et al. (2013)--'Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors'. 
  • Letters to the editors 
  • Leukocytosis and hypoalbuminemia in mixed bipolar states: evidence for immune activation. 
  • Leukoencephalopathy and depression. 
  • Leukoencephalopathy in elderly depressed patients referred for ECT. 
  • Leukoencephalopathy in patients diagnosed as major depressive. 
  • Levels of urinary free cortisol in social phobia. 
  • Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium. 
  • Levetiracetam in social phobia: a placebo controlled pilot study. 
  • Levocarnitine-induced hypophosphatemia in a hemodialysis patient with acute valproic acid toxicity. 
  • Lid retraction test. 
  • Life Span Studies of ADHD-Conceptual Challenges and Predictors of Persistence and Outcome. 
  • Life events and post-traumatic stress: the development of a new measure for children and adolescents. 
  • Lifestyle and Neurocognition in Older Adults With Cardiovascular Risk Factors and Cognitive Impairment. 
  • Lifetime Trauma and Depressive Symptoms Predict Mortality in HIV 
  • Lifetime and current prevalence of specific psychiatric disorders among Vietnam veterans and controls. 
  • Lifetime comorbidity, lifetime history of psychosis and suicide attempts, and current symptoms of patients with deteriorated affective disorder. 
  • Lifetime major depression and comorbid disorders among current-era women veterans. 
  • Lifetime perturbations of bipolar disorder. 
  • Lifetime trauma exposure among those with combat-related PTSD: Psychiatric risk among U.S. military personnel. 
  • Lifetime trauma exposure in veterans with military-related posttraumatic stress disorder: association with current symptomatology. 
  • Lifetime use of mental health and substance abuse treatment services by incarcerated women felons. 
  • Limitations in efficacy of antidepressant monotherapy. 
  • Linkage analysis of schizophrenia in African-American families. 
  • Linking physical and mental health: Comparing users and non-users of mental health services in medical care utilization 
  • Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder. 
  • Lithium Toxicity after Roux-en-Y Gastric Bypass is Not Just Limited to Perioperative Period. 
  • Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. 
  • Lithium-induced nephrotic syndrome. 
  • Lithium-induced renal ectasia. 
  • Lobar distribution of lesion volumes in late-life depression: the Biomedical Informatics Research Network (BIRN). 
  • Localization of age-associated white matter hyperintensities in late-life depression. 
  • Locus of Control and Symptoms of Psychological Distress Among Chinese﷓Americans. 
  • Locus of control and vasomotor response to sensory processing. 
  • Loneliness in young adulthood: Findings from an epidemiological cohort study 
  • Lonely young adults in modern Britain: findings from an epidemiological cohort study. 
  • Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife. 
  • Long-acting risperidone vs. placebo in the treatment of hospital inpatients with schizophrenia. 
  • Long-term (2-year) effectiveness of collaborative care for late-life depression 
  • Long-term Neural Embedding of Childhood Adversity in a Population-Representative Birth Cohort Followed for 5 Decades. 
  • Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD. 
  • Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits? 
  • Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. 
  • Long-term issues in the treatment of sleep disorders 
  • Long-term issues in the treatment of sleep disorders. 
  • Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. 
  • Long-term psychosocial effects of childhood exposure to parental problem drinking. 
  • Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. 
  • Long-term treatment and prevention of posttraumatic stress disorder. 
  • Long-term treatment gains of a brief exposure-based treatment for PTSD. 
  • Long-term treatment of social phobia with clonazepam. 
  • Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. 
  • Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy and Pharmacotherapy in Geriatric Major Depressive Disorder 
  • Longitudinal classification in schizophrenia: The relationship between kraepelinian and deficit syndrome subtypologies 
  • Longitudinal cohort study of depression, post-traumatic stress, and alcohol use in South African women who attend alcohol serving venues. 
  • Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study. 
  • Longitudinal study of neuropsychological functioning in patients on chronic hemodialysis: a preliminary report. 
  • Loss of appetite and weight associated with the monoamine oxidase inhibitor isocarboxazid. 
  • Low Seizure Threshold with Ultra-Brief Pulse Right Unilateral ECT in the Elderly: Preliminary Data from Phase I of the PRIDE Study 
  • Low educational attainment, John Henryism, and cardiovascular reactivity to and recovery from personally relevant stress. 
  • Low plasma GABA is a trait-like marker for bipolar illness. 
  • Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. 
  • Low plasma gamma-aminobutyric acid levels in male patients with depression. 
  • Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. 
  • Low yield of thyroid-stimulating hormone testing in elderly patients with depression. 
  • Low-Frequency Right Repetitive Transcranial Magnetic Stimulation for the Treatment of Depression After Traumatic Brain Injury: A Randomized Sham-Controlled Pilot Study. 
  • Low-dimensional chaos in bipolar disorder? 
  • Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. 
  • Lower SES and increased illness risk: A role for gene-environment interactions? 
  • Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. 
  • Loxapine in psychogeriatrics: A placebo- and standard-controlled clinical investigation 
  • Lying for patients: physician deception of third-party payers. 
  • MAO inhibition and control of anxiety following amitriptyline therapy. A pilot study. 
  • MAO inhibitor therapy in trichotillomania associated with depression: case report. 
  • MAOA genotype, childhood maltreatment, and their interaction in the etiology of adult antisocial behaviors. 
  • MAOA, early adversity, and gene-environment interaction predicting children's mental health: New evidence and a meta-analysis 
  • MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. 
  • MAOIs in the contemporary treatment of depression. 
  • MDPV Has Potent and Atypical Effects on Dopamine Release in Adolescent and Adult Rats 
  • MET BDNF protects against morphological S allele effects of 5-HTTLPR 
  • METHODOLOGY IN PSYCHOSOMATIC RESEARCH 
  • MICROVASCULAR FUNCTION AND COGNITIVE PERFORMANCE AMONG INDIVIDUALS WITH MAJOR DEPRESSION 
  • MODELING THE EXPRESSION AND COURSE OF DEVELOPMENTAL ABNORMALITIES PRECEDING ADULT SCHIZOPHRENIA: CHARACTERIZATION OF A NEW DEVELOPMENTAL ULTRA-HIGH-RISK GROUP IN 2 BIRTH COHORTS 
  • MODELING THE IMPACT OF CHRONIC ILLNESS, RELIGION, AND SOCIAL SUPPORT ON DEPRESSIVE SYMPTOMS 
  • MR signal intensity of gray matter/white matter contrast and intracranial fat: effects of age and sex. 
  • MRI changes in schizophrenia in late life: a preliminary controlled study. 
  • MRI correlates of suicide attempt history in unipolar depression. 
  • MRI of corpus callosum and septum pellucidum in depression. 
  • MRI scans in patients with tardive dyskinesia. 
  • MRI signal hyperintensities in geriatric depression. 
  • MRI-defined vascular depression. 
  • Magnetic Seizure Therapy (MST) 
  • Magnetic Seizure Therapy (MST): Acute cognitive effects of MST compared with ECT. 
  • Magnetic resonance assessment of cerebral perfusion in depressed cardiac patients: preliminary findings. 
  • Magnetic resonance findings in patients with early-onset Alzheimer's disease. 
  • Magnetic resonance imaging abnormalities and psychiatric illness. 
  • Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years. 
  • Magnetic resonance imaging changes in putamen nuclei iron content and distribution in normal subjects. 
  • Magnetic resonance imaging correlates of depression in early- and late-onset Alzheimer's disease. 
  • Magnetic resonance imaging in biological psychiatry. 
  • Magnetic resonance imaging in social phobia. 
  • Magnetic resonance imaging of Alzheimer's disease. 
  • Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. 
  • Magnetic resonance imaging signal hypointensity and iron content of putamen nuclei in elderly depressed patients. 
  • Magnetic resonance imaging using deoxyhemoglobin contrast versus positron emission tomography in the assessment of brain function. 
  • Magnetic resonance in patients with affective illness. 
  • Magnetic resonance spectroscopy in social phobia: preliminary findings. 
  • Magnetic seizure induction for the treatment of major depression 
  • Magnetic seizure therapy and other convulsive therapies 
  • Magnetic seizure therapy improves mood in refractory major depression. 
  • Magnetic seizure therapy of major depression. 
  • Magnetic seizure therapy: Development of a novel intervention for treatment resistant depression 
  • Magnetic stimulation therapy: A novel convulsive technique 
  • Magnetic-resonance morphometry in patients with major depression. 
  • Magnitude of placebo response and drug-placebo differences across psychiatric disorders. 
  • Maintaining a Steady Course: One of the "hottest Journals of the Millennium..." 
  • Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study. 
  • Major depression and physical illness trajectories in heart failure and pulmonary disease. 
  • Major depression and the NIMH Diagnostic Interview Schedule: validation in medically ill hospitalized patients. 
  • Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study. 
  • Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards. 
  • Major depressive disorder treatment guidelines in America and Europe. 
  • Major depressive disorder treatment guidelines in America and Europe. 
  • Making Therapy Widely Available: Clinical Research Triumph or Existential Catastrophe? 
  • Making clinicians lives easier: guidance on use of the QIDS self-report in place of the MADRS. 
  • Maladaptive coping mediates the influence of childhood trauma on depression and PTSD among pregnant women in South Africa. 
  • Male-female differences in the setting and construction of violence among people with severe mental illness. 
  • Managed depression care reduces mortality in older adults with major depression. 
  • Management of SIADH-related hyponatremia due to psychotropic medications - An expert consensus from the Association of Medicine and Psychiatry. 
  • Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs. 
  • Management of late-life depression in the nursing home 
  • Management of late-life depression: focus on comorbid conditions. 
  • Management of posttraumatic stress disorder: diagnostic and therapeutic issues. 
  • Managing Stigma Effectively: What Social Psychology and Social Neuroscience Can Teach Us. 
  • Managing depression in countries with low and middle incomes: an imperative for human immunodeficiency virus/acquired immune deficiency syndrome care and treatment and general public health. 
  • Managing depression in geriatric populations. 
  • Managing patients with vascular disease and depression 
  • Managing the risks of repetitive transcranial stimulation. 
  • Mandated community treatment: beyond outpatient commitment. 
  • Mania in Alzheimer's disease. 
  • Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders. 
  • Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. 
  • Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. 
  • Marketing off-label uses: Shady practices within a gray market 
  • Massage therapy effects on depression and somatic symptoms in chronic fatigue syndrome 
  • Maternal depression and children's antisocial behavior: nature and nurture effects. 
  • Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model. 
  • Maternal mental health priorities, help-seeking behaviors, and resources in post-conflict settings: a qualitative study in eastern Uganda. 
  • Maternal prenatal pregnancy-related anxiety and spontaneous preterm birth in Baltimore, Maryland. 
  • Maternal psychological distress, prenatal cortisol, and fetal weight. 
  • Maternal separation in neonatal rats elicits activation of the hypothalamic-pituitary-adrenocortical axis: a putative role for corticotropin-releasing factor. 
  • Maternal smoking during pregnancy and risk to boys' conduct disturbance: an examination of the causal hypothesis. 
  • Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. 
  • Meal-related cholecystokinin secretion in eating and affective disorders. 
  • Measurement invariance of posttraumatic stress disorder symptoms among U.S. military personnel. 
  • Measurement of depression treatment among patients receiving HIV primary care: Whither the truth? 
  • Measurement of intracerebral electric field induced by electroconvulsive therapy 
  • Measurement of the process of coping with sexual trauma 
  • Measurement reliability of cardiovascular reactivity change scores: a comparison of intermittent and continuous methods of assessment. 
  • Measurement-based care for the treatment of depression 
  • Measurement-based care in psychiatric practice: a policy framework for implementation. 
  • Measures and predictors of community-based employment and earnings of persons with schizophrenia in a multisite study. 
  • Measures of cognitive change in schizophrenia clinical trials 
  • Measuring Depressive Symptomatology in China. 
  • Measuring childhood maltreatment to predict early-adult psychopathology: Comparison of prospective informant-reports and retrospective self-reports. 
  • Measuring outcome priorities and preferences in people with schizophrenia. 
  • Measuring results of treatment of PTSD. 
  • Measuring the Quality of VA Care. 
  • Measuring the role of psychological inflexibility in Trichotillomania. 
  • Mecamylamine increases cigarette smoking in psychiatric patients. 
  • Mechanistic link between right prefrontal cortical activity and anxious arousal revealed using transcranial magnetic stimulation in healthy subjects. 
  • Meclizine enhancement of sensorimotor gating in healthy male subjects with high startle responses and low prepulse inhibition. 
  • Medial orbital frontal lesions in late-onset depression. 
  • Mediation of employment discrimination disputes involving persons with psychiatric disabilities. 
  • Medical Mistrust in Perinatal Mental Health. 
  • Medical comorbidity and alcohol dependence. 
  • Medical comorbidity in a bipolar outpatient clinical population. 
  • Medical comorbidity in bipolar disorder: re-prioritizing unmet needs. 
  • Medical comorbidity: Special patient populations 
  • Medical diplomacy and global mental health: from community and national institutions to regional centers of excellence. 
  • Medical service utilization by veterans seeking help for posttraumatic stress disorder. 
  • Medical test development and implementation: a multistep journey. 
  • Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. 
  • Medication compliance. 
  • Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability. 
  • Medication optimization during clozapine treatment. 
  • Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives. 
  • Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project. 
  • Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes. 
  • Medico-legal risk associated with pediatric mental health telephone consultation programs. 
  • Meet our editorial board member 
  • Meeting of minds in psychiatry and homeopathy: an example in social phobia. 
  • Meeting the needs of primary care physicians: a guide to content for programs on depression. 
  • Melancholia and response to ECT. 
  • Melancholic symptom features and DSM-IV. 
  • Membrane biophysical studies of lymphocytes and erythrocytes in manic-depressive illness. 
  • Memory performance by mild hypertensives following beta-adrenergic blockade. 
  • Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele. 
  • Memory, language, and praxis in Alzheimer's disease: norms for outpatient clinical trial populations. 
  • Mental Disorders and Violence in a Total,::Birth Cohorts Results from the Dunedin Study 
  • Mental Health Courts: Does Treatment Make a Difference? 
  • Mental Health Paraprofessional Training for Filipina Foreign Domestic Workers in Singapore: Feasibility and Effects on Knowledge About Depression and Cognitive Behavioral Therapy Skills 
  • Mental Health Policy in the Era of COVID-19. 
  • Mental Health and Functional Outcomes in Young Adulthood of Children With Psychotic Symptoms: A Longitudinal Cohort Study. 
  • Mental Health and Psychosocial Characteristics Associated With COVID-19 Among U.S. Adults. 
  • Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. 
  • Mental disorder and violence in a total birth cohort 
  • Mental disorders and violence in a total birth cohort: results from the Dunedin Study. 
  • Mental disorders in primary care: epidemiologic, diagnostic, and treatment research directions. 
  • Mental health and reoffending outcomes of jail diversion participants with a brief incarceration after arraignment. 
  • Mental health and substance abuse services to parents of children involved with child welfare: a study of racial and ethnic differences for American Indian parents. 
  • Mental health care from the public perspective: the Texas Medication Algorithm Project. 
  • Mental health impact of the Iraq and Afghanistan conflicts: a review of US research, service provision, and programmatic responses. 
  • Mental health issues among female clients of domestic violence programs in North Carolina. 
  • Mental health screenings for couples at churches in Nigeria: a strategy for enhancing community-based maternal mental health services in low-resource settings. 
  • Mental health service utilization in the U.S. Army. 
  • Mental health training of primary care residents: a review of recent literature (1974-1981). 
  • Mental illness in U.S. Presidents between 1776 and 1974: a review of biographical sources. 
  • Meta-Analysis of DNA Methylation and PTSD in the Psychiatric Genomics Consortium PTSD Epigenetics Workgroup 
  • Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy. 
  • Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders. 
  • Metabolic effects associated with atypical antipsychotic treatment in the developmentally disabled. 
  • Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. 
  • Metabolic syndrome among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study. 
  • Metabolomic mapping of atypical antipsychotic effects in schizophrenia. 
  • Metabolomic mapping of schizophrenia and atypical antipsychotic effects 
  • Metabolomic mapping of schizophrenic patients treated with atypical antipsychotics discloses drug-specific differences in global lipid changes 
  • Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study. 
  • Metabolomics and lipidomics of neuropsychiatric disorders: Emerging data 
  • Metabolomics: A Global Biochemical Approach to the Study of Neuropsychiatric Disorders 
  • Metabolomics: a global biochemical approach to the study of central nervous system diseases. 
  • Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial. 
  • Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder. 
  • Methadone dose for cocaine abuse. 
  • Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders. 
  • Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders. 
  • Methodological issues in developing new acute treatments for patients with bipolar illness. 
  • Methodological issues in negative symptom trials. 
  • Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D). 
  • Methods to improve diagnostic accuracy in a community mental health setting. 
  • Metoclopramide-induced tardive respiratory dyskinesia. 
  • Mianserin: Determination of therapeutic dose range 
  • Microvascular abnormality in schizophrenia as shown by retinal imaging. 
  • Middle cerebral artery velocity during upright posture after marijuana smoking. 
  • Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation. 
  • Mild ventriculomegaly detected in utero with ultrasound: clinical associations and implications for schizophrenia. 
  • Mind the Gaps: Ethical and Epistemic Issues in the Digital Mental Health Response to Covid-19. 
  • Mind-Body Dualism and Medical Student Attitudes toward Mental Illness in Saudi Arabia. 
  • Mindfulness, Self-Compassion, Posttraumatic Stress Disorder Symptoms, and Functional Disability in U.S. Iraq and Afghanistan War Veterans. 
  • Mineralocorticoid receptor Iso/Val (rs5522) genotype moderates the association between previous childhood emotional neglect and amygdala reactivity. 
  • Mini-SPIN: A brief screening assessment for generalized social anxiety disorder. 
  • Minimal maintenance medication: Effects of three dose schedules on relapse rates and symptoms in chronic schizophrenic outpatients 
  • Minimum Electric Field Exposure for Seizure Induction with Electroconvulsive Therapy and Magnetic Seizure Therapy. 
  • Minor depression and physical outcome trajectories in heart failure and pulmonary disease. 
  • Minor depression in family practice: functional morbidity, co-morbidity, service utilization and outcomes. 
  • Minor depression: a review of the literature. 
  • Minor self-harm and psychiatric disorder: a population-based study. 
  • Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. 
  • Mismatch in Spouses' Anger-Coping Response Styles and Risk of Early Mortality: A 32-Year Follow-Up Study. 
  • Mismatch of posttraumatic stress disorder (PTSD) symptoms and DSM-IV symptom clusters in a cancer sample: exploratory factor analysis of the PTSD Checklist-Civilian Version. 
  • Missing the sweet spot disengagement in schizophrenia. 
  • Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. 
  • Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. 
  • Mobile device use among inpatients on a psychiatric unit: A preliminary study. 
  • Moclobemide in social phobia: a controlled dose-response trial. 
  • Modafinil for atypical depression: Effects of open-label and double-blind discontinuation treatment (vol 26, pg 373, 2006) 
  • Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment. 
  • Model utility in postpartum psychosis 
  • Modeling Health Disparities and Outcomes in Disenfranchised Populations. 
  • Models of dopaminergic and serotonergic signaling. 
  • Models of mental health training for primary care physicians: a validation study. 
  • Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. 
  • Modification effects of coping on post-traumatic morbidity among earthquake rescuers. 
  • Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine. 
  • Modulation Effect of Rumination Trait and Low Tryptophan on Default-Mode Network Connectivity 
  • Modulation of motor cortex excitability in obsessive-compulsive disorder: an exploratory study on the relations of neurophysiology measures with clinical outcome. 
  • Molecular genetics of successful smoking cessation: convergent genome-wide association study results. 
  • Money management, mental health, and psychiatric disability: a recovery-oriented model for improving financial skills. 
  • Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. 
  • Monitoring of clozapine blood levels in the real world [10] 
  • Monoamine oxidase inhibitors in patients with chronic pain. 
  • Mood Disorders 
  • Mood alters amygdala activation to sad distractors during an attentional task. 
  • Mood and suicidality outcomes 3-11 years following pediatric anxiety disorder treatment. 
  • Mood disorders and chronic obstructive pulmonary disease: current research and future needs. 
  • Mood disorders in the medically ill: scientific review and recommendations. 
  • Mood variability in adolescents: a study of depressed, nondepressed and comorbid patients. 
  • Moral Injury and Burnout in Health Care Professionals During the COVID-19 Pandemic. 
  • Moral Injury and Religiosity in US Veterans With Posttraumatic Stress Disorder Symptoms. 
  • Moral engagement, combat trauma, and the lure of psychiatric dualism: why psychiatry is more than a technical discipline. 
  • Moral injury, posttraumatic stress disorder, and religious involvement among U.S. veterans. 
  • Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. 
  • More data on speed of remission with ECT in geriatric depression. 
  • More than the loss of a parent: potentially traumatic events among orphaned and abandoned children. 
  • Morphological differences associated with a serotonin transporter polymorphism (5-HTTLPR) in rhesus macaques 
  • Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. 
  • Motor cortex excitability after vagus nerve stimulation in major depression. 
  • Moving assertive community treatment into standard practice. 
  • Much ado about small differences. 
  • Multi-ancestry genome-wide gene-sleep interactions identify novel loci for blood pressure. 
  • Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. 
  • Multicomponent smoking cessation treatment including mobile contingency management in homeless veterans. 
  • Multidimensional effects of sertraline in social anxiety disorder. 
  • Multidisciplinary training in the College Mental Health Service. 
  • Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy. 
  • Multifamily group treatment for veterans with traumatic brain injury: what is the value to participants? 
  • Multilevel growth curve analyses of behavioral activation for anhedonia (BATA) and mindfulness-based cognitive therapy effects on anhedonia and resting-state functional connectivity: Interim results of a randomized trial✰. 
  • Multilevel regression analyses to investigate the relationship between two variables over time: examining the longitudinal association between intrusion and avoidance. 
  • Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. 
  • Multiple rare SAPAP3 missense variants in trichotillomania and OCD. 
  • Multiple sources of internal calcium stores mediate ethanol-induced presynaptic inhibitory GABA release in the central nucleus of the amygdala in mice. 
  • N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. 
  • NATURALISTIC STRESSORS ARE ASSOCIATED WITH REDUCED 24-HOUR HRV IN ACUTE POST-MI PATIENTS 
  • NCAM1 and neurocognition in schizophrenia. 
  • NEUROENDOCRINE EFFECTS OF CAFFEINE AT WORK 
  • NEUROENDOCRINE FACTORS IN PREMENSTRUAL DYSPHORIC DISORDER 
  • NEUROENDOCRINE RESPONSES ARE ASSOCIATED WITH LIPIDS IN HOSTILE WOMEN 
  • NEUROSTEROIDS AS NOVEL THERAPEUTIC AGENTS IN SCHIZOPHRENIA AND PTSD 
  • NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats. 
  • NORMATIVE DATA FOR RUSSIAN POPULATION AND STANDARDIZATION OF THE SCALE "BRIEF ASSESSMENT OF COGNITION IN SCHIZOPHRENIA" 
  • Naltrexone blockade of nicotine effects in cigarette smokers. 
  • Naltrexone in patients with bipolar disorder and alcohol dependence. 
  • Naltrexone potentiates glycemic responses during stress and epinephrine challenge in genetically obese mice. 
  • Narcissism and the development of chronic pain. 
  • Narcissistic Admiration and Rivalry: An Interpersonal Approach to Construct Validation. 
  • Narcolepsy: preliminary retrospective study of psychiatric and psychosocial aspects. 
  • Narrowing the gaps between what we know and what we do in psychiatry. 
  • National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. 
  • National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. 
  • National Institute of Mental Health Workshop Report on the Treatment of Bipolar Disorder. 
  • Naturalistic study of the early psychiatric use of citalopram in the United States. 
  • Navigating diagnoses: understanding mind-body relations, mental health, and stigma in Nepal. 
  • Nefazodone in post-traumatic stress disorder: results from six open-label trials. 
  • Negative Emotionality Interacts with Trauma Exposure to Prospectively Predict Posttraumatic Stress Disorder Symptoms During Firefighters' First 3 Years of Service. 
  • Negative affect and chemical intolerance as risk factors for building-related symptoms: a controlled exposure study. 
  • Negative life stress and longitudinal hippocampal volume changes in older adults with and without depression. 
  • Neighborhood Context and Social Disparities in Cumulative Biological Risk Factors 
  • Neighborhood characteristics moderate effects of caregiving on glucose functioning. 
  • Neighbourhood Adversity, Crime Victimisation and Adolescent Psychotic Experiences: Findings from a Longitudinal Cohort Study 
  • Neocortical modulation of the amygdala response to fearful stimuli. 
  • Neonatal bacterial infection alters fever to live and simulated infections in adulthood. 
  • Neonatal cerebral ventricle volume: A comparison of 3D ultrasound and MRI 
  • Nepali concepts of psychological trauma: the role of idioms of distress, ethnopsychology and ethnophysiology in alleviating suffering and preventing stigma. 
  • Network Analysis of Intrinsic Functional Organization of the Brain in Mild Traumatic Brain Injury 
  • Network-dependent facilitation of cognitive task performance with rTMS 
  • Neural Correlates of Social Reward Processing Differ Between Young Adult Smokers and Non-Smokers 
  • Neural Effects of rTMS: Single Neuron Recordings From a Rhesus Macaque 
  • Neural Mechanisms Underlying Effects of Propranolol on Drug Cue Reactivity 
  • Neural Mechanisms of Emotion Regulation in Major Depression and Implications for Psychotherapy Effectiveness 
  • Neural activity in functional movement disorders after inpatient rehabilitation. 
  • Neural bases of different cognitive strategies for facial affect processing in schizophrenia. 
  • Neural correlates of automatic and controlled auditory processing in schizophrenia. 
  • Neural correlates of conceptual-level fear generalization in posttraumatic stress disorder. 
  • Neural correlates of emotional processing in depression: changes with cognitive behavioral therapy and predictors of treatment response. 
  • Neural correlates of food addiction. 
  • Neural mechanisms of cognitive reappraisal in remitted major depressive disorder. 
  • Neural mechanisms of subclinical depressive symptoms in women: a pilot functional brain imaging study. 
  • Neural mechanisms underlying 5-HTTLPR-related sensitivity to acute stress. 
  • Neural signatures of saliency-mapping in anhedonia: A narrative review. 
  • Neural substrates of orthographic lexical access as demonstrated by functional brain imaging. 
  • Neural systems for executive and emotional processing are modulated by level of posttraumatic stress disorder symptoms in Iraq war veterans 
  • Neural systems for executive and emotional processing are modulated by symptoms of posttraumatic stress disorder in Iraq War veterans. 
  • Neuroactive Steroids Enhance Activation of Emotion Regulation Brain Circuits 
  • Neuroactive steroid alterations in posterior cingulate and parietal cortex in subjects with schizophrenia and bipolar disorder: Potential gender specificity 
  • Neuroactive steroid alterations in schizophrenia and bipolar disorder: A negative ion chemical ionization gas chromatography/mass spectrometry investigation in posterior cingulate 
  • Neuroactive steroid alterations in schizophrenia and bipolar disorder: Negative ion chemical ionization gas chromatography/mass spectrometry investigations in posterior cingulate and parietal cortex 
  • Neuroactive steroids and neurodegenerative disorders: Investigations in subjects with Alzheimer's and relevance to neuropathological disease stage 
  • Neuroactive steroids and suicidality in posttraumatic stress disorder. 
  • Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics. 
  • Neuroactive steroids are related to psychiatric symptoms in veterans returning from iraq and Afghanistan 
  • Neuroactive steroids in Alzheimer's disease: Investigations in prefrontal cortex 
  • Neuroactive steroids in schizophrenia, PTSD, and Alzheimer's disease: Relevance to pathophysiology and treatment 
  • Neuroactive steroids in schizophrenia: Relevance to symptoms and therapeutics 
  • Neuroactive steroids, mood stabilizers, and neuroplasticity: Alterations following lithium and changes in Bcl-2 knockout mice 
  • Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice. 
  • Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers. 
  • Neuroanatomical changes and hypothalamo-pituitary-adrenal axis abnormalities. 
  • Neuroanatomical substrates of depression in the elderly. 
  • Neurobehavioral functioning in a nonconfounded group of asymptomatic HIV-seropositive homosexual men. 
  • Neurobiochemical changes in tardive dyskinesia. 
  • Neurobiological mechanisms in generalized anxiety disorder. 
  • Neurobiological pathways that link gene and environment: early life stress disorder. 
  • Neurobiology of chronic fatigue syndrome. 
  • Neurobiology, cellular and molecular biology, and psychosomatic medicine. 
  • Neurocognitive Effects of Combined Electroconvulsive Therapy and Venlafaxine in Elderly Adults With Major Depressive Disorder 
  • Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. 
  • Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. 
  • Neurocognitive disorders in DSM-5. 
  • Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. 
  • Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial 
  • Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder 
  • Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis 
  • Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis 
  • Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis 
  • Neurocognitive effects of transcranial direct current stimulation (tDCS) in unipolar and bipolar depression: Findings from an international randomized controlled trial. 
  • Neurocognitive function in individuals "at-risk" for psychosis 
  • Neurocognitive markers of childhood abuse in individuals with PTSD: Findings from the INTRuST Clinical Consortium. 
  • Neuroendocrine Responses to Acute Psychosocial Stress are Predictive of Cognitive Disorganization in Adolescents 
  • Neuroendocrine biomarkers of prolonged exposure treatment response in military-related PTSD. 
  • Neuroendocrine response to magnetic seizure therapy (MST) in major depression: Comparison with electroconvulsive therapy 
  • Neuroendocrine responses to caffeine in the work environment. 
  • Neuroendocrine, cardiovascular, and emotional responses of hostile men: the role of interpersonal challenge. 
  • Neurogenesis and depression. 
  • Neurogranin, Encoded by the Schizophrenia Risk Gene NRGN, Bidirectionally Modulates Synaptic Plasticity via Calmodulin-Dependent Regulation of the Neuronal Phosphoproteome. 
  • Neuroimaging in late-life depression. 
  • Neuroimaging of Nicotine Dependence: Key Findings and Application to the Study of Smoking-Mental Illness Comorbidity. 
  • Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson's disease 
  • Neuroleptic dose and the need for prophylactic anticholinergic drugs. 
  • Neuroleptic effects on CPT and eye tracking in schizophrenia 
  • Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients 
  • Neuron-specific Sumo1-3 knockdown in mice impairs episodic and fear memories. 
  • Neuronal pathology in orbitofrontal cortex in elderly subjects with MDD is more severe than that in age-matched control subjects 
  • Neuropathologic examination after 91 ECT treatments in a 92-year-old woman with late-onset depression. 
  • Neuropathology in affective illness. 
  • Neurophysiological characterization of high-dose magnetic seizure therapy: comparisons with electroconvulsive shock and cognitive outcomes. 
  • Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. 
  • Neuropsychiatric considerations in the use of electroconvulsive therapy. 
  • Neuropsychiatric manifestations of porphyria. 
  • Neuropsychiatric problems after traumatic brain injury: unraveling the silent epidemic. 
  • Neuropsychological aspects of eating disorders 
  • Neuropsychological characterization of dementia patients 
  • Neuropsychological characterization of dementia patients 
  • Neuropsychological characterization of dementia patients. 
  • Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function. 
  • Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study. 
  • Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. 
  • Neuropsychological deficits associated with medical conditions: Implications for psychological services in criminal legal settings. 
  • Neuropsychological deficits at age 13 and later schizophreniform disorder: A longitudinal birth cohort study 
  • Neuropsychological dysfunctions in unipolar nonpsychotic major depressions. 
  • Neuropsychological function at age 13 and later schizophreniform disorder in a longitudinal birth cohort 
  • Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. 
  • Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. 
  • Neuropsychological functions of prefrontal cortex are selectively impaired early in the course of schizophrenia 
  • Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. 
  • Neuropsychological performance at the age of 13 years and adult schizophreniform disorder: prospective birth cohort study. 
  • Neuropsychological profile in adult schizophrenia measured with the CMINDS. 
  • Neuropsychological status of subjects at high risk for a first episode of psychosis. 
  • Neuropsychological test scores at age 13 and later schizophreniform disorder: a prospective longitudinal birth cohort study 
  • Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. 
  • Neuroserpin Protects Parvalbumin Interneurons Against Perineuronal Net Degradation for Cortical Stability 
  • Neurosteroid Levels in Patients With Bipolar Disorder and a History of Cannabis Use Disorders. 
  • Neurosteroid modulation of GABAergic neurotransmission in the central amygdala 
  • Neurosteroids and pharmacological treatment strategies in schizophrenia, depression, and anxiety disorders 
  • Neurosteroids as Novel Therapeutics and Biomarker Candidates in Schizophrenia and PTSD 
  • Neurosteroids as candidate modulators of pathophysiology in Alzheimer's disease and nicotine dependence 
  • Neuroticism and personality disorder in depression. 
  • Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone. 
  • Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness 
  • Neurovegetative symptoms in chronic pain and depression. 
  • Neutrality, autonomy and mental health: a closer look. 
  • Neutrophil beta2-adrenergic receptor coupling efficiency to Gs protein in subjects with post-traumatic stress disorder and normal controls. 
  • New Challenges for Anxiety Disorders: Where Treatment, Resilience, and Economic Priority Converge 
  • New Developments in Insomnia Medications of Relevance to Mental Health Disorders. 
  • New designs for studies of the prophylaxis of bipolar disorder. 
  • New developments in dosing strategies for ECT 
  • New developments in electroconvulsive therapy and magnetic seizure therapy. 
  • New directions in research on involuntary outpatient commitment. 
  • New directions in the rational design of electrical and magnetic seizure therapies: individualized Low Amplitude Seizure Therapy (iLAST) and Magnetic Seizure Therapy (MST). 
  • New frontiers in psychiatric neuroimaging. 
  • New onset and remission of suicidal ideation among a depressed adult sample. 
  • New onset of neuropsychiatric symptoms in the elderly: possible primary hyperparathyroidism. 
  • New perspectives on techniques for the clinical psychiatrist: Brain stimulation, chronobiology and psychiatric brain imaging. 
  • New strategies for the treatment of posttraumatic stress disorder 
  • New treatment options to improve clinical outcomes 
  • Newer pharmacotherapies for depression in primary care: A literature synthesis 
  • Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). 
  • Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade. 
  • Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats. 
  • Nicotine and non-nicotine smoking factors differentially modulate craving, withdrawal and cerebral blood flow as measured with arterial spin labeling. 
  • Nicotine and nonnicotine factors in cigarette addiction. 
  • Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia. 
  • Nicotine deprivation influences P300 markers of cognitive control. 
  • Nicotine effects on adults with attention-deficit/hyperactivity disorder. 
  • Nicotine effects on learning in zebrafish: the role of dopaminergic systems. 
  • Nicotine increases anterior insula activation to expected and unexpected outcomes among nonsmokers. 
  • Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats. 
  • Nicotine preloading: the importance of a pre-cessation reduction in smoking behavior. 
  • Nicotine psychopharmacology 
  • Nicotine self-administration in animals and humans: similarities and differences. 
  • Nicotine skin patch treatment and adverse reactions: skin irritation, skin sensitization, and nicotine as a hapten. 
  • Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. 
  • Nicotine therapy in adulthood reverses the synaptic and behavioral deficits elicited by prenatal exposure to phenobarbital. 
  • Nicotine withdrawal modulates frontal brain function during an affective Stroop task 
  • Nicotine withdrawal modulates frontal brain function during an affective Stroop task. 
  • Nicotine-antipsychotic drugs interaction and sustained attention in rats 
  • Nicotine-haloperidol interactions and cognitive performance in schizophrenics. 
  • Nicotinic acetylcholine involvement in cognitive function in animals. 
  • Nicotinic attention-deficit/hyperactivity disorder treatment. 
  • Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. 
  • Nicotinic receptor modulation of attention: An endophenotype for therapeutic drug development 
  • Nicotinic systems and cognitive function. 
  • Nicotinic-serotonergic drug interactions and attentional performance in rats. 
  • Nighttime heart rate and survival in depressed patients post acute myocardial infarction. 
  • Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial. 
  • No association between RORA polymorphisms and PTSD in two independent samples. 
  • Nocturnal and early morning secretion of ACTH and cortisol in humans. 
  • Non-N-methyl-D-aspartate Autoimmune Encephalopathy and Catatonia Treated With Electroconvulsive Therapy: A Pediatric Case Series and Treatment Guidelines. 
  • Non-REM sleep EEG spectral analysis in insomnia 
  • Non-cholinergic strategies for treating and preventing Alzheimer's disease. 
  • Non-pharmacological treatment modalities in children and adolescents: A review of electroconvulsive therapy, transcranial magnetic stimulation, vagus nerve stimulation, magnetic seizure therapy, and deep brain stimulation 
  • Non-suicidal self-injury as a predictor of active and passive suicidal ideation among Iraq/Afghanistan war veterans. 
  • Non-suicidal self-injury with and without borderline personality disorder: differences in self-injury and diagnostic comorbidity. 
  • Noninvasive neuromodulation of the prefrontal cortex in mental health disorders. 
  • Nonmedical stimulant use among young Asian-Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals aged 12-34 years in the United States. 
  • Nonpharmacologic treatments for depression in patients with coronary heart disease. 
  • Nonsuicidal Self-Injury Disorder, Borderline Personality Disorder, and Lifetime History of Suicide Attempts among Male and Female Veterans with Mental Health Disorders. 
  • Nonsuicidal Self-Injury and Borderline Personality Features as Risk Factors for Suicidal Ideation Among Male Veterans With Posttraumatic Stress Disorder. 
  • Nonsuicidal self-injury and interpersonal violence in U.S. veterans seeking help for posttraumatic stress disorder. 
  • Nonsuicidal self-injury and suicide attempts in Iraq/Afghanistan war veterans. 
  • Nonsuicidal self-injury in men: a serious problem that has been overlooked for too long. 
  • Nonsuicidal self-injury in veterans: Prevalence, clinical characteristics, and gender differences from a national cohort. 
  • Normal female and male adolescent psychological development: an overview of theory and research. 
  • Normal smooth pursuit eye movements in volunteer subjects meeting schizotypal personality disorder criteria. 
  • Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). 
  • North Carolina Specialty Courts, Treatment Access, and the Substance Use Crisis: A Promising but Underfunded Model. 
  • Not So Fast: Recent Successes and Failures in Treating Depression. 
  • Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study. 
  • Novel rapid-acting sublingual nicotine tablet as a cigarette substitution strategy. 
  • Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. 
  • Nuclear magnetic resonance spectroscopy: a review of neuropsychiatric applications. 
  • Nutrition and Bipolar Depression. 
  • O12.3. PROTECTIVE FACTORS FOR PSYCHOTIC EXPERIENCES AMONGST ADOLESCENTS EXPOSED TO MULTIPLE FORMS OF VICTIMIZATION 
  • O8.3. CLINICAL AND FUNCTIONAL OUTCOMES IN YOUNG ADULTHOOD OF CHILDREN WITH PSYCHOTIC SYMPTOMS: A LONGITUDINAL TWIN COHORT STUDY 
  • OBESITY IS ASSOCIATED WITH POORER NEUROCOGNITIVE PERFORMANCE AMONG ADULTS WITH HIGH BLOOD PRESSURE 
  • ON SIMULATING POSTTRAUMATIC-STRESS-DISORDER - REPLY 
  • Obesity: a public health approach. 
  • Obesity: overview of an epidemic. 
  • Objective assessment of peritraumatic dissociation: psychophysiological indicators. 
  • Objective evidence of sleep disturbance in women with posttraumatic stress disorder. 
  • Observable Social Cognition--A Rating Scale: an interview-based assessment for schizophrenia. 
  • Observations on pain and suffering. 
  • Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. 
  • Obsessive compulsive symptoms in schizophrenia: frequency and clinical features. 
  • Obsessive-compulsive disorder in callers to the Anxiety Disorders Association of America. 
  • Occupational Reflection as Intervention in Inpatient Psychiatry. 
  • Occurrence of subcortical hyperintensities in elderly subjects with mania. 
  • Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. 
  • Olanzapine and fluoxetine effects on hippocampal pregnenolone and peripheral deoxycorticosterone: Relevance to therapeutic efficacy 
  • Olanzapine and haloperidol in first episode psychosis: two-year data. 
  • Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study. 
  • Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. 
  • Olanzapine increases allopregnanolone in the rat cerebral cortex. 
  • Olanzapine induced reductions in frontal lobe lactate levels correlate with treatment response in first episode psychosis 
  • Olanzapine on trial. 
  • Olanzapine, new-onset diabetes mellitus, and risk for insulin overdose. 
  • Omission of bupropion as a recommended treatment for PTSD. 
  • On Thoughts, Threats, and Throwing the Spear. 
  • On chronic fatigue syndrome. 
  • On the Concurrent Use of Self-System Therapy and Functional Magnetic Resonance Imaging-Guided Transcranial Magnetic Stimulation as Treatment for Depression. 
  • On the new clinical case conferences. 
  • On the psychometric validity of the domains of the PDSQ: an illustration of the bi-factor item response theory model. 
  • Once-monthly extended-release naltrexone injections improve opioid abstinence over 24 weeks compared with placebo. 
  • One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. 
  • One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites. 
  • One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies. 
  • One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. 
  • Ongoing life stressors and suicidal ideation among HIV-infected adults with depression. 
  • Online Repetitive Transcranial Magnetic Stimulation Enhances Working Memory Performance in Younger and Older Adults 
  • Onset and persistence of postpartum depression in an inner-city maternal health clinic system. 
  • Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis. 
  • Ontogenetic studies of tolerance development: effects of chronic morphine on the hypothalamic-pituitary-adrenal axis. 
  • Ontogeny of the behavioral response to dopamine agonists after chronic cocaine. 
  • Open trial of nefazodone for combat-related posttraumatic stress disorder. 
  • Open-label pilot study of ziprasidone for refractory generalized anxiety disorder. 
  • Operant conditioning: a new theoretical approach in psychosomatic medicine. 
  • Ophthalmology issues in schizophrenia. 
  • Opiate withdrawal in the neonatal rat: relationship to duration of treatment and naloxone dose. 
  • Opioid Self-Administration is Attenuated by Early-Life Experience and Gene Therapy for Anti-Inflammatory IL-10 in the Nucleus Accumbens of Male Rats. 
  • Opioid dysfunction and risk for hypertension: naloxone and blood pressure responses during different types of stress. 
  • Opioid use affects antioxidant activity and purine metabolism: preliminary results. 
  • Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose. 
  • Optimal interval for hot water immersion tail-flick test in rats. 
  • Optimization of a multinomial model for investigating hallucinations and delusions with source monitoring. 
  • Optimizing Stimulus Pulse Characteristics for Transcranial Magnetic Stimulation and Electroconvulsive Therapy via Device Development, Computational Modeling, and Biophysically-motivated Dosing Paradigms 
  • Optimizing Treatment for Insomnia. 
  • Optimizing outcome with antipsychotic treatment in first-episode schizophrenia: balancing efficacy and side effects. 
  • Optimizing the Effects of Theta-Burst Stimulation (TBS) 
  • Oral contraceptives and depressive symptomatology: biologic mechanisms. 
  • Orbitofrontal cortex volume and intrinsic religiosity in non-clinical psychosis. 
  • Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. 
  • Organic affective disorder in a patient with congenital adrenal hyperplasia. 
  • Organic anxiety disorder. Iatrogenic hyperthyroidism. 
  • Organic brain syndromes in DSM-III. 
  • Organization of the social cognition network predicts future depression and interpersonal impairment: a prospective family-based study 
  • Organizing and conducting clinical trials 
  • Origins of depression in later life. 
  • Oscillations of attachment in borderline personality disorder. 
  • Outcome in children with fetal isolated mild ventriculomegaly: A case study 
  • Outcome in children with fetal mild ventriculomegaly: a case series. 
  • Outcomes of early pubertal timing in young women: a prospective population-based study. 
  • Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial. 
  • Outpatient Mental Health Services in Mozambique: Use and Treatments. 
  • Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression. 
  • Overconfidence in false autobiographical memories in patients with schizophrenia. 
  • Overload: impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodeficiency virus cohort study. 
  • Overriding psychiatric advance directives: factors associated with psychiatrists' decisions to preempt patients' advance refusal of hospitalization and medication. 
  • Overt Aggression and Psychotic Symptoms in Patients with Schizophrenia Treated with Clozapine, Olanzapine, Risperidone, or Haloperidol 
  • Overview of psychiatric disorders and the role of newer antidepressants. 
  • P.2.137 Can the PANSS cognitive factor be a validsurrogate for neurocognon in schizophrenia? 
  • P.2.a.017 Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levels 
  • P.2.f.013 Clinical evidence for improvement in cognitive dysfunction in patients with major depressive disorder (MDD) after treatment with vortioxetine 
  • P.T. Barnum and the borderline personality disorder muddle (I: Reply) 
  • PERCEIVED SOCIAL SUPPORT IS RELEVANT IN THE MANAGEMENT OF PAIN AND DEPRESSION AMONG ADULTS WITH SICKLE CELL DISEASE (SCD) 
  • PERCEPTION OF COGNITIVE IMPAIRMENT IN OLDER ADULTS UNDERGOING CARDIAC SURGERY 
  • PERFORMANCE ON TESTS SENSITIVE TO FRONTAL-LOBE DYSFUNCTION AND DEFICIT-LIKE SYMPTOMS IN SCHIZOTYPAL PERSONALITY-DISORDER 
  • PET imaging of prefrontal dopamine D1 receptors in chronic ketamine human abusers: A model for schizophrenia 
  • PET studies of the influences of nicotine on neural systems in cigarette smokers. 
  • PIP syndrome. 
  • PL.05.01 The future of molecular pharmacology and drug discovery in psychiatry 
  • PLASMA OXYTOCIN CONCENTRATION AND DEPRESSIVE SYMPTOMS: A REVIEW OF CURRENT EVIDENCE AND DIRECTIONS FOR FUTURE RESEARCH. 
  • POPULATION DIFFERENCES IN ASSOCIATIONS OF SEROTONIN TRANSPORTER PROMOTER POLYMORPHISM (5HTTLPR) DI- AND TRIALLELIC GENOTYPES WITH BLOOD PRESSURE AND HYPERTENSION PREVALENCE 
  • POSITIVE FAMILY HISTORY AFFECTS NEUROPSYCHOLOGICAL PERFORMANCE IN HYPERTENSIVE PATIENTS 
  • PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin. 
  • PROFILES OF DISORDERED EATING BEHAVIORS IN TYPE 1 DIABETES 
  • PROPERTIES OF THE TELEPHONE INTERVIEW FOR COGNITIVE STATUS - APPLICATION IN EPIDEMIOLOGIC AND LONGITUDINAL-STUDIES 
  • PSYCHOLOGICAL CORRELATES OF CHRONIC BLOOD-GLUCOSE CONTROL IN DIABETIC CHILDREN AND ADOLESCENTS 
  • PSYCHOLOGICAL EFFECTS OF LIPID-LOWERING DRUGS 
  • PTSD Care Among Veterans With and Without Co-Occurring Substance Use Disorders. 
  • PTSD and substance abuse. 
  • PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors. 
  • PTSD in women is associated with a block in conversion of progesterone to the GABAergic neurosteroids allopregnanolone and pregnanolone measured in plasma. 
  • PTSD symptom clusters associated with physical health and health care utilization in rural primary care patients exposed to natural disaster. 
  • Pain catastrophizing in patients with noncardiac chest pain: relationships with pain, anxiety, and disability. 
  • Pain in depression: STAR*D study findings. 
  • Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. 
  • Palinacousis after closed-head injury in a patient with schizophrenia [13] 
  • Panel discussion: changing how we think about insomnia. 
  • Panic attacks and suicide attempts in mid-adolescence. 
  • Panic disorder: making clinical sense of the latest research. 
  • Parental history of hypertension and cardiovascular responses to behavioral stress in young black women. 
  • Parents' and teachers' concordance with children's self-ratings of suicidality: findings from a high-risk sample. 
  • Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. 
  • Paroxetine as a treatment for premenstrual dysphoric disorder. 
  • Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. 
  • Part 2. Adult ADHD: Clinical Criteria for Diagnosis and Management 
  • Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling. 
  • Partial REM sleep deprivation, schizophrenia and field articulation. 
  • Participant reactions to a pretreatment research assessment during a treatment outcome study for PTSD. 
  • Participation in trauma research: is there evidence of harm? 
  • Partnering in support of war zone veterans and their families 
  • Partners' ratings of combat veterans' anger. 
  • Parvalbumin Interneurons of the Mouse Nucleus Accumbens are Required For Amphetamine-Induced Locomotor Sensitization and Conditioned Place Preference. 
  • Pastoral care use among post-9/11 veterans who screen positive for mental health problems. 
  • Paternal history of mental illness associated with posttraumatic stress disorder among veterans. 
  • Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis. 
  • Pathophysiology of depression: The emerging role of substance P 
  • Pathophysiology of hypercortisolism in depression. 
  • Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback. 
  • Pathways into and through mental health services for children and adolescents. 
  • Pathways to PTSD, part II: Sexually abused children. 
  • Patient compliance with MAO inhibitor therapy. 
  • Patient preferences for ketamine-based antidepressant treatments in treatment-resistant depression: Results from a clinical trial and panel 
  • Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication. 
  • Patient, Therapist, and System Factors Influencing the Effectiveness of Prolonged Exposure for Veterans With Comorbid Posttraumatic Stress Disorder and Traumatic Brain Injury. 
  • Patient-centered mental health care for female veterans. 
  • Patients of psychiatrists and psychologists in office-based practice: 1980. 
  • Patients' Civil Liberties: Improving Policies While Keeping the Patient at the Center. 
  • Patients' Preferences Related to Benefits, Risks, and Formulations of Schizophrenia Treatment. 
  • Patterns and correlates of major depression in Chinese adults: a cross-sectional study of 0.5 million men and women. 
  • Patterns and predictors of pain following lung transplantation. 
  • Patterns of change in hostility from college to midlife in the UNC Alumni Heart Study predict high-risk status. 
  • Patterns of cocaine abuse and indications for treatment 
  • Patterns of justice involvement among adults with schizophrenia and bipolar disorder: key risk factors. 
  • Patterns of pharmacotherapy and treatment response in elderly adults with bipolar disorder. 
  • Perceived Feasibility, Acceptability, and Cultural Adaptation for a Mental Health Intervention in Rural Haiti. 
  • Perceived Social Support among Depressed Elderly, Middle-Aged, and Young Adult Samples 
  • Perceived burden and family functioning among informal caregivers of individuals living with schizophrenia in Tanzania: a cross-sectional study. 
  • Perceived cannabis use norms and cannabis use among adolescents in the United States. 
  • Perceived coercion among jail diversion participants in a multisite study. 
  • Perceived social support among depressed elderly, middle-aged, and young-adult samples: cross-sectional and longitudinal analyses. 
  • Perceived social support as a predictor of mortality in coronary patients: effects of smoking, sedentary behavior, and depressive symptoms. 
  • Perceived stress in anxiety disorders and the general population: a study of the Sheehan stress vulnerability scale. 
  • Perceptual learning with right unilateral versus bilateral electroconvulsive therapy. 
  • Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone. 
  • Performance feedback deficit in geriatric depression. 
  • Performance of depression rating scales in patients with chronic kidney disease: an item response theory-based analysis. 
  • Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests. 
  • Performance of patients with schizophrenia on a pen and paper visuospatial working memory task with short delay. 
  • Performance on a working memory task can be differentially impaired or improved with rTMS stimulation of the precuneus: Frequency- and time-dependent effects 
  • Perfusion abnormalities and decision making in cocaine dependence. 
  • Perinatal depression in HIV-infected African women: a systematic review. 
  • Perioperative pain management. 
  • Peripheral alpha-adrenergic receptor subtypes. 
  • Peritraumatic dissociation and posttraumatic stress in male Vietnam theater veterans. 
  • Permanent, sex-selective effects of prenatal or adolescent nicotine exposure, separately or sequentially, in rat brain regions: indices of cholinergic and serotonergic synaptic function, cell signaling, and neural cell number and size at 6 months of age. 
  • Peroneal palsy in depressed patients. Weight loss, psychomotor retardation predispose patients to this complication. 
  • Peroneal palsy in depression. 
  • Perseverative behaviour after amphetamine; dissociation of response tendency from reward association. 
  • Persistence of combat-related posttraumatic stress symptoms for 75 years. 
  • Persistent Depressive Symptoms in a Population With High Levels of Occupational Stress: Trajectories Offer Insights Into Both Chronicity and Resilience. 
  • Persistent cardiovascular effects with repeated caffeine administration. 
  • Persistent cortisol non-suppression after clinical recovery predicts symptomatic relapse in unipolar depression. 
  • Persistent infection with neurotropic herpes viruses and cognitive impairment. 
  • Persistent pain and depression: a biopsychosocial perspective. 
  • Personal genomes in progress: From the human genome project to the Personal Genome Project 
  • Personal genomes in progress: From the human genome project to the Personal Genome Project 
  • Personal genomes in progress: from the human genome project to the personal genome project. 
  • Personality Traits Are Associated with Academic Achievement in Medical School: A Nationally Representative Study. 
  • Personality and problem gambling: a prospective study of a birth cohort of young adults. 
  • Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. 
  • Personality disorders at the interface of psychiatry and the law: legal use and clinical classification. 
  • Personality facets and all-cause mortality among Medicare patients aged 66 to 102 years: a follow-on study of Weiss and Costa (2005). 
  • Personality--life event congruence effects in late-life depression. 
  • Perspectives on depression, mild cognitive impairment, and cognitive decline. 
  • Perspectives on healthcare leadership opportunities for psychologists: An interview with Antonette Zeiss. 
  • Perspectives on pain-related suffering: presentations and discussions 
  • Perspectives on the Management of Vascular Depression. 
  • Pervasively Thinner Neocortex as a Transdiagnostic Feature of General Psychopathology. 
  • Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction. 
  • Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study. 
  • Pharmacogenetics studies in STAR*D: strengths, limitations, and results. 
  • Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure. 
  • Pharmacokinetics and clinical effects of multidose sublingual triazolam in healthy volunteers. 
  • Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients. 
  • Pharmacokinetics of oral triazolam in children. 
  • Pharmacologic and behavioral interventions to improve cardiovascular risk factors in adults with serious mental illness: a systematic review and meta-analysis. 
  • Pharmacologic treatment of acute and chronic stress following trauma: 2006. 
  • Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use. 
  • Pharmacological agents to treat severe neuropsychiatric symptoms in major neurocognitive disorders. 
  • Pharmacotherapy for complicated depressions in women 
  • Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions. 
  • Pharmacotherapy for anxiety disorders in children and adolescents: An evidence-based medicine review 
  • Pharmacotherapy for post-traumatic stress disorder. 
  • Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions. 
  • Pharmacotherapy of chronic hospitalized schizophrenics: Diagnosis and treatment 
  • Pharmacotherapy of chronic hospitalized schizophrenics: Prescription practices 
  • Pharmacotherapy of generalized anxiety disorder. 
  • Pharmacotherapy of impaired affect in recovering schizophrenic patients. 
  • Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome. 
  • Pharmacotherapy of social anxiety disorder. 
  • Pharmacotherapy of social anxiety disorder: what does the evidence tell us? 
  • Pharmacotherapy of social phobia. 
  • Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia. 
  • Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism 
  • Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder. 
  • Phobia: prevalence and risk factors. 
  • Phobic anxiety and increased risk of mortality in coronary heart disease. 
  • Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. 
  • Phosphorylation of MeCP2 in Reward-Related Circuits is Required for Amphetamine-Induced Conditioned Place Preference in Mice 
  • Photoperiod affects the expression of sex and species differences in leukocyte number and leukocyte trafficking in congeneric hamsters. 
  • Physical activity and depressive symptoms among adolescents in a school-based sample. 
  • Physical activity and depressive symptoms among pregnant women: the PIN3 study. 
  • Physical activity and psychosocial function following cardiac rehabilitation: One-year follow-up of the ENHANCED study. 
  • Physician Beliefs about Physical and Mental Competency of Patients Applying for Concealed Weapon Permits. 
  • Physician race and treatment preferences for depression, anxiety, and medically unexplained symptoms. 
  • Physicians' Beliefs about the nature of addiction: a survey of primary care physicians and psychiatrists. 
  • Physicians' beliefs about faith-based treatments for alcoholism. 
  • Physiologic impairment of olfactory stimulus processing in schizophrenia. 
  • Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. 
  • Physiological characteristics of Magnetic Seizure Therapy (MST) induced seizures in nonhuman primates and patients with major depression 
  • Physiological predictors of posttraumatic stress disorder. 
  • Pilot RCT of the Attempted Suicide Short Intervention Program (ASSIP) adapted for rapid delivery during hospitalization to adult suicide attempt patients with substance use problems. 
  • Pilot Study of An Intracranial Electroencephalography Biomarker of Depressive Symptoms in Epilepsy. 
  • Pilot Study of Sustained Oxytocin Treatment in Children and Adolescents with Autistic Disorder 
  • Pituitary abnormalities in eating disorders: further evidence from MRI studies. 
  • Pituitary and Adrenal Changes in Depression 
  • Pivotal studies of clonazepam in panic disorder. 
  • Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders. 
  • Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. 
  • Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. 
  • Plasma GABA in mood disorders. 
  • Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder. 
  • Plasma GABA predicts acute response to divalproex in mania. 
  • Plasma HVA correlates of attentional performance in unmedicated schizophrenics 
  • Plasma acylcarnitines as metabolic signatures of longitudinal decline in health-related quality of life measure in community-dwelling older adults 
  • Plasma amyloid beta 1-42 levels in geriatric depression: A pilot study 
  • Plasma dexamethasone concentrations and the dexamethasone suppression test. 
  • Plasma haloperidol levels drawn at neuroleptic threshold doses: A pilot study 
  • Plasma homovanillic acid and performance on motor and cognitive tasks in community-dwelling elderly: MacArthur studies of successful aging. 
  • Plasma oxytocin and vasopressin levels in young and older men and women: Functional relationships with attachment and cognition. 
  • Platelet MAO activity in posttraumatic stress disorder. 
  • Platelet MAO inhibition following tricyclic antidepressant therapy. 
  • Platelet [3H]-imipramine binding and leukoencephalopathy in geriatric depression. 
  • Platelet alpha 2-adrenergic receptors in schizophrenic patients before and after phenothiazine treatment. 
  • Platelet alpha-2-adrenergic dysfunction in negative symptom schizophrenia: a preliminary study. 
  • Platelet alpha2-adrenergic receptor coupling efficiency to Gi protein in subjects with post-traumatic stress disorder and normal controls. 
  • Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome. 
  • Platelet gamma-aminobutyrate-alpha-ketoglutarate transaminase (GABA-T) in schizophrenia. 
  • Platelet monoamine oxidase activity and the classification of depression. 
  • Platelet monoamine oxidase activity in schizophrenia. 
  • Police Mental Health: A Neglected Element of Police Reform. 
  • Political violence and mental health in Nepal: prospective study. 
  • Poly-victimisation and Adolescent Psychotic Symptoms in a Nationally-Representative Prospective Cohort Study of Twins 
  • Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia. 
  • Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls. 
  • Polypharmacy in pregnant women with major psychiatric illness: a pilot study. 
  • Polysomnographic findings and dexamethasone nonsuppression in unipolar depression: a replication and extension. 
  • Polysomnographic findings in recently drug-free and clinically remitted depressed patients. 
  • Polysomnographic parameters in first-degree relatives of unipolar probands. 
  • Poor executive function at age 13 predicts later schizophreniform disorder: A longitudinal birth cohort study 
  • Portuguese version of Duke Religious Index - DUREL 
  • Position statement on school-based health clinics 
  • Positive Association Between Nightmares and Heart Rate Response to Loud Tones: Relationship to Parasympathetic Dysfunction in PTSD Nightmares. 
  • Positive Correlation Between Nightmares and Heart Rate Response to Loud Tones Supports Parasympathetic Dysfunction in Posttraumatic Stress Disorder 
  • Positive and negative valence systems in major depression have distinct clinical features, response to antidepressants, and relationships with immunomarkers. 
  • Possibilities within acceptance and commitment therapy for approaching moral injury 
  • Possible bipolar nature of irritability in major depressive disorder. 
  • Possible lack of anticholinergic effects with mianserin: A pilot study 
  • Post Hoc Analysis of the Impact of Lemborexant on Patient-Reported Sleep and Insomnia Severity in Adults with Insomnia and Depression Histories. 
  • Post traumatic stress disorder: Guidelines for investigating efficacy of pharmacological intervention 
  • Post-Katrina stabilization of the LSU/Ochsner Psychiatry Residency Program: caveats for disaster preparedness. 
  • Post-partum mood change in Jamaican women: a description and discussion on its significance. 
  • Post-traumatic stress after terrorist attack: psychological reactions following the US embassy bombing in Nairobi: Naturalistic study. 
  • Post-traumatic stress disorder in Vietnam veterans: An experimental validation of the DSM-III diagnostic criteria 
  • Post-traumatic stress disorder in the community: an epidemiological study. 
  • Post-traumatic stress disorder in women: current concepts and treatments. 
  • Post-traumatic stress disorder. 
  • Post-traumatic symptom severity mediates the association between combat exposure and suicidal ideation in veterans. 
  • Poster #143 AT RISK FOR PSYCHOSIS: THE ROLE OF COGNITION 
  • Poster #199 CLINICAL TRIALS OF POTENTIAL COGNITIVE-ENHANCING DRUGS IN SCHIZOPHRENIA: WHAT HAVE WE LEARNED SO FAR? 
  • Poster Abstracts 
  • Posterior fossa abnormalities in major depression: a controlled magnetic resonance imaging study. 
  • Postictal reductions in rCBF following ECT: Preliminary findings with fully-quantified PET. 
  • Postpartum psychiatric syndromes. 
  • Postsynaptic Mechanisms Render Syn I/II/III Mice Highly Responsive to Psychostimulants. 
  • Posttraumatic Stress Disorder Symptom Cluster Structure in Prolonged Exposure Therapy and Virtual Reality Exposure. 
  • Posttraumatic Stress Disorder Treatment Effects on Cardiovascular Physiology: A Systematic Review and Agenda for Future Research. 
  • Posttraumatic Stress Disorder and Common Genetic Variants Affect Subcortical Brain Volumes in Recent Military Veterans 
  • Posttraumatic Stress Disorder in the Elderly. 
  • Posttraumatic distress and coping strategies among rescue workers after an earthquake. 
  • Posttraumatic growth in treatment-seeking female assault victims. 
  • Posttraumatic mental and physical health correlates of forgiveness and religious coping in military veterans. 
  • Posttraumatic stress among young children after the death of a friend or acquaintance in a terrorist bombing. 
  • Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing. 
  • Posttraumatic stress disorder and interpersonal process in homeless veterans participating in a peer mentoring intervention: Associations with program benefit. 
  • Posttraumatic stress disorder and smoking cessation in veteran smokers 
  • Posttraumatic stress disorder and smoking relapse: A theoretical model. 
  • Posttraumatic stress disorder and traumatic brain Injury: Sex differences in veterans. 
  • Posttraumatic stress disorder in Iraeli combat veterans 
  • Posttraumatic stress disorder in callers to the Anxiety Disorders Association of America. 
  • Posttraumatic stress disorder: Recent advances in basic science and clinical research 
  • Posttraumatic stress disorder: acquisition, recognition, course, and treatment. 
  • Posttraumatic stress disorder: anxiety or traumatic stress disorder? 
  • Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment. 
  • Posttraumatic stress disorder: epidemiology and health-related considerations. 
  • Posttraumatic stress without trauma in children. 
  • Posttraumatic stress, heart rate variability, and the mediating role of behavioral health risks. 
  • Posttraumatic stress, mental health professionals, and the clergy: a need for collaboration, training, and research. 
  • Postural effects on blood pressure reactivity: implications for studies of laboratory-field generalization. 
  • Potential interactions between GABAb and cholinergic systems: baclofen augments scopolamine-induced performance deficits in the eight-arm radial maze. 
  • Potential role of pregabalin in the treatment of lithium-induced tremor: a case report. 
  • Practical aspects of MAO inhibitor therapy. 
  • Practical assessment and evaluation of mental health problems following a mass disaster. 
  • Practical evidence-based medicine. 
  • Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. 
  • Practice guideline for the treatment of patients with nicotine dependence. American Psychiatric Association. 
  • Practice guidelines in mental health and addiction services: contributions from the American College of Mental Health Administration. 
  • Practice patterns in the diagnosis and treatment of anxiety and depression in the medically ill. A survey of psychiatrists. 
  • Practitioner versus medication-expert opinion on psychiatric pharmacotherapy of mentally retarded patients with mental disorders. 
  • Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report. 
  • Preadult onset vs. adult onset of major depressive disorder: a replication study. 
  • Precision non-implantable neuromodulation therapies: a perspective for the depressed brain. 
  • Preclinical atherosclerosis covaries with individual differences in reactivity and functional connectivity of the amygdala. 
  • Preclinical perspectives on posttraumatic stress disorder criteria in DSM-5. 
  • Predict Resident Exam Performance (PREP) study. 
  • Predicting antipsychotic use in children. 
  • Predicting future suicidal events in adolescents using the Concise Health Risk Tracking Self-Report (CHRT-SR). 
  • Predicting persistent alcohol problems: a prospective analysis from the Great Smoky Mountain Study. 
  • Predicting personality in adulthood from college MMPI scores: implications for follow-up studies in psychosomatic medicine. 
  • Predicting response to amitriptyline in posttraumatic stress disorder. 
  • Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. 
  • Predicting the risk of future depression among school-attending adolescents in Nigeria using a model developed in Brazil. 
  • Predicting three types of dissociation in female survivors of intimate partner violence. 
  • Prediction from low birth weight to female adolescent depression: a test of competing hypotheses. 
  • Prediction in drug abuse: Cocaine interactions with alcohol and buprenorphine 
  • Prediction in drug abuse: cocaine interactions with alcohol and buprenorphine. 
  • Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials. 
  • Prediction of differential adult health burden by conduct problem subtypes in males. 
  • Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: evidence from 2 birth cohorts. 
  • Prediction of nonremission to antidepressant therapy using diffusion tensor imaging. 
  • Prediction of numbing and effortful avoidance in female rape survivors with chronic PTSD. 
  • Prediction of response to fluoxetine and placebo in children and adolescents with major depression: a hypothesis generating study. 
  • Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings. 
  • Prediction of smoking cessation with treatment: the emerging contribution of brain imaging research. 
  • Prediction of the utility of a switch from unilateral to bilateral ECT in the elderly using treatment 2 ictal EEG indices. 
  • Prediction of treatment outcomes to exercise in patients with nonremitted major depressive disorder. 
  • Predictive relationships between chronic pain and negative emotions: a 4-month daily process study using Therapeutic Interactive Voice Response (TIVR). 
  • Predictive value of family history on severity of illness: the case for depression, anxiety, alcohol dependence, and drug dependence. 
  • Predictors and patterns of participant adherence to a cortisol collection protocol. 
  • Predictors of High-Intensity Psychiatric Service Utilization by Veterans Health Administration Patients With Early Psychosis. 
  • Predictors of acute and posttraumatic stress symptoms in parents following their child's cancer diagnosis. 
  • Predictors of antidepressant use among older adults: have they changed over time? 
  • Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. 
  • Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. 
  • Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. 
  • Predictors of attrition during one year of depression treatment: a roadmap to personalized intervention. 
  • Predictors of children's involvement in parents' treatment among homeless veterans in community residential care. 
  • Predictors of depression recovery in HIV-infected individuals managed through measurement-based care in infectious disease clinics. 
  • Predictors of emotional numbing in posttraumatic stress disorder. 
  • Predictors of intimate partner violence revictimization: the relative impact of distinct PTSD symptoms, dissociation, and coping strategies. 
  • Predictors of mental health care use among male and female veterans deployed in support of the wars in Afghanistan and Iraq. 
  • Predictors of nonresponse to treatment in primary care patients with dysthymia. 
  • Predictors of posttraumatic outcomes following the 1999 Taiwan earthquake. 
  • Predictors of primary care physicians' self-reported intention to conduct suicide risk assessments. 
  • Predictors of recurrence in remitted late-life depression. 
  • Predictors of response to monoamine oxidase inhibitors: do they exist? 
  • Predictors of suicidal ideation in a gender-stratified sample of OEF/OIF veterans. 
  • Predictors of therapeutic response to haloperidol in acute schizophrenia. 
  • Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. 
  • Predictors of treatment engagement in ethnically diverse, urban children receiving treatment for trauma exposure. 
  • Predictors of treatment response in patients with posttraumatic stress disorder. 
  • Predictors of workforce turnover in a transported treatment program. 
  • Preferences for psychiatric advance directives among Latinos: views on advance care planning for mental health. 
  • Preferential amygdala reactivity to the negative assessment of neutral faces. 
  • Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans. 
  • Preferred intensity exercise for adolescents receiving treatment for depression: a pragmatic randomised controlled trial. 
  • Prefrontal mechanisms for executive control over emotional distraction are altered in major depression. 
  • Prefrontal neuropsychological predictors of treatment remission in late-life depression. 
  • Prefrontal white matter lesions and prefrontal task impersistence in depressed and nondepressed elders. 
  • Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype. 
  • Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study. 
  • Pregabalin in generalized anxiety disorder: a placebo-controlled trial. 
  • Pregnancy anxiety and comorbid depression and anger: effects on the fetus and neonate. 
  • Pregnenolone Rescues Schizophrenia-Like Behavior in Dopamine Transporter Knockout Mice 
  • Pregnenolone alterations in parietat cortex are associated with death by suicide in patients with schizophrenia 
  • Pregnenolone reductions in parietal cortex are associated with suicide in patients with schizophrenia 
  • Preliminary Evidence for Emotion Dysregulation as a Mechanism Underlying Poor Sleep Quality in Borderline Personality Disorder. 
  • Preliminary study of carbamazepine in post-traumatic stress disorder. 
  • Premenstrual mood changes: A [feminist] guide to evaluation and treatment 
  • Premenstrual symptom changes and plasma beta-endorphin/beta-lipotropin throughout the menstrual cycle 
  • Premenstrual symptoms in black and white community samples. 
  • Premorbid behavioral and intellectual functioning in schizophrenia patients with poor response to treatment with antipsychotic drugs. 
  • Premorbid sociosexual functioning and long-term outcome in schizophrenia. 
  • Prenatal dysthymia versus major depression effects on maternal cortisol and fetal growth. 
  • Prenatal mild ventriculomegaly predicts abnormal development of the neonatal brain. 
  • Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal. 
  • Prenatal nicotine exposure alters the responses to subsequent nicotine administration and withdrawal in adolescence: Serotonin receptors and cell signaling. 
  • Prenatal opioid exposure inhibits microglial sculpting of the dopamine system selectively in adolescent male offspring. 
  • Prenatal smoking and early childhood conduct problems: testing genetic and environmental explanations of the association. 
  • Prenatal smoking and young children’s antisocial behavior: Testing genetic and environmental explanations of the association 
  • Preparing Psychiatrists for Leadership Roles in Healthcare 
  • Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial. 
  • Preserved working memory and altered brain activation in persons at risk for psychosis. 
  • Pressor hyperreactivity is a predictor of the future development of essential hypertension. 
  • Pretreatment brain connectivity during positive emotion upregulation predicts decreased anhedonia following behavioral activation therapy for depression. 
  • Prevalence and Predictors of Moral Injury Symptoms in Health Care Professionals. 
  • Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study. 
  • Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. 
  • Prevalence and development of psychiatric disorders in childhood and adolescence. 
  • Prevalence and diagnostic reliability of methadone maintenance detoxification fear. 
  • Prevalence and factors associated with antenatal depressive symptoms among women enrolled in Option B+ antenatal HIV care in Malawi: a cross-sectional analysis. 
  • Prevalence and factors associated with diagnosed depression among hospitalized cancer patients with metastatic disease. 
  • Prevalence and impact of obsessive-compulsive symptoms in depression: a STAR*D report. 
  • Prevalence and incidence of probable perinatal depression among women enrolled in Option B+ antenatal HIV care in Malawi. 
  • Prevalence of HIV infection in a general psychiatric outpatient population. 
  • Prevalence of antithyroid antibodies in mood disorders 
  • Prevalence of baseline lipid monitoring in patients prescribed second-generation antipsychotics during their index hospitalization: a retrospective cohort study. 
  • Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. 
  • Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal. 
  • Prevalence of depression and its treatment in an elderly population: the Cache County study. 
  • Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. 
  • Prevalence of obstructive sleep apnea in suicidal patients with major depressive disorder. 
  • Prevalence of psychiatric disorders among incarcerated women. II. Convicted felons entering prison. 
  • Prevalence of psychiatric morbidity in United States military spouses: The Millennium Cohort Family Study. 
  • Prevalence of seasonal affective disorder. 
  • Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. 
  • Prevalence of traumatic brain injury in incarcerated groups compared to the general population: a meta-analysis. 
  • Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children. 
  • Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder. 
  • Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. 
  • Prevalence, factorial structure, and clinical correlates of first rank symptoms in urban, African-American patients with first-episode nonaffective psychosis 
  • Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. 
  • Preventing Suicide Through Better Firearm Safety Policy in the United States. 
  • Preventing suicide in primary care patients: the primary care physician's role. 
  • Preventing the unpredicted: managing violence risk in mental health care. 
  • Prevention in the Era of COVID-19 and the Role of Behavioral Health Care Teams. 
  • Primary Care Physicians', Psychiatrists', and Oncologists' Coordination While Prescribing Medications for Patients With Multiple Chronic Conditions. 
  • Primary care physicians' and psychiatrists' approaches to treating mild depression. 
  • Primary care physicians' and psychiatrists' willingness to refer to religious mental health providers. 
  • Primate models of transcranial magnetic stimulation (TMS) effects 
  • Priming deficits in patients with dementia of the Alzheimer type. 
  • Primum non nocere (first do no harm): symptom worsening and improvement in female assault victims after prolonged exposure for PTSD. 
  • Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects. 
  • Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. 
  • Private health insurance coverage for substance abuse and mental health services, 1995 to 1998. 
  • Probability of Major Depression Classification Based on the SCID, CIDI, and MINI Diagnostic Interviews: A Synthesis of Three Individual Participant Data Meta-Analyses. 
  • Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews. 
  • Probing reward function in post-traumatic stress disorder with beautiful facial images. 
  • Problem-solving therapy for the treatment of depression in primary care (PST-PC): A brief and practical treatment approach 
  • Problems associated with the diagnosis of depression. 
  • Problems of Southeast Asian children in a refugee camp. 
  • Proceedings of the 2013 CINP summit: innovative partnerships to accelerate CNS drug discovery for improved patient care. 
  • Producing Guanxi: Sentiment, Self and Subculture in a North China Village 
  • Profiling posttraumatic functional impairment. 
  • Prognosis for psychophysiologic disorders in the naval service. 
  • Progression of subcortical ischemic disease from vascular depression to vascular dementia. 
  • Progression to AIDS: the effects of stress, depressive symptoms, and social support. 
  • Project among African-Americans to explore risks for schizophrenia (PAARTNERS): recruitment and assessment methods. 
  • Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. 
  • Prolactin response to ECT: Effects of electrode placement and dosage 
  • Prolactin response to ect: Effects of electrode placement and dosage 
  • Prolactin response to electroconvulsive therapy - Response 
  • Prolactin response to electroconvulsive therapy. 
  • Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage. 
  • Prolactin-related and metabolic adverse effects of atypical antipsychotic agents. 
  • Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine. 
  • Prolonged Exposure Therapy With Veterans and Active Duty Personnel Diagnosed With PTSD and Traumatic Brain Injury. 
  • Prolonged confusional state and EEG seizure activity following concurrent ECT and lithium use. 
  • Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression. 
  • Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. 
  • Promising Strategies for Treatment-Resistant Depression 
  • Promoting mental health recovery and improving clinical assessment using video technology. 
  • Promoting trauma-informed parenting of children in out-of-home care: An effectiveness study of the resource parent curriculum. 
  • Proof of concept study to develop a novel connectivity-based electric-field modelling approach for individualized targeting of transcranial magnetic stimulation treatment. 
  • Proof-of-Concept Randomized Controlled Trial with Pregnenolone in Mild Traumatic Brain Injury 
  • Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia. 
  • Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. 
  • Proof-of-concept trial with the neurosterold pregnenolone targeting neurocognitive and negative symptoms in schizophrenia 
  • Properties of the telephone interview for cognitive status: Application in epidemiological and longitudinal studies 
  • Propranolol treatment of an ECT-related ventricular arrythmia. 
  • Prospective Study of Major Loss Life Events and Risk for Suicidal Thoughts and Behaviors Among Adolescents and Young Adults. 
  • Prospective assessment of electroencephalographic sleep in remitted major depression. 
  • Prospective association between suicide cognitions and emotional responses to a laboratory stressor: The mediating role of nightly subjective sleep quality. 
  • Prospective study of externalizing and internalizing subtypes of posttraumatic stress disorder and their relationship to mortality among Vietnam veterans. 
  • Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. 
  • Prospective, observational cohort study of JAKE™, an autism knowledge 
  • Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. 
  • Protective factors and risk modification of violence in Iraq and Afghanistan War veterans. 
  • Protective factors for psychotic experiences amongst adolescents exposed to multiple forms of victimization. 
  • Protective mechanisms and prevention of violence and aggression in veterans. 
  • Protein kinase a in major depression: the link between hypothalamic-pituitary-adrenal axis hyperactivity and neurogenesis. 
  • Proton spectroscopy of human brain: effects of age and sex. 
  • Providers' Behaviors and Beliefs on Prescribing Antipsychotic Medication to Children: A Qualitative Study. 
  • Providers' perceptions of barriers to the treatment of emotional disorders in non-urban primary care clinics 
  • Proximal Risk Factors for Short-Term Community Violence Among Adults With Mental Illnesses. 
  • Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study. 
  • Pseudoseizures: recognition and treatment. 
  • Psychiatric Care of the Post-September 11 Combat Veteran: A Review. 
  • Psychiatric Disorders in Individuals with Alcoholic Parents: An Epidemiologic Enquiry 
  • Psychiatric advance directives among public mental health consumers in five U.S. cities: prevalence, demand, and correlates. 
  • Psychiatric advance directives and reduction of coercive crisis interventions. 
  • Psychiatric advance directives and social workers: an integrative review. 
  • Psychiatric advance directives: a tool for consumer empowerment and recovery. 
  • Psychiatric advance directives: an alternative to coercive treatment? 
  • Psychiatric and medical comorbidities of bipolar disorder. 
  • Psychiatric and psychosocial correlates of sexual risk behavior among adults with severe mental illness. 
  • Psychiatric co-morbidities and patients with head and spinal cord trauma. Effects on acute hospital care. 
  • Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential. 
  • Psychiatric consequences of the 1998 US Embassy bombing in Nairobi, Kenya 
  • Psychiatric consultation in a Vietnamese refugee camp. 
  • Psychiatric disease in the genomic era: rational approach. 
  • Psychiatric disease in the twenty-first century: The case for subcortical ischemic depression. 
  • Psychiatric disorder, impairment, and service use in rural African American and white youth. 
  • Psychiatric disorders after terrorist bombings among rescue workers and bombing survivors in Nairobi and rescue workers in Oklahoma City. 
  • Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. 
  • Psychiatric disorders in adult children of alcoholics: data from the Epidemiologic Catchment Area project. 
  • Psychiatric disorders in pediatric primary care. Prevalence and risk factors. 
  • Psychiatric disorders in primary care patients receiving complementary medical treatments. 
  • Psychiatric disorders. A rural/urban comparison. 
  • Psychiatric education in the State Hospital: A current approach 
  • Psychiatric education in the emergency room: must teaching stop at 5 p.m.? 
  • Psychiatric emergency service use after implementation of managed care in a public mental health system. 
  • Psychiatric health service areas in the southeast. 
  • Psychiatric impairment, social contact, and violent behavior: evidence from a study of outpatient-committed persons with severe mental disorder. 
  • Psychiatric morbidity during the early phase of coronary care for myocardial infarction: association with cardiac diagnosis and outcome. 
  • Psychiatric outcomes of bullying victimization: a study of discordant monozygotic twins. 
  • Psychiatric sequelae of traumatic brain injury: a case report. 
  • Psychiatric syncope: a new look at an old disease. 
  • Psychiatric violence risk assessment 
  • Psychiatrists' and primary care physicians' beliefs about overtreatment of depression and anxiety. 
  • Psychiatrists' judgments about antipsychotic benefit and risk outcomes and formulation in schizophrenia treatment. 
  • Psychiatrists' transition from training to career: stress and mastery. 
  • Psychiatry Takes to the Streets 
  • Psychiatry and Deaths of Despair. 
  • Psychiatry and social values: the American Psychiatric Association and immigration restriction, 1880-1930. 
  • Psychiatry and the oldest old. 
  • Psychiatry's Opportunity to Prevent the Rising Burden of Age-Related Disease. 
  • Psychoanalytic and cognitive therapies: a comparison of theory and tactics. 
  • Psychodynamic psychotherapy for PTSD. 
  • Psychogenomics and psychiatric practice, a new paradigm 
  • Psychological Functioning, Neurosteroids, and White Matter Microstructure in the Context of Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury 
  • Psychological Impact of COVID-19 on Minority Women. 
  • Psychological Impact of COVID-19 on Pregnancy. 
  • Psychological Inflexibility Predicts of Suicidal Ideation Over Time in Veterans of the Conflicts in Iraq and Afghanistan. 
  • Psychological and contextual risk factors for first-onset depression among adolescents and young people around the globe: A systematic review and meta-analysis. 
  • Psychological and physiological effects of physical conditioning on the elderly. 
  • Psychological aspects of hypertension. II. The differential influence of interview variables on blood pressure. 
  • Psychological changes accompany aerobic exercise in healthy middle-aged adults. 
  • Psychological distress among medically complex veterans with a recent emergency department visit. 
  • Psychological distress and alcohol use disorder during the COVID-19 era among middle- and low-income U.S. adults. 
  • Psychological outcomes following sexual assault: Differences by sexual assault setting. 
  • Psychological treatments delivered by community health workers in low-resource government health systems: effectiveness of group interpersonal psychotherapy for caregivers of children affected by nodding syndrome in Uganda. 
  • Psychological variables in hypertension: relationship to casual or ambulatory blood pressure in men. 
  • Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients. 
  • Psychometric detection of fabricated symptoms of posttraumatic stress disorder. 
  • Psychometric properties of the Persian version of preschool age psychiatric assessment (PAPA) for attention-deficit/hyperactivity disorder: Based on DSM-5. 
  • Psychometric properties of the Quick Inventory of Depressive Symptomatology in adolescents. 
  • Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. 
  • Psychometric properties of the UCLA PTSD reaction index. part II: investigating factor structure findings in a national clinic-referred youth sample. 
  • Psychometric properties of the UCLA PTSD reaction index: part I. 
  • Psychometric properties of the concise health risk tracking (CHRT) in adolescents with suicidality. 
  • Psychometric properties of the moral injury symptom scale among Chinese health professionals during the COVID-19 pandemic. 
  • Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam. 
  • Psychomotor retardation in depression: biological underpinnings, measurement, and treatment. 
  • Psychoneuroendocrinology and brain imaging in depression. 
  • Psychoneuroendocrinology of schizophrenia. 
  • Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys. 
  • Psychopharmacology and Leonhard's classification of chronic schizophrenias 
  • Psychopharmacology curriculum field test. 
  • Psychosis Secondary to Brain Tumor. 
  • Psychosis in Parkinson's disease: diagnosis and treatment. 
  • Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. 
  • Psychosocial and physical correlates of chronic depression. 
  • Psychosocial and physical predictors of anginal pain relief with medical management. 
  • Psychosocial benefits of three formats of a standardized behavioral stress management program. 
  • Psychosocial context of antidepressant response. 
  • Psychosocial correlates of job strain in a sample of working women. 
  • Psychosocial protective factors and suicidal ideation: Results from a national longitudinal study of veterans. 
  • Psychosocial risk factors and urban/rural differences in the prevalence of major depression. 
  • Psychosocial risk factors for CHD and biobehavioral mechanisms: The role of CNS serotonin and serotonin-related genes 
  • Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial. 
  • Psychotherapeutic Treatment of Bipolar Depression. 
  • Psychotherapeutic treatment of opiate addiction. 
  • Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? 
  • Psychotherapy in the Third Reich: Goering Institute by Geoffrey Cocks, 
  • Psychotherapy in the Third Reich: The Göring Institute 
  • Psychotherapy in the overall management strategy for social anxiety disorder: Comments 
  • Psychotic disorders cause the greatest mortality disparity among mental disorders, though more deaths are attributable overall to mood and anxiety disorders. 
  • Psychotic experiences and risk of death in the general population: 24-27 year follow-up of the Epidemiologic Catchment Area study. 
  • Psychotropic drugs on general medical and surgical wards of a teaching hospital. 
  • Psychotropic medication claims among religious clergy. 
  • Pubertal changes in hormone levels and depression in girls. 
  • Puberty and depression: the roles of age, pubertal status and pubertal timing. 
  • Puberty onset of gender differences in rates of depression: a developmental, epidemiologic and neuroendocrine perspective. 
  • Public anti-stigma programmes might impove help-seeking. 
  • Public policy and obesity: the need to marry science with advocacy. 
  • Public's view of mental health services for the elderly: responses to Dear Abby. 
  • QTc monitoring in adults with medical and psychiatric comorbidities: Expert consensus from the Association of Medicine and Psychiatry. 
  • Qualitative analysis of participant experiences during an ecological momentary assessment study of nonsuicidal self-injury among veterans. 
  • Quality assessment and improvement in group psychotherapy. 
  • Quality of Life in Geriatric Depression Preliminary Data From Phase I of the PRIDE Study 
  • Quality of life and cost factors in panic disorder 
  • Quality of life and cost factors in panic disorder. 
  • Quality of life and physical activity associated to lower prevalence of depression in community-dwelling elderly subjects from Sao Paulo. 
  • Quality of life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine. 
  • Quality of life and recovery after cardiac surgery. 
  • Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode. 
  • Quality of medical care and excess mortality in older patients with mental disorders. 
  • Quantitative EEG amplitude across REM sleep periods in depression: preliminary report. 
  • Quantitative analysis of T2 signal intensities in Alzheimer's disease. 
  • Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. 
  • Quetiapine XR: current status for the treatment of major depressive disorder. 
  • Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study. 
  • Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. 
  • Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. 
  • Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. 
  • RACE DIFFERENCES IN RESTING AND STRESS-RELATED HEART RATE VARIABILITY IN PATIENTS WITH HEART FAILURE 
  • RACE, PARENTAL HISTORY OF HYPERTENSION, AND PATTERNS OF CARDIOVASCULAR REACTIVITY IN WOMEN 
  • RAGE-associated s100A8/A9 levels associated with serum cortisol and cancer-related hyperarousal in patients with breast cancer 
  • REDUCED ADRENAL MEDULLARY ACTIVITY MAY BE IMPORTANT FOR THE MAINTENANCE OF NORMAL GLUCOSE REGULATION IN THE OBESE STATE 
  • REM latency concordance in depressed family members. 
  • REMOVED: Investigating misophonia: A review of the literature, clinical implications and research agenda reflecting current neuroscience and emotion research perspectives. 
  • RISPERIDONE IN ELDERLY SCHIZOPHRENIC-PATIENTS 
  • RU486 in depression. 
  • RUSH,JULIA DIARY - COPING WITH LOSS IN THE EARLY 19TH-CENTURY 
  • Racial Disparities in the Administration of ECT in Texas, 1998-2013. 
  • Racial differences in antidepressant treatment preceding suicide in a Medicaid population. 
  • Racial differences in blood pressure and forearm vascular responses to the cold face stimulus. 
  • Racial/ethnic differences in parent-reported barriers to accessing children's health services. 
  • Racial/ethnic variations in substance-related disorders among adolescents in the United States. 
  • Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs. 
  • Radiologic correlates of antidepressant-induced delirium: the possible significance of basal-ganglia lesions. 
  • Randomized Placebo-Controlled Trial of Methylphenidate or Galantamine for Persistent Emotional and Cognitive Symptoms Associated with PTSD and/or Traumatic Brain Injury. 
  • Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia. 
  • Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. 
  • Randomized controlled trial of the cognitive side effects of magnetic seizure therapy and electroconvulsive shock 
  • Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). 
  • Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression. 
  • Randomized sham controlled trial of transcranial magnetic stimulation (TMS) to the supplementary motor area (SMA) for the treatment of medication resistant obsessive-compulsive disorder (OCD) 
  • Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder. 
  • Randomized, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study of GSK239512 for Cognitive Impairment in Stable Schizophrenia Subjects on Background Antipsychotic Therapy 
  • Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia. 
  • Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. 
  • Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. 
  • Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. 
  • Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. 
  • Rapastinel, a Nonopioid Pharmacotherapy for Opioid Dependence? 
  • Rape: The misunderstood crime. By Julie A. Allison & Lawrence S. Wrightsman. Newbury Park, CA: Sage Publications, 1993, 307 pages. Hardcover: $45.00, softcover: $21.95 
  • Rapid Reduction in Suicide Risk in Depressed Elderly Treated with Electroconvulsive Therapy (ECT): Data from Phase I of the PRIDE Study 
  • Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy. 
  • Rapid selection for serotonin-1A sensitivity in rats. 
  • Rapid shifts in therapeutic and extrapyramidal effects of neuroleptics. 
  • Rapid tranquilization: A comparative study of thiothixene and haloperidol 
  • Rate of head growth decelerates and symptoms worsen in the second year of life in autism. 
  • Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. 
  • Rates and predictors of rehospitalization among formerly hospitalized adolescents. 
  • Rationale for Spiritually Oriented Cognitive Processing Therapy for Moral Injury in Active Duty Military and Veterans With Posttraumatic Stress Disorder. 
  • Re-evaluating the Electroconvulsive Therapy Stimulus: Frequency and Directionality 
  • Re-evaluating the Electroconvulsive Therapy Stimulus: Train Duration 
  • Re: Community treatment orders for psychiatric patients: the emperor with no clothes. 
  • Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers. 
  • Reactivity to sensations in borderline personality disorder: a preliminary study. 
  • Real-Time fMRI as a CBT Adjunct: Predicting the Behavioral Impact of Neurofeedback 
  • Realizing the dream. 
  • Reassessing the Mental Health Treatment Gap: What Happens if We Include the Impact of Traditional Healing on Mental Illness? 
  • Recall bias in patients with schizophrenia 
  • Receipt, Spending, and Clinical Correlates of the Economic Impact Payment Among Middle- and Low-Income U.S. Adults. 
  • Recent advances in poststroke depression. 
  • Recent advances in the design of multisite clinical trials using transcranial magnetic stimulation 
  • Recent advances in the pharmacologic treatment of bipolar illness 
  • Recent advances in the use of imaging in psychiatry: functional magnetic resonance imaging of large-scale brain networks in late-life depression. 
  • Recent victimization in women and men with severe mental illness: prevalence and correlates. 
  • Recognition and Prevention of Major Mental and Substance Use Disorders 
  • Recognition and assessment of shift work disorder. 
  • Recognition of depression in medical patients with heart failure. 
  • Recognizing and managing insomnia in primary care and specialty settings. 
  • Recommendations for depression publications. 
  • Recommendations for depression publications. 
  • Recommendations for depression publications. 
  • Recommendations for depression publications. 
  • Recommendations for depression publications. 
  • Recommendations for scientific reports on depression. 
  • Reconsideration of the training of psychiatrists and mental health professionals: helping to make soup. 
  • Reconsidering somatic presentation of generalized anxiety disorder in Nepal. 
  • Recovery and recurrence following treatment for adolescent major depression. 
  • Recursive subsetting to identify patients in the STAR*D: a method to enhance the accuracy of early prediction of treatment outcome and to inform personalized care. 
  • Red blood cell catechol O-methyl transferase and response to imipramine in unipolar depressive women. 
  • Redefining the role of psychiatry in medicine. 
  • Redirecting the Mental Health and Gun Violence Conversation From Mass Shootings to Suicide. 
  • Reduced Amygdala and Hippocampal Volumes Associated with PTSD in Recent Military Veterans from Iraq and Afghanistan 
  • Reduced REM latency predicts response to tricyclic medication in depressed outpatients. 
  • Reduced amygdala response in youths with disruptive behavior disorders and psychopathic traits: decreased emotional response versus increased top-down attention to nonemotional features. 
  • Reduced amygdala-orbitofrontal connectivity during moral judgments in youths with disruptive behavior disorders and psychopathic traits. 
  • Reduced blue cone electroretinogram in cocaine-withdrawn patients. 
  • Reduced cannabis use after low-dose naltrexone addition to opioid detoxification. 
  • Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. 
  • Reduced delta power and synchrony and increased gamma power during the P3 time window in schizophrenia. 
  • Reduced hippocampal and amygdala activity predicts memory distortions for trauma reminders in combat-related PTSD. 
  • Reduced inhibitory effect of imipramine on radiolabeled serotonin uptake into platelets in geriatric depression. 
  • Reduced neural habituation in the amygdala and social impairments in autism spectrum disorders. 
  • Reduced rapid eye movement latency. A predictor of recurrence in depression. 
  • Reduced tolerance and cardiovascular response to ischemic pain in minor depression. 
  • Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: a diffusion tensor imaging study. 
  • Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial. 
  • Reducing barriers to completing psychiatric advance directives. 
  • Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone. 
  • Reduction of dorsolateral prefrontal cortex gray matter in late-life depression. 
  • Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female rats. 
  • Reduction of orbital frontal cortex volume in geriatric depression. 
  • Reduction of synapsin III in the prefrontal cortex of individuals with schizophrenia. 
  • Reductions in arrest under assisted outpatient treatment in New York. 
  • Referrals to psychiatrists. Assessing the communication interface between psychiatry and primary care. 
  • Refining the diagnoses of inattention and overactivity syndromes: A reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder 
  • Refining the latent structure of neuropsychological performance in schizophrenia. 
  • Reflechi twòp--thinking too much: description of a cultural syndrome in Haiti's Central Plateau. 
  • Refractory calculation-induced idiopathic generalized epilepsy. A case report and review of the literature 
  • Refractory calculation-induced idiopathic generalized epilepsy: A case report and review of the literature 
  • Regional brain activity correlates of nicotine dependence. 
  • Regional cerebral blood flow alterations in unipolar depression. 
  • Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. 
  • Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy. 
  • Regional cerebral blood flow correlates of a dichotic listening task. 
  • Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study. 
  • Regular sources of medical care among persons with severe mental illness at risk of hepatitis C infection. 
  • Regulation and function of MeCP2 Ser421 phosphorylation in U50488-induced conditioned place aversion in mice. 
  • Regulation of appetite and cholecystokinin secretion in anorexia nervosa. 
  • Regulation of sensorimotor gating via Disc1/Huntingtin-mediated Bdnf transport in the cortico-striatal circuit. 
  • Regulation of the deleterious effects of binge-like exposure to alcohol during adolescence by α7 nicotinic acetylcholine receptor agents: prevention by pretreatment with a α7 negative allosteric modulator and emulation by a α7 agonist in alcohol-preferring (P) male and female rats. 
  • Regulatory Focus and Reward Sensitivity: Integrating Social-Cognitive and Affective Neuroscience Perspectives 
  • Regulatory focus and the p factor: Evidence for self-regulatory dysfunction as a transdiagnostic feature of general psychopathology. 
  • Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD). 
  • Reinforcing effects of nicotine and non-nicotine components of cigarette smoke. 
  • Relapse following combined treatment discontinuation in a placebo-controlled trial for panic disorder. 
  • Relapse, side effects, and monoamine oxidase inhibition during long term use of isocarboxazid: a case report. 
  • Relating Intrinsic Low-Frequency BOLD Cortical Oscillations to Cognition in Schizophrenia. 
  • Relation between informant-rated personality and clinician-rated depression in patients with memory disorders. 
  • Relation of lifetime trauma and depressive symptoms to mortality in HIV. 
  • Relation of serum valproate concentration to response in mania. 
  • Relation of subjective and received social support to clinical and self-report assessments of depressive symptoms in an elderly population. 
  • Relations of trait depression and anxiety to low lipid and lipoprotein concentrations in healthy young adult women. 
  • Relationship between abdominal pain subgroups in the community and psychiatric diagnosis and personality. A birth cohort study. 
  • Relationship between all-cause mortality and cumulative working life course psychosocial and physical exposures in the United States labor market from 1968 to 1992. 
  • Relationship between change in in-vivo exposure distress and PTSD symptoms during exposure therapy for active duty soldiers. 
  • Relationship between obesity and depression: characteristics and treatment outcomes with antidepressant medication. 
  • Relationship between objective and subjective sleep measures in depressed patients and healthy controls. 
  • Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. 
  • Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo. 
  • Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers. 
  • Relationship between traumatic brain injury history and recent suicidal ideation in Iraq/Afghanistan-era veterans. 
  • Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women. 
  • Relationship of clinic, ambulatory, and laboratory stress blood pressure to left ventricular mass in overweight men and women with high blood pressure. 
  • Relationship of cognition and psychopathology to functional impairment in schizophrenia. 
  • Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patients. 
  • Relationship of dysfunctional attitudes and dexamethasone response in endogenous and nonendogenous depression. 
  • Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery. 
  • Relationship of health and demographic characteristics to Mini-Mental State examination score among community residents. 
  • Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. 
  • Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia. 
  • Relationship of pharmaceutical promotion to antidepressant switching and adherence: a retrospective cohort study. 
  • Relationship of prolactin response to meta-chlorophenylpiperazine with severity of drug use in cocaine dependence. 
  • Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence. 
  • Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence. 
  • Relationship of trauma symptoms to amygdala-based functional brain changes in adolescents. 
  • Relationships Between Maltreatment, Posttraumatic Symptomatology, and the Dissociative Subtype of PTSD Among Adolescents. 
  • Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. 
  • Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings. 
  • Relationships between maternal and adolescent weight-related behaviors and concerns: the role of perception. 
  • Relationships of maternal folate and vitamin B12 status during pregnancy with perinatal depression: The GUSTO study. 
  • Relationships of mental health problems with stress among civil servants in Guangzhou, China. 
  • Relative accuracy and reproducibility of regional MRI brain volumes for point-counting methods. 
  • Relative impact of maternal depression and associated risk factors on offspring psychopathology. 
  • Release bias in accessing medical records in clinical trials: a STAR*D report. 
  • Relevance of religion and spirituality in German patients with chronic diseases. 
  • Reliabilities and intercorrelations of reported and objective measures of smoking in patients with schizophrenia. 
  • Reliability and validity of SAFTEE: Preliminary analyses 
  • Reliability of reports of violent victimization and posttraumatic stress disorder among men and women with serious mental illness. 
  • Reliability of the services assessment for children and adolescents. 
  • Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale. 
  • Relief from catatonic immobility can be maintained. 
  • Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. 
  • Religion and beliefs about treating medically unexplained symptoms: a survey of primary care physicians and psychiatrists. 
  • Religion and medicine I: historical background and reasons for separation. 
  • Religion and medicine II: religion, mental health, and related behaviors. 
  • Religion and medicine III: developing a theoretical model. 
  • Religion and medicine IV: religion, physical health, and clinical implications. 
  • Religion and mental health: Evidence for an association 
  • Religion and mental health: What should psychiatrists do? 
  • Religion and psychotic experiences. 
  • Religion and remission of depression in medical inpatients with heart failure/pulmonary disease. 
  • Religion index for psychiatric research. 
  • Religion, Culture and Mental Health. By K. Loewenthal. (Pp. 169; $85.00; ISBN 13-978-0-521-85023-0 hb.) Cambridge University Press: New York. 2007. 
  • Religion, sense of calling, and the practice of medicine: findings from a national survey of primary care physicians and psychiatrists. 
  • Religion, spirituality and depression in prospective studies: A systematic review. 
  • Religion, spirituality and psychiatry: A new era in mental health care 
  • Religion, spirituality and psychotic disorders 
  • Religion, spirituality, and depression in adolescent psychiatric outpatients. 
  • Religion, spirituality, and health: a review and update. 
  • Religion, spirituality, and medicine: a rebuttal to skeptics. 
  • Religion, spirituality, and medicine: psychiatrists' and other physicians' differing observations, interpretations, and clinical approaches. 
  • Religion, spirituality, and mental health of U.S. military veterans: Results from the National Health and Resilience in Veterans Study. 
  • Religion, spirituality, and mental health: current controversies and future directions. 
  • Religion, spirituality, and mental health: what we know and why this is a tough topic to research. 
  • Religion, spirituality, and mysticism. 
  • Religion, spirituality, and risk for incident posttraumatic stress disorder, suicidal ideation, and hazardous drinking in U.S. military veterans: A 7-year, nationally representative, prospective cohort study. 
  • Religion, spirituality, and suicide risk in Iraq and Afghanistan era veterans. 
  • Religion/spirituality and depression: what can we learn from empirical studies? 
  • Religiosity and decreased risk of substance use disorders: is the effect mediated by social support or mental health status? 
  • Religiosity and remission of depression in medically ill older patients. 
  • Religiosity and self-rated health among Latin American and Caribbean elders. 
  • Religiosity as a protective factor in depressive disorder. 
  • Religiosity enhances cardiovascular reactivity among black males with low education 
  • Religiosity may help preserve the cortisol rhythm in women with stress-related illness. 
  • Religiosity, depression and telomere length in Chinese older adults. 
  • Religiosity, depression, and quality of life in bipolar disorder: a two-year prospective study. 
  • Religiosity/spirituality and pain in patients with sickle cell disease. 
  • Religious Coping Among Adults Caring for Family Members with Serious Mental Illness. 
  • Religious Involvement and Telomere Length in Women Family Caregivers. 
  • Religious activities as predictors of health and survival 
  • Religious affiliations in mental health research samples as compared with national samples. 
  • Religious and spiritual factors and the consequences of trauma: a review and model of the interrelationship. 
  • Religious beliefs and alcohol control policies: a Brazilian nationwide study. 
  • Religious content in the DSM-III-R glossary of technical terms. 
  • Religious coping and ambulatory blood pressure: The moderating effects of ethnicity 
  • Religious coping and cognitive symptoms of depression in elderly medical patients. 
  • Religious coping and depression among elderly, hospitalized medically ill men. 
  • Religious coping and health status in medically ill hospitalized older adults. 
  • Religious coping and quality of life among individuals living with schizophrenia. 
  • Religious coping in the nursing home: a biopsychosocial model. 
  • Religious coping, ethnicity, and ambulatory blood pressure 
  • Religious coping, ethnicity, and ambulatory blood pressure. 
  • Religious involvement is associated with greater purpose, optimism, generosity and gratitude in persons with major depression and chronic medical illness. 
  • Religious involvement, suicidal ideation and behavior in mainland China. 
  • Religious vs. conventional cognitive behavioral therapy for major depression in persons with chronic medical illness: a pilot randomized trial. 
  • Religious, spiritual, and traditional beliefs and practices and the ethics of mental health research in less wealthy countries. 
  • Religiousness and mental health: a review. 
  • Remission in post-traumatic stress disorder (PTSD): effects of sertraline as assessed by the Davidson Trauma Scale, Clinical Global Impressions and the Clinician-Administered PTSD scale. 
  • Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XR. 
  • Remission of maternal depression and child symptoms among single mothers: a STAR*D-Child report. 
  • Remission rates for depression in STAR*D study - Dr. Trivedi and colleagues reply 
  • Remitted major depression is characterized by reduced prefrontal cortex reactivity to reward loss. 
  • Remitted major depression is characterized by reward network hyperactivation during reward anticipation and hypoactivation during reward outcomes. 
  • Remote Liaison to Families: a Psychiatric Response to Medical Care Gaps Created by Pandemic Surge Conditions in New York City. 
  • Repairing the shattered self: recovering from trauma. 
  • Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression. 
  • Repetitive Transcranial Magnetic Stimulation (rTMS) of the Superior Frontal Gyrus Modulates Craving for Cigarettes 
  • Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). 
  • Repetitive transcranial magnetic stimulation (rTMS): A noninvasive neuromodulation probe and intervention (Journal of ECT (2011) 27, (2)) 
  • Repetitive transcranial magnetic stimulation (rTMS): a noninvasive neuromodulation probe and intervention. 
  • Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes. 
  • Replicability of structural brain alterations associated with general psychopathology: evidence from a population-representative birth cohort. 
  • Replication analysis for composition of the Delirium Motor Subtype Scale (DMSS) in a referral cohort from Northern India. 
  • Replication in Imaging Genetics: The Case of Threat-Related Amygdala Reactivity. 
  • Reply 
  • Reply 
  • Reply 
  • Reply to Dr Ng's comments on "A Randomized, Double-Blind, Placebo-Controlled Trial of Augmentation with An Extended Release Formulation of Methylphenidate in Outpatients with Treatment-Resistant Depression" [11] 
  • Reply to El-Mallakh et al. letter 
  • Reply to Mushtaq et al. 
  • Reply to: Declining use of electroconvulsive therapy in U.S. general hospitals is not restricted to unipolar depression. 
  • Report by the ACNP Task Force on response and remission in major depressive disorder. 
  • Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia. 
  • Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia. 
  • Reproductive Hormones Regulate Affect and Reward Circuit Function in Women 
  • Research and clinical practice: Bridging the gap 
  • Research design features and patient characteristics associated with the outcome of antidepressant clinical trials. 
  • Research issues in psychological studies of chronic dialysis. 
  • Research issues in the study of difficult-to-treat depression. 
  • Research on field-based services: models for reform in the delivery of mental health care to populations with complex clinical problems. 
  • Research on religion, spirituality, and mental health: a review. 
  • Research priorities in adolescent psychiatry: report of the committee on research of the American Society for Adolescent Psychiatry. 
  • Research to Clinical Practice-Youth seeking mental health information online and its impact on the first steps in the patient journey. 
  • Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. 
  • Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. 
  • Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo. 
  • Resilience as a translational endpoint in the treatment of PTSD. 
  • Resilience in the face of chronic illness and family caregiving in middle and later life 
  • Resolution of trauma-related guilt following treatment of PTSD in female rape victims: a result of cognitive processing therapy targeting comorbid depression? 
  • Resolved: psychosocial interventions can improve clinical outcomes in organic disease (pro). 
  • Resolved: psychosocial interventions can improve clinical outcomes in organic disease--rebuttals and closing arguments. 
  • Responding to a Population Mental Health Crisis. 
  • Response 
  • Response 
  • Response 
  • Response 
  • Response 
  • Response characteristics to antidepressants and placebo in post-traumatic stress disorder. 
  • Response from GlaxoSmithKline 
  • Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline. 
  • Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges 
  • Response to Baandrup letter 
  • Response to Blier letter 
  • Response to Bora. 
  • Response to Burns. 
  • Response to Fred W. Becker's 'The politics of closing state mental hospitals' 
  • Response to Gorelick. 
  • Response to Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) 
  • Response to Kahn and Kahn, "group treatment assignment for outpatients with schizophrenia" 
  • Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. 
  • Response to effect of the first ECT in a series by C. Kellner, MD [5] 
  • Response to isocarboxazid and the DST. 
  • Response to letters to the editor [3] 
  • Response, remission, and recovery in bipolar disorders: what are the realistic treatment goals? 
  • Responses to hypercarbia induced by acetazolamide in panic disorder patients. 
  • Resting State Connectivity Between Amygdalar Subregions and the Prefrontal Cortex is Disrupted in PTSD 
  • Resting state cortical connectivity reflected in EEG coherence in individuals with autism. 
  • Resting-state brain fluctuation and functional connectivity dissociate moral injury from posttraumatic stress disorder. 
  • Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives. 
  • Resting-state connectivity predictors of response to psychotherapy in major depressive disorder. 
  • Resting-state mapping of neural signatures of vulnerability to depression relapse. 
  • Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms. 
  • Restored WAVE1 Levels in a Model of NMDA Receptor Hypofunction Attenuates Working Memory Deficits 
  • Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder. 
  • Results of phase 3 of the CATIE schizophrenia trial. 
  • Retention and attrition among African Americans in the STAR*D study: what causes research volunteers to stay or stray? 
  • Rethinking funding priorities in mental health research. 
  • Retinal microvessels reflect familial vulnerability to psychotic symptoms: A comparison of twins discordant for psychotic symptoms and controls. 
  • Retrograde amnesia with electroconvulsive therapy: characteristics and implications. 
  • Reversal of Consolidated Behavioral Sensitization and Associated Neurochemical Changes by Local Infusion of PKC Zeta (zeta) Inhibitory Pseudosubstrate (ZIP) Peptide in Nucleus Accumbens Core 
  • Reversal of clozapine effects on working memory in rats with fimbria-fornix lesions. 
  • Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors. 
  • Review of literature on aftercare services among children and adolescents. 
  • Review: More RCTs on early intensive behavioural intervention for young children with autism spectrum disorders needed. 
  • Review: Nicotine replacement treatments achieve smoking abstinence at 6-12 months: Commentary 
  • Review: Pharmacotherapy increases response and reduces symptom severity in paediatric anxiety disorders 
  • Review: Self help interventions alone minimally increase smoking cessation: Commentary 
  • Review: antidepressants are effective for the treatment of major depressive disorder in individuals aged 55 years or older. 
  • Review: clozapine shows some improved clinical efficacy over risperidone and zotepine in treatment of schizophrenia, but robust evidence is lacking. 
  • Revised PORT recommendations. 
  • Revisiting monoamine oxidase inhibitors. 
  • Revisiting the backward masking deficit in schizophrenia: individual differences in performance and modeling with transcranial magnetic stimulation. 
  • Reward Processing in Novelty Seekers: A Transdiagnostic Psychiatric Imaging Biomarker. 
  • Reward-related learning via multiple memory systems. 
  • Richard Dadd and the Fairy Feller's Master-Stroke. 
  • Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study. 
  • Risk Factors for New-Onset Depression After First-Time Traumatic Brain Injury. 
  • Risk factors for ADHD and comorbid psychiatric, academic and behavior problems among primary school students in Jeddah, Saudi Arabia. 
  • Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness. 
  • Risk factors for early unplanned readmission in patients with bipolar disorder: A retrospective observational study. 
  • Risk factors in families of unipolar depression. I. Psychiatric illness and reduced REM latency. 
  • Risk factors prospectively associated with adult obsessive-compulsive symptom dimensions and obsessive-compulsive disorder. 
  • Risk for depression tripled during the COVID-19 pandemic in emerging adults followed for the last 8 years. 
  • Risk of Cognitive Bias Associated With the Treatment of Urinary Tract Infection in Patients With Psychiatric Disorders. 
  • Risk of smoking and receipt of cessation services among veterans with mental disorders. 
  • Risk reconsidered: targets of violence in the social networks of people with serious psychiatric disorders. 
  • Risk-Based Temporary Firearm Removal Orders: A New Legal Tool for Clinicians. 
  • Risks versus benefits of different types of long-acting injectable antipsychotics. 
  • Risks, Benefits, and Recommendations for Pastoral Care on Inpatient Psychiatric Units: A Systematic Review. 
  • Risperidone and cognitive function in children with disruptive behavior disorders. 
  • Risperidone and pituitary tumors: a pharmacovigilance study 
  • Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. 
  • Robbing Peter to pay Paul: did New York State's outpatient commitment program crowd out voluntary service recipients? 
  • Role of GABRA2 in trajectories of externalizing behavior across development and evidence of moderation by parental monitoring. 
  • Role of individual and developmental differences in voluntary cocaine intake in rats. 
  • Role of nicotinic receptors in the lateral habenula in the attenuation of amphetamine-induced prepulse inhibition deficits of the acoustic startle response in rats. 
  • Role of serotonin in hypothalamo pituitary adrenal axis escape from dexamethasone suppression. 
  • Role of stress in the etiology and treatment of diabetes mellitus. 
  • Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms. 
  • Roles of mental health professionals in multidisciplinary medically supervised treatment programs for obesity. 
  • Roth and batson reply to "creative balance" commentary 
  • Rudolf Steiner (1861-1925). 
  • Rurality and mental health treatment. 
  • S.03.02 Gene-environment interaction in depression 
  • S.05.04 Prolonging remission in depressed elderly (PRIDE; NCT01028508) 
  • S.14.04 CATIE trial results 
  • S112. A Spectral Method for Determining Cortical Silent Period Induced by Transcranial Magnetic Stimulation 
  • S147. Resting-State EEG Source Analysis in Depressed Patients Treated With Electroconvulsive Therapy and Magnetic Seizure Therapy 
  • S57. Does the Acquisition of Social Cognitive Skills Over Adolescence Coincide With Neurophysiological Metric of Brain Maturation? A Cross-Sectional Analysis of the NAPLS-II Consortium Sample 
  • S7. General Functional Connectivity: Shared Features of Resting State and Task fMRI Drive Reliable and Heritable Individual Differences in Functional Brain Networks 
  • SLEEP PATTERNS OF INDIVIDUALS WITH SCHIZOPHRENIA 
  • SLITRK1 mutations in trichotillomania. 
  • SPRINT: a brief global assessment of post-traumatic stress disorder. 
  • SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept. 
  • STAR*D: revising conventional wisdom. 
  • STAR*D: what have we learned? 
  • STATIC AND DYNAMIC COGNITIVE DEFICITS IN CHILDHOOD PRECEDE ADULT SCHIZOPHRENIA: A 30-YEAR STUDY 
  • SYNERGISTIC IMPACT OF PERCEIVED DISCRIMINATION AND HOSTILITY ON ADRENERGIC RESPONSIVITY 
  • Safety and antipsychotic efficacy of "forced" intramuscular olanzapine over five days: a case report. 
  • Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder. 
  • Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. 
  • Safety and tolerability of TMS in the treatment of major depression: Evidence from extended exposure and reintroduction treatment 
  • Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. 
  • Salivary testosterone and a trinucleotide (CAG) length polymorphism in the androgen receptor gene predict amygdala reactivity in men. 
  • Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats. 
  • Schedule for affective disorders and schizophrenia for school-age children (K-SADS-PL) for the assessment of preschool children--a preliminary psychometric study. 
  • Schirophrenia, substance misuse, and smoking 
  • Schizophrenia, narrative, and neurocognition: The utility of life-stories in understanding social problem-solving skills. 
  • Schizophrenic-like deficits in nonpsychotic children and adolescents with 22Q11 deletion syndrome 
  • Science and recovery in schizophrenia. 
  • Scoring Nonresponse on the Mini Mental State Examination 
  • Scoring nonresponse on the Mini-Mental State Examination. 
  • Screening for Early Alzheimer's Disease: Is There Still a Role for the Mini-Mental State Examination? 
  • Screening for major depression in private practice. 
  • Screening for panic-related anxiety in emergency department patients with cardiopulmonary complaints: A comparison of two self-report instruments. 
  • Screening for trauma history on an inpatient affective-disorders unit: a pilot study. 
  • Screening for violence risk in military veterans: predictive validity of a brief clinical tool. 
  • Seclusion. 
  • Secondary agoraphobia: two case reports. 
  • Secondary depression: a comparison among subtypes. 
  • Secondary outcomes from the pediatric obsessive compulsive disorder treatment study II. 
  • Secular trend in unipolar depression: a hypothesis. 
  • Segmented hippocampal volume in children and adolescents with posttraumatic stress disorder. 
  • Seizure Induction With Low-Amplitude-Current Electroconvulsive Therapy: A Case Series 
  • Seizure induction with low-amplitude-current (0.5 A) electroconvulsive therapy. 
  • Seizure length and clinical outcome in electroconvulsive therapy using methohexital or thiopental. 
  • Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT. 
  • Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. 
  • Seizures and bupropion: a review. 
  • Seizures associated with clozapine treatment in a state hospital 
  • Seizures terminable and interminable with ECT. 
  • Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. 
  • Selecting methodologies for the evaluation of differences in time to response between antidepressants. 
  • Selective cutoff reporting in studies of the accuracy of the Patient Health Questionnaire-9 and Edinburgh Postnatal Depression Scale: Comparison of results based on published cutoffs versus all cutoffs using individual participant data meta-analysis. 
  • Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS). 
  • Selective serotonin reuptake inhibitors in post-traumatic stress disorder. 
  • Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial. 
  • Self- and parent-reported depressive symptoms rated by the mood and feelings questionnaire. 
  • Self-Compassion as a prospective predictor of PTSD symptom severity among trauma-exposed U.S. Iraq and Afghanistan war veterans. 
  • Self-Regulation and Psychopathology: Toward an Integrative Translational Research Paradigm. 
  • Self-monitoring deficits in schizophrenia: Autonoetic agnosia 
  • Self-mutilative behaviors in male veterans with posttraumatic stress disorder. 
  • Self-punishment as a regulation strategy in borderline personality disorder. 
  • Self-rated depressive symptoms in medical inpatients: age and racial differences. 
  • Self-rated global measure of the frequency, intensity, and burden of side effects. 
  • Self-ratings of type A (coronary prone) adults: do type A's know they are type A's? 
  • Self-report and longitudinal predictors of violence in Iraq and Afghanistan war era veterans. 
  • Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. 
  • Self-reported drug abuse in male adolescents with behavioural disturbances and follow-up for future schizophrenia 
  • Self-reported health and physician diagnosed illnesses in women with posttraumatic stress disorder and major depressive disorder. 
  • Self-reported medication nonadherence predicts cholesterol levels over time. 
  • Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression. 
  • Self-reported sleep disturbances associated with procedural learning impairment in adolescents at ultra-high risk for psychosis. 
  • Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans. 
  • Sensory acuity and reasoning in delusional disorder. 
  • Separating hope from hype: some ethical implications of the development of deep brain stimulation in psychiatric research and treatment. 
  • Separating mood disturbance from mild cognitive impairment in geriatric depression. 
  • Serious physical illness as a stressor: effects on family use of medical services. 
  • Serotonergic cell signaling in an animal model of aging and depression: olfactory bulbectomy elicits different adaptations in brain regions of young adult vs aging rats. 
  • Serotonin deficiency alters susceptibility to the long-term consequences of adverse early life experience. 
  • Serotonin syndrome after a massive overdose of controlled-release paroxetine. 
  • Serotonin syndrome in a chronic-pain patient receiving concurrent methadone, ciprofloxacin, and venlafaxine. 
  • Serotonin syndrome produced by a combination of fluoxetine and lithium. 
  • Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. 
  • Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. 
  • Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results. 
  • Serotonin transporter gene polymorphisms and brain function during emotional distraction from cognitive processing in posttraumatic stress disorder. 
  • Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. 
  • Serotonin transporter polymorphism influences the prolactin response to tryptophan and stress 
  • Serotonin transporter promoter genotypes, CNS serotonin turnover, and cardiovascular reactivity to stress 
  • Serotonin-related gene polymorphisms and central nervous system serotonin function. 
  • Serotonin. 
  • Sertraline and the Cheshire cat in geriatric depression. 
  • Sertraline versus imipramine to prevent relapse in chronic depression. 
  • Serum dopamine-beta-hydroxylase (DBH) activity and blood pressure response of rat strains to shock-induced fighting. 
  • Service Utilization Patterns as Predictors of Response to Trauma-Informed Integrated Treatment for Women With Co-occurring Disorders. 
  • Service costs of caring for adolescents with mental illness in a rural community, 1993-2000. 
  • Service system involvement and delinquent offending at system of care entry. 
  • Service use and health status of persons with severe mental illness in full-risk and no-risk medicaid programs. 
  • Service use patterns for adolescents with ADHD and comorbid conduct disorder 
  • Services for adolescents with psychiatric disorders: 12-month data from the National Comorbidity Survey-Adolescent. 
  • Severe Extrapyramidal Symptoms in a Patient with Niemann-Pick Type C Disease After a Long-Acting Injection of Risperidone 
  • Severe episode of depression in late life: the long road to recovery. 
  • Severe hyperglycemia associated with high doses of clozapine. 
  • Severe life stress as a predictor of early disease progression in HIV infection. 
  • Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol. 
  • Severe stress and adjustment disorder diagnoses in the population of Denmark. 
  • Severity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. 
  • Severity of depressive symptoms and hostility jointly predict interleukin-6 levels in healthy men 
  • Severity of posttraumatic stress disorder and involvement with the criminal justice system 
  • Severity of subcortical gray matter hyperintensity predicts ECT response in geriatric depression. 
  • Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. 
  • Sex Differences in Conditioned Taste Aversion 
  • Sex Differences in Conditioned Taste Aversion 
  • Sex Differences in Early-Life Programming of Neuroinflammation and Behavioral Abnormalities by High Fat Diet 
  • Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. 
  • Sex and depression in the National Comorbidity Survey. II: Cohort effects. 
  • Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy. 
  • Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. 
  • Sex differences in neurochemical effects of dopaminergic drugs in rat striatum. 
  • Sex differences in novelty- and psychostimulant-induced behaviors of C57BL/6 mice. 
  • Sex differences in predictors of recurrent major depression among current-era military veterans. 
  • Sex differences in response to citalopram: a STAR*D report. 
  • Sex differences in the distribution of EEG frequencies during sleep: unipolar depressed outpatients. 
  • Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats. 
  • Sex roles and regional cerebral blood flow. 
  • Sex-dependent neurobiological features of prenatal immune activation via TLR7. 
  • Sex-differentiated changes in C-reactive protein from ages 9 to 21: the contributions of BMI and physical/sexual maturation. 
  • Sex-specific effects of cigarette mentholation on brain nicotine accumulation and smoking behavior. 
  • Sexual Assault and Psychiatric Disorders Among Women in a Community Population 
  • Sexual assault and psychiatric disorders among a community sample of women. 
  • Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine. 
  • Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination. 
  • Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial. 
  • Sexual harassment in the Marines, posttraumatic stress symptoms, and perceived health: evidence for sex differences. 
  • Sexual orientation, attraction and risk for deliberate self-harm: Findings from a nationally representative sample. 
  • Sexual revictimization among Iraq and Afghanistan war era veterans. 
  • Sexuality in middle and late life. The effects of age, cohort, and gender. 
  • Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. 
  • Shame as a mediator between posttraumatic stress disorder symptoms and suicidal ideation among veterans. 
  • Shared features of neuroleptic malignant syndrome and alcohol abuse complications. 
  • Shift work disorder case studies: applying management principles in clinical practice. 
  • Short stature, growth hormone deficiency, and social anxiety. 
  • Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: critical periods, patterns of exposure, dose thresholds. 
  • Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. 
  • Shortening self-report mental health symptom measures through optimal test assembly methods: Development and validation of the Patient Health Questionnaire-Depression-4. 
  • Shortening the Edinburgh postnatal depression scale using optimal test assembly methods: Development of the EPDS-Dep-5. 
  • Should cognitive impairment be included in the diagnostic criteria for schizophrenia? 
  • Should physicians screen for depression in elderly medical inpatients?: Results of a decision analysis. 
  • Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease? 
  • Should we be anxious when assessing anxiety using the Beck Anxiety Inventory in clinical insomnia patients? 
  • Significance of monoclonal antibodies in diagnosis and therapy of tumors of the central nervous system 
  • Silent cerebrovascular events and Alzheimer's disease: an overlooked opportunity for prevention? 
  • Simultaneous Benzodiazepine and SSRI Initiation in Young People With Anxiety Disorders. 
  • Simultaneous major depression and panic disorder: treatment with electroconvulsive therapy. 
  • Single case study. Complementary effects of phenelzine and psychotherapy in long term treatment of depression. 
  • Single-blind, placebo phase-in trial of two escalating doses of selegiline in the chronic fatigue syndrome. 
  • Single-session psychotherapy. 
  • Situational determinants of cardiovascular and emotional reactivity in high and low hostile men. 
  • Six-month outcomes for MRI-related vascular depression. 
  • Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disorders. 
  • Sleep Disturbance After Traumatic Brain Injury 
  • Sleep Disturbances in the Elderly. 
  • Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders. 
  • Sleep EEG and dexamethasone suppression testing findings in unipolar depressions 
  • Sleep EEG features of adolescents with major depression. 
  • Sleep EEG findings in depressed children and adolescents. 
  • Sleep EEG in bulimic, depressed, and normal subjects. 
  • Sleep and Mood: Chicken or Egg? 
  • Sleep and psychiatric disorders: future directions. 
  • Sleep difficulties and alcohol use motives in female rape victims with posttraumatic stress disorder. 
  • Sleep disturbance and PTSD. 
  • Sleep disturbance and baroreceptor sensitivity in women with posttraumatic stress disorder. 
  • Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504. 
  • Sleep disturbance in euthymic bipolar patients. 
  • Sleep disturbance in euthymic bipolar patients: a STEP-BD study 
  • Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. 
  • Sleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosis. 
  • Sleep electroencephalographic coherence abnormalities in individuals at high risk for depression: a pilot study. 
  • Sleep impairment, mood symptoms, and psychosocial functioning in adolescent bipolar disorder. 
  • Sleep microarchitecture as a predictor of recurrence in children and adolescents with depression. 
  • Sleep outcomes following eszopiclone discontinuation in patients with primary insomnia co-existing with major depressive disorder or generalized anxiety disorder 
  • Sleep parameters in bipolar I, bipolar II, and unipolar depressions. 
  • Sleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorder. 
  • Sleep quality varies as a function of 5-HTTLPR genotype and stress. 
  • Sleep quality, depressive symptoms, and transplant outcomes: Follow-up analyses from the ADAPT prospective pilot study. 
  • Sleep therapeutics and neuropsychiatric illness. 
  • Sleeping with one eye open: loneliness and sleep quality in young adults. 
  • Slow-release delivery enhances the pharmacological properties of oral 5-hydroxytryptophan: mouse proof-of-concept. 
  • Slow-wave activity during non-REM sleep in men with schizophrenia and major depressive disorders. 
  • Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls. 
  • Sluggish cognitive tempo (SCT) in an adult outpatient sample seeking an attention-deficit/hyperactivity disorder assessment: Age of onset and assessment method impact on SCT rates. 
  • Small for gestational age boys at increased risk of later psychiatric hospitalisation. 
  • Smaller Hippocampal Volume in Posttraumatic Stress Disorder: A Multisite ENIGMA-PGC Study: Subcortical Volumetry Results From Posttraumatic Stress Disorder Consortia. 
  • Smaller hippocampal CA1 subfield volume in posttraumatic stress disorder. 
  • Smaller orbital frontal cortex volumes associated with functional disability in depressed elders 
  • Smaller orbital frontal cortex volumes associated with functional disability in depressed elders. 
  • Smoking Abstinence-Induced Changes in Resting State Functional Connectivity with Ventral Striatum Predict Lapse During a Quit Attempt. 
  • Smoking and psychosis in patients with bipolar I disorder. 
  • Smoking and therapeutic response to clozapine in patients with schizophrenia. 
  • Smoking automaticity and tolerance moderate brain activation during explore-exploit behavior. 
  • Smoking cessation delivered by medical students is helpful to homeless population. 
  • Smoking in Vietnam combat veterans with post-traumatic stress disorder. 
  • Smoking in first-episode patients with schizophrenia [12] 
  • Smoking intensity and severity of specific symptom clusters in posttraumatic stress disorder. 
  • Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances 
  • Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances. 
  • Smoking withdrawal is associated with increases in brain activation during decision making and reward anticipation: a preliminary study. 
  • Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control. 
  • Social Inequality and Alcohol Consumption-Abuse in Bahia, Brazil: Interactions of Gender, Ethnicity, and Social Class 
  • Social Support Scales: A Methodological Note. 
  • Social Support and Depression: A Panel Study. 
  • Social and personal resources and the prevalence of phobic disorder in a community population. 
  • Social anxiety disorder in callers to the Anxiety Disorders Association of America. 
  • Social anxiety disorder in review: two decades of progress. 
  • Social anxiety disorder under scrutiny. 
  • Social anxiey disorder: Etiology and early clinical presentation: Comments 
  • Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis. 
  • Social dominance and 22-year all-cause mortality in men. 
  • Social ecology interventions for post-traumatic stress disorder: what can we learn from child soldiers? 
  • Social ecology of child soldiers: child, family, and community determinants of mental health, psychosocial well-being, and reintegration in Nepal. 
  • Social functioning in urban, predominantly African American, socially disadvantaged patients with first-episode nonaffective psychosis. 
  • Social inequality and alcohol consumption-abuse in Bahia, Brazil-- interactions of gender, ethnicity and social class. 
  • Social isolation, loneliness and depression in young adulthood: a behavioural genetic analysis. 
  • Social learning and systems family therapy for childhood oppositional disorder: comparative treatment outcome. 
  • Social phobia in review 
  • Social phobia: biological aspects and pharmacotherapy. 
  • Social phobia: outlook for the '90s. 
  • Social regulation of inflammation related gene expression in the multi-ethnic study of atherosclerosis. 
  • Social skills training in unipolar nonpsychotic depression. 
  • Social support and coronary heart disease: epidemiologic evidence and implications for treatment. 
  • Social support and experimental pain. 
  • Social support and hostility as predictors of depressive symptoms in cardiac patients one month after hospitalization: a prospective study. 
  • Social support and the outcome of major depression. 
  • Social support as a predictor of the natural history of major depression 
  • Social support in elderly patients with bipolar disorder. 
  • Social support in social interaction: a moderator of cardiovascular reactivity. 
  • Social support, type A behavior, and coronary artery disease. 
  • Sociodemographic and clinical correlates of number of previous depressive episodes in the depressed elderly. 
  • Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial. 
  • Socioeconomic indices as independent correlates of C-reactive protein in the National Longitudinal Study of Adolescent Health. 
  • Socioeconomic status moderates associations between CNS serotonin and expression of beta2-integrins CD11b and CD11c. 
  • Socioeconomic status moderates the association between John Henryism and NEO PI-R personality domains. 
  • Sociotropy, autonomy, and personality disorder criteria in psychiatric patients. 
  • Sodium oxybate for the treatment of fibromyalgia: A double-blind, placebo-controlled trial 
  • Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression. 
  • Somatic treatments for mood disorders. 
  • Somatic, positive and negative domains of the Center for Epidemiological Studies Depression (CES-D) scale: a meta-analysis of genome-wide association studies. 
  • Somatization Disorder in a Southern Community 
  • Somatization disorder in a US southern community: use of a new procedure for analysis of medical classification. 
  • Somatization disorder in a community population. 
  • Somatization disorder in the community. A study of diagnostic concordance among three diagnostic systems. 
  • Somatization symptoms in the community: a rural/urban comparison. 
  • Source monitoring deficits in patients with schizophrenia; a multinomial modelling analysis. 
  • Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications. 
  • Source-monitoring deficits for self-generated stimuli in schizophrenia: multinomial modeling of data from three sources. 
  • Sources of differentiation of cocaine withdrawal symptomatology 
  • Spanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controls. 
  • Special Issue on Therapeutics 
  • Special section on assertive community treatment: an introduction. 
  • Special section on involuntary outpatient commitment: introduction. 
  • Specialist/generalist division of responsibility for patients with mental disorders. 
  • Specialty knowledge and competency standards for pharmacotherapy for pediatric obsessive-compulsive disorder. 
  • Specific psychotherapies for childhood and adolescent depression. 
  • Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study. 
  • Specificity of symptoms in RDC endogenous depression. 
  • Spectral and topographic analysis of EEG in schizophrenic patients. 
  • Speculations on the Future of Psychiatric Diagnosis. 
  • Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. 
  • Speed of response to electroconvulsive therapy compared with ketamine. 
  • Spillover Effects of Massachusetts Health Reform on Mental Health Use by VA and Medicare Dual Enrollees. 
  • Spiritual Transformation and Healing 
  • Spirituality and depressive symptoms in a racially diverse US sample of community-dwelling adults. 
  • Spirituality and religion in outpatients with schizophrenia: a multi-site comparative study of Switzerland, Canada, and the United States. 
  • Spirituality and religion in psychiatry practice: parameters and implications. 
  • Spirituality in geriatric psychiatry. 
  • Spirituality in medical school curricula: findings from a national survey. 
  • Spirituality or religiosity: is there any difference? 
  • Spirituality, religion, and clinical outcomes in patients recovering from an acute myocardial infarction (Psychosomatic Medicine (2007) 69, (501-508)) 
  • Spirituality, religion, and clinical outcomes in patients recovering from an acute myocardial infarction (vol 69, pg 501, 2007) 
  • Spirituality, religion, and clinical outcomes in patients recovering from an acute myocardial infarction. 
  • Spirituality, resilience, and anger in survivors of violent trauma: a community survey. 
  • St. John's wort in generalized anxiety disorder: three case reports. 
  • Stability amidst turmoil: Grit buffers the effects of negative life events on suicidal ideation. 
  • Stability of cardiovascular reactivity to laboratory stressors: a 2 1/2 yr follow-up. 
  • Stability of cardiovascular reactivity to psychological stressors: A two and a half year follow-up 
  • Stability of mismatch negativity event-related potentials in a multisite study. 
  • Stability of plasma GABA at four-year follow-up in patients with primary unipolar depression. 
  • Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: A randomized, double-blind, fixed-dose study 
  • Standardizing the use of the Continuous Performance Test in schizophrenia research: a validation study. 
  • Star-D: lessons learned and future implications. 
  • State Laws on Emergency Holds for Mental Health Stabilization. 
  • State of the art and promise of electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS) and magnetic seizure therapy (MST) in medication resistant depression 
  • State-Level Stay-at-Home Orders and Objectively Measured Movement in the United States During the COVID-19 Pandemic. 
  • Static and Dynamic Cognitive Deficits in Childhood Precede Adult Schizophrenia: A 30-Year Study 
  • Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. 
  • Statins and cognition: what can we learn from existing randomized trials? 
  • Statistical guidelines for Psychosomatic Medicine 
  • Statistical procedures for analyzing mental health services data. 
  • Status of minor depression or dysthymia in primary care following a randomized controlled treatment. 
  • Stelazine advertisement "dismays" readers. 
  • Stereological and neuropathological examination of the safety of electroconvulsive shock (ECS) and magnetic seizure therapy (MST) in nonhuman primates 
  • Stigma and treatment delay in first-episode psychosis: a grounded theory study. 
  • Stimulant prescription cautions: addressing misuse, diversion and malingering. 
  • Stimulating advances in the treatment of depression 
  • Stimulation strength in hippocampus for various ECT electrode configurations computed in a realistic head model 
  • Stimulus intensity and the efficacy and cognitive side effects of right unilateral and bilateral ECT. 
  • Stoltzman, R., McEvoy, L., & Nestadt, G. The Exclusion Criteria of DSM-III: A Study of the Co-occurrence of Hierarchy-free Syndromes 
  • Storm clouds over the public mental health safety net. 
  • Strategies and tactics in the management of maintenance treatment for depressed patients. 
  • Strategies and tactics in the treatment of chronic depression. 
  • Strategies for assessing mental health in Haiti: local instrument development and transcultural translation. 
  • Strategies for implementing psychiatric medication algorithms in the public sector 
  • Strategy for investigating interactions between measured genes and measured environments. 
  • Strengthening clinical effectiveness trials: equipoise-stratified randomization. 
  • Stress Vulnerability Moderates the Association between White Matter Lesions and Late-Life Depression 
  • Stress alleviation and reward enhancement: two promising targets for relapse prevention. 
  • Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. 
  • Stress and the heart 
  • Stress in employed women: impact of marital status and children at home on neurohormone output and home strain. 
  • Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. 
  • Stress-related anhedonia is associated with ventral striatum reactivity to reward and transdiagnostic psychiatric symptomatology. 
  • Stress-system genes and life stress predict cortisol levels and amygdala and hippocampal volumes in children. 
  • Stressful life events and the onset of a generalized anxiety syndrome. 
  • Stressful life events, intimate partner violence, and perceived stress in the postpartum period: longitudinal findings in rural Pakistan 
  • Stressful politics: voters' cortisol responses to the outcome of the 2008 United States Presidential election. 
  • Stressors and mood measured on a momentary basis are associated with salivary cortisol secretion. 
  • Striatal abnormalities and spontaneous dyskinesias in non-clinical psychosis. 
  • Striatal dopamine D2/D3 receptor availability in male smokers. 
  • Structural Violence with Child Welfare Systems 
  • Structural alterations within cerebellar circuitry are associated with general liability for common mental disorders. 
  • Structural brain changes revealed by MRI. 
  • Structural changes in the brain of patients with bipolar affective disorder by MRI: a review of the literature. 
  • Structural covariance network centrality in maltreated youth with posttraumatic stress disorder. 
  • Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. 
  • Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. 
  • Structural neuroimaging of geriatric depression. 
  • Structured diagnostic assessment and depot fluphenazine treatment of multiple suicide attempters in the emergency department. 
  • Structured interview for PTSD (SIP): psychometric validation for DSM-IV criteria. 
  • Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. 
  • Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results. 
  • Subcortical brain anatomy in anorexia and bulimia. 
  • Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. 
  • Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. 
  • Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression. 
  • Subcortical shape in pediatric and adult obsessive-compulsive disorder. 
  • Subcortical white matter lesions and functional impairment in geriatric depression. 
  • Subjective effects and changes in steroid hormone concentrations in humans following acute consumption of alcohol. 
  • Subjective social support and depressive symptoms in major depression: separate phenomena or epiphenomena. 
  • Substance P (NK-1 receptor) antagonists in major depression 
  • Substance Use and Psychosocial Functioning in Schizophrenia Among New Enrollees in the NIMH CATIE Study 
  • Substance abuse (including nicotine) in schizophrenic patients 
  • Substance abuse and cerebral blood flow. 
  • Substance abuse and the transmission of hepatitis C among persons with severe mental illness. 
  • Substance use after bariatric surgery: A review. 
  • Substance use among patients with a psychotic disorder in a psychiatric emergency room. 
  • Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa 
  • Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study. 
  • Substance use and schizophrenia: adverse correlates in the CATIE study sample. 
  • Substance use disorders and co-morbidities among Asian Americans and Native Hawaiians/Pacific Islanders 
  • Substance use disorders and co-morbidities among Asian Americans and Native Hawaiians/Pacific Islanders. 
  • Substance use disorders and comorbid Axis I and II psychiatric disorders among young psychiatric patients: findings from a large electronic health records database. 
  • Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. 
  • Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study. 
  • Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study. 
  • Subtypes of mania determined by grade of membership analysis. 
  • Successful coping styles in professional women. 
  • Successful treatment of self-monitoring deficits predicts psychotic symptom decrease 
  • Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia. 
  • Suicidal Behavior and Problems with Emotion Regulation. 
  • Suicidal events in the Treatment for Adolescents With Depression Study (TADS). 
  • Suicidal ideation and sex differences in relation to 18 major psychiatric disorders in college and university students: anonymous web-based assessment. 
  • Suicidal ideation and thoughts of self-harm during the COVID-19 pandemic: The role of COVID-19-related stress, social isolation, and financial strain. 
  • Suicidal or self-harming ideation in military personnel transitioning to civilian life. 
  • Suicidality as a Possible Side Effect of Antidepressant Treatment. 
  • Suicidality as a possible side effect of antidepressant treatment. 
  • Suicidality, aggression, and other treatment considerations among pregnant, substance-dependent women with posttraumatic stress disorder. 
  • Suicide Behaviors in Bipolar Disorder: A Review and Update for the Clinician. 
  • Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics. 
  • Suicide in Nepal: Qualitative Findings from a Modified Case-Series Psychological Autopsy Investigation of Suicide Deaths. 
  • Suicide in Nepal: a modified psychological autopsy investigation from randomly selected police cases between 2013 and 2015. 
  • Suicide mortality among youth in southern Brazil: a spatiotemporal evaluation of socioeconomic vulnerability. 
  • Suicide risk analysis among patients assigned to psychotropics and placebo. 
  • Suicide risk protocols: addressing the needs of high risk youths identified through suicide prevention efforts and in clinical settings. 
  • Supernatural Explanations of Neurological and Psychiatric Disorders Among Health Care Professionals at an Academic Tertiary Care Hospital in Saudi Arabia. 
  • Supplemental Material for Actuarial Prediction of Psychotherapy Retention Among Iraq–Afghanistan Veterans With Posttraumatic Stress Disorder 
  • Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. 
  • Suppression of alcohol and saccharin preference in rats by a novel Ca2+ channel inhibitor, Goe 5438. 
  • Suppression of cortisol following dexamethasone in demented patients. 
  • Survey analysis of combat-related stress disorders in Viet Nam veterans. 
  • Survey evaluates: Complex trauma exposure outcome, and intervention among children and adolescents 
  • Surveying treatment preferences in U.S. Iraq-Afghanistan Veterans with PTSD symptoms: a step toward veteran-centered care. 
  • Surviving disaster: what comes after the trauma? 
  • Suspiciousness, health, and mortality: a follow-up study of 500 older adults. 
  • Sustained anterior cingulate cortex activation during reward processing predicts response to psychotherapy in major depressive disorder. 
  • Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials. 
  • Swim test immobility co-segregates with serotonergic but not cholinergic sensitivity in cross-breeds of Flinders Line rats. 
  • Symposium 2. New Developments in Brain Stimulation. 
  • Symposium on atropine toxicity therapy; experience of use in private practice. 
  • Symptom and comorbidity patterns in World War II and Vietnam veterans with posttraumatic stress disorder. 
  • Symptom exacerbation in psychotically depressed adolescents due to high desipramine plasma concentrations. 
  • Symptom features of postpartum depression: are they distinct? 
  • Symptom profiles of psychiatric disorders based on graded disease classes: an illustration using data from the WHO International Pilot Study of Schizophrenia. 
  • Symptom-specific effects of fluoxetine in post-traumatic stress disorder. 
  • Symptomatic and functional assessment of social anxiety disorder in adults. 
  • Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy. 
  • Symptoms of depression among community-dwelling elderly African-American and white older adults. 
  • Symptoms of interpersonal sensitivity in depression. 
  • Symptoms of neurasthenia following earthquake trauma: re-examination of a discarded syndrome. 
  • Syndrome of inappropriate antidiuretic hormone secretion. 
  • Synergism in Fetal Programming: The Combined Effects of Prenatal Air Pollution & Stress Exposures on Offspring Neuroimmune Function & Behavior 
  • Synergistic effects of HIV and marijuana use on functional brain network organization. 
  • Systematic analysis of research on religious variables in four major psychiatric journals, 1978-1982. 
  • Systematic review of multifaceted interventions to improve depression care. 
  • Systematic studies with amoxapine, a new antidepressant 
  • T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment 
  • T15. Repetitive Transcranial Magnetic Stimulation Reveals a Causal Link Between Right dlPFC Activity and Anxiety Expression 
  • T157. Using Real-Time fMRI Neurofeedback as a Tool for Demonstrating Therapeutic Efficacy 
  • T176. Controllability of Structural Brain Networks in Depressed Patients Receiving Repetitive Transcranial Magnetic Stimulation 
  • T73GENOME-WIDE ASSOCIATION STUDY FOR PSYCHIATRIC RESPONSE TO ANTI-PSYCHOTIC TREATMENT 
  • TASKS FROM MONKEY CORTEX STUDIES AND SPECIFIC PREFRONTAL DYSFUNCTION IN SCHIZOPHRENIA 
  • TELEMEDICINE VERSUS IN-PERSON DELIVERY OF COGNITIVE PROCESSING THERAPY FOR WOMEN WITH POSTTRAUMATIC STRESS DISORDER: A RANDOMIZED NONINFERIORITY TRIAL. 
  • THE EFFECTS OF EXERCISE TRAINING ON CARDIOVASCULAR AND PSYCHOLOGICAL FUNCTIONING IN THE ELDERLY 
  • THE EFFECTS OF RELAXATION ON GLUCOSE-TOLERANCE 
  • THE EVOLUTION OF COGNITIVE PROCESSING THERAPY FOR POST-TRAUMATIC STRESS DISORDER 
  • THE EXTENT OF WORKING-MEMORY DEMANDS PREDICTS RESPONSE TO NEUROLEPTIC MEDICATION ON CONTINUOUS PERFORMANCE TESTS 
  • THE JOINT EFFECT OF SOCIAL SUPPORT AND HOSTILITY ON BETA2-ADRENOCEPTOR FUNCTION 
  • TMS in the acute treatment of major depression: Clinical response in an open-label extension trial 
  • TMS in the acute treatment of major depression: Improvements in functional status and quality of life 
  • TRH-induced prolactin release is blunted in females with endogenous unipolar major depression. 
  • TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics. 
  • TYPE-A BEHAVIOR AND CHOLESTEROL LEVELS PREDICT NEURO-ENDOCRINE REACTIVITY TO MENTAL ARITHMETIC STRESS 
  • TYPE-A BEHAVIOR PATTERN AND NEUROENDOCRINE RESPONSE DURING MENTAL WORK 
  • Taking issue 
  • Taking the wrong drugs: the role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. 
  • Tardive dyskinesia: 21st century may bring new treatments to a forgotten disorder. 
  • Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin. 
  • Teaching evidence-based approaches to suicide risk assessment and prevention that enhance psychiatric training. 
  • Teaching scholarly activity in psychiatric training: years 6 and 7. 
  • Telephone adaptation of the Modified Mini-Mental State Exam (3MS). The Cache County Study. 
  • Temozolomide 
  • Temporal disintegration and its psychological and physiological correlates: Changes in the experience of time after marijuana smoking 
  • Temporal lobe volume in bipolar disorder: relationship with diagnosis and antipsychotic medication use. 
  • Temporal stability of individual differences in amygdala reactivity. 
  • Temporo-Parietal Junction Stimulation in the Treatment of Depersonalization Disorder 
  • Temporo-parietal junction stimulation in the treatment of depersonalization disorder. 
  • Tension and Other Idioms of Distress Among Slum Dwelling Young Men: A Qualitative Study of Depression in Urban Bangladesh. 
  • Termination of psychotherapy: a training perspective. 
  • Test-retest reliability of the dot test of visuospatial working memory in patients with schizophrenia and controls. 
  • Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis. 
  • Testosterone Rapidly Increases Neural Reactivity to Threat in Healthy Men: A Novel Two-Step Pharmacological Challenge Paradigm 
  • Testosterone rapidly increases neural reactivity to threat in healthy men: a novel two-step pharmacological challenge paradigm. 
  • Testosterone responses to competition predict decreased trust ratings of emotionally neutral faces. 
  • Testosterone, antisocial behavior, and social dominance in boys: pubertal development and biosocial interaction. 
  • Testosterone-attenuated stereotype and hyperactivity induced by beta-phenylethylamine in pargyline-pretreated rats. 
  • Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. 
  • Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. 
  • Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms. 
  • Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. 
  • Textbook of psychyosomatic medicine 
  • The 'difficult-to-treat depression' and the 'response paradigm' models: Implications and relevance to patient management. 
  • The 'offset effect' of mental health treatment on ambulatory medical care utilization and charges. Month-by-month and grouped-month analyses of a five-year study. 
  • The 13- and 20-item Hopkins Symptom Checklist Depression Scale: psychometric properties in primary care patients with minor depression or dysthymia. 
  • The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. 
  • The 2-week duration criterion and severity and course of early childhood depression: implications for nosology. 
  • The AMDP-system in chronic hospitalized schizophrenics 
  • The Accuracy of the Patient Health Questionnaire-9 Algorithm for Screening to Detect Major Depression: An Individual Participant Data Meta-Analysis. 
  • The Alzheimer's Disease Assessment Scale: Predictors of baseline cognitive performance in clinical trials 
  • The Alzheimer's disease assessment scale .6. Noncognitive signs and symptoms in outpatients with Alzheimer's disease 
  • The American Psychiatric Press Textbook of Psychopharmacology (Second Edition) 
  • The Association Between a Sense of Calling and Physician Well-Being: A National Study of Primary Care Physicians and Psychiatrists. 
  • The Association between the Perceived Adequacy of Workplace Infection Control Procedures and Personal Protective Equipment with Mental Health Symptoms: A Cross-sectional Survey of Canadian Health-care Workers during the COVID-19 Pandemic: L'association entre le caractère adéquat perçu des procédures de contrôle des infections au travail et de l'équipement de protection personnel pour les symptômes de santé mentale. Un sondage transversal des travailleurs de la santé canadiens durant la pandémie COVID-19. 
  • The BENEFIT through spirituality/religiosity scale--a 6-item measure for use in health outcome studies. 
  • The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. 
  • The Bridge Between Racial Justice and Clinical Practice. 
  • The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. 
  • The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controls. 
  • The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. 
  • The Brief Social Phobia Scale. 
  • The Brief Social Phobia Scale: a psychometric evaluation. 
  • The COMT Val158Met polymorphism and temporal lobe morphometry in healthy adults. 
  • The Challenge of Bipolar Depression in the 21st Century. 
  • The Child and Adolescent Psychiatric Assessment (CAPA). 
  • The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. 
  • The Clinical Significance of Bilateral Basal Ganglia Calcification Presenting With Mania and Delusions 
  • The Clinical Significance of Posterior Insular Volume in Adolescent Anorexia Nervosa. 
  • The Clinical Specialty Unit: the use of the psychiatry inpatient unit to treat chronic pain syndromes. 
  • The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. 
  • The Cognitive Assessment Interview (CAI): reliability and validity of a brief interview-based measure of cognition. 
  • The Cognitive Effects of Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex in Major Depression 
  • The Concept of "Concept Mapping" Is Useful in Teaching Residents to Teach. 
  • The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluation. 
  • The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients. 
  • The Cook-Medley hostility scale: item content and ability to predict survival. 
  • The Cumulative Impact of Chronic Stressors on Risks of Myocardial Infarction in US Older Adults. 
  • The DST and posttraumatic stress disorder. 
  • The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. 
  • The Design of the Epidemiologic Catchment Area Surveys: The Control and Measurement of Error 
  • The Differential Effects of an Index Course of Magnetic Seizure Therapy and Electroconvulsive Therapy on Autobiographical Memory Specificity 
  • The Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED) approach. 
  • The Dunedin Multidisciplinary Health and Development Study: overview of the first 40 years, with an eye to the future. 
  • The Dunedin Multidisciplinary Health and Development Study: overview of the first 40 years, with an eye to the future 
  • The Dynamic Duo: Combining noninvasive brain stimulation with cognitive interventions. 
  • The Effect of Patient Education on Chinese Adolescent and Parental Beliefs About Counselors' Breaches of Confidentiality. 
  • The Effect of Support and Training for Family Members on Access to Outpatient Services for Veterans with Posttraumatic Stress Disorder (PTSD). 
  • The Effect of Testosterone Levels on Mood in Men: A Review 
  • The Effects of Tryptophan Enhancement and Depletion on Plasma Catecholamine Levels in Healthy Individuals. 
  • The Effects of an Index Course of Magnetic Seizure Therapy and Electroconvulsive Therapy on Verbal Learning and Memory 
  • The FDA and ECT. 
  • The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later? 
  • The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. 
  • The Fawn-Hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism. 
  • The G72/G30 gene complex and cognitive abnormalities in schizophrenia. 
  • The Garrett Lee Smith memorial suicide prevention program. 
  • The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project. 
  • The Great Smoky Mountains Study of Youth. Functional impairment and serious emotional disturbance. 
  • The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. 
  • The Great Smoky Mountains Study: developmental epidemiology in the southeastern United States. 
  • The History of Coordinated Specialty Care for Early Intervention in Psychosis in the United States: A Review of Effectiveness, Implementation, and Fidelity. 
  • The Impact of Acute Stress on Dynamic Neural Circuits in Adolescence: Relationships to Psychosis-Related Symptomatology and Development 
  • The Impact of Borderline Personality Disorder on Post-Traumatic Stress in the Community: A Study of Health Status, Health Utilization, and Functioning 
  • The Impact of Cannabis Use Disorder on Suicidal and Nonsuicidal Self-Injury in Iraq/Afghanistan-Era Veterans with and without Mental Health Disorders. 
  • The Impact of Eszopiclone Insomnia Treatment on Cognition in Schizophrenia: A Double-blind, Randomized, Placebo-controlled Trial 
  • The Impact of Exposure Therapy on Resting Heart Rate and Heart Rate Reactivity Among Active-Duty Soldiers With Posttraumatic Stress Disorder. 
  • The Impact of Hazardous Drinking Among Active Duty Military With Posttraumatic Stress Disorder: Does Cognitive Processing Therapy Format Matter? 
  • The Impact of Hostility on Quality of Life, Functioning, and Suicidal Ideation Among Male Veterans with Posttraumatic Stress Disorder. 
  • The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia. 
  • The Impact of Military Status on Cognitive Processing Therapy Outcomes in the Community. 
  • The Importance of Scrutinizing Emergent ADHD Symptoms in Adults: Response to Chamberlain and Müller. 
  • The Influence of APOE Genotype on Aging's Effect on Brain Structure and Cognition in Younger Adults with and without Depression 
  • The Inpatient Milieu: Organizational and Functional Principles 
  • The Invalidating Childhood Environment Scale (ICES): psychometric properties and relationship to borderline personality symptomatology. 
  • The Inventory for Depressive Symptomatology (IDS): preliminary findings. 
  • The Inventory of Depressive Symptomatology (IDS): psychometric properties. 
  • The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. 
  • The Latino mental health project: a local mental health needs assessment. 
  • The Life History Calendar: A Research and clinical assessment method for collecting retrospective event-history data 
  • The Life Trajectory Interview for Youth (LTI-Y): method development and psychometric properties of an instrument to assess life-course models and achievement. 
  • The Lives and Legends of Jacques Lacan 
  • The Longitudinal Youth at Risk Study (LYRIKS)--an Asian UHR perspective. 
  • The MARIGOLD study: Feasibility and enhancement of an online intervention to improve emotion regulation in people with elevated depressive symptoms. 
  • The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. 
  • The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. 
  • The MATRICS consensus cognitive battery in patients with bipolar I disorder. 
  • The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. 
  • The Many Channels of Screen Media Technology in ADHD: a Paradigm for Quantifying Distinct Risks and Potential Benefits. 
  • The Medication Appropriateness Index: A Clinimetric Measure. 
  • The Microbiome-Immune-Brain Axis and Cognitive Side Effects of Electroconvulsive Therapy 
  • The Millennium Cohort Family Study: a prospective evaluation of the health and well-being of military service members and their families. 
  • The Mini Mental State Exam as a predictor of neuropsychological functioning after cardiac surgery. 
  • The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures. 
  • The Montgomery-Asberg Depression Scale: reliability and validity. 
  • The Morbidity of Insomnia 
  • The NIMH Child Emotional Faces Picture Set (NIMH-ChEFS): a new set of children's facial emotion stimuli. 
  • The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. 
  • The NIMH epidemiologic catchment area program 
  • The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. 
  • The Newcastle Anxiety Depression Diagnostic Index in relationship to the effects of monoamine oxidase inhibitors and tricyclic antidepressants. 
  • The Newcastle Endogenous Depression Diagnostic Index: validity and reliability. 
  • The Origins of Cognitive Deficits in Victimized Children: Implications for Neuroscientists and Clinicians. 
  • The Post-Deployment Mental Health (PDMH) study and repository: A multi-site study of US Afghanistan and Iraq era veterans. 
  • The Potential Impact of Job Automation on Veterans in Vocational Rehabilitation Programs. 
  • The Psychiatric Genomics Consortium Posttraumatic Stress Disorder Workgroup: Posttraumatic Stress Disorder Enters the Age of Large-Scale Genomic Collaboration. 
  • The Relationship Between Posttraumatic Stress Symptoms and Physical Health in a Survey of U.S. Veterans of the Iraq and Afghanistan Era. 
  • The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms. 
  • The Role of Serotonin (5-HT) in Behavioral Control: Findings from Animal Research and Clinical Implications. 
  • The Role of Serotonin in Posttraumatic Stress Disorder: Neurobiology and Pharmacotherapy 
  • The Role of the Caregiver in the Drug Treatment of Dementia 
  • The STAR*D Project results: a comprehensive review of findings. 
  • The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. 
  • The Schizophrenia Cognition Rating Scale: validation of an interview-based assessment of cognitive functioning in Asian patients with schizophrenia. 
  • The Screen for Nonsuicidal Self-Injury: Development and initial validation among veterans with psychiatric disorders. 
  • The Singapore flagship programme in translational and clinical research in psychosis. 
  • The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatments. 
  • The Stanley Foundation Bipolar Network. I. Rationale and methods. 
  • The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. 
  • The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. 
  • The Stress﷓Buffering Role of Social Support. 
  • The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes. 
  • The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. 
  • The Texas Medication Algorithm Project Patient and Family Education Program: a consumer-guided initiative. 
  • The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. 
  • The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. 
  • The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm. 
  • The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. 
  • The Texas medication algorithm project: clinical results for schizophrenia. 
  • The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. 
  • The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. 
  • The Urgency of Racial Justice and Reducing Law Enforcement Involvement in Involuntary Civil Commitment. 
  • The Use of Carbamazepine to Expedite Metabolism of Risperidone Long-Acting Injection Through Induction of CYP3A4 in a Patient With Extrapyramidal Symptoms 
  • The Veterans Health Administration's integrated model of care increases accessibility and delivery of mental health services. 
  • The WHO EQUIP Foundational Helping Skills Trainer's Curriculum. 
  • The accumulative effect of trauma exposure on short-term and delayed verbal memory in a treatment-seeking sample of female rape victims. 
  • The adrenal gland and depression [1] 
  • The age at onset of attention deficit hyperactivity disorder. 
  • The age-of onset of attention-deficit hyperactivity disorder. 
  • The aims and design of the sequenced treatment alternatives to relieve depression (STAR*D) study 
  • The assertive community treatment team as a complex dynamic system of care. 
  • The assessment and management of insomnia: an update. 
  • The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF). 
  • The association between cognitive function and subsequent depression: a systematic review and meta-analysis. 
  • The association between spiritual and religious involvement and depressive symptoms in a Canadian population. 
  • The association between weight change and symptom reduction in the CATIE schizophrenia trial. 
  • The association of alcohol consumption patterns with self-rated physical health and psychiatric distress among Afghanistan- and Iraq-era U.S. veterans. 
  • The association of dehydroepiandrosterone and dehydroepiandrosterone sulfate with anxiety sensitivity and electronic diary negative affect among smokers with and without posttraumatic stress disorder. 
  • The association of self-blame with treatment preferences in a multi-country cohort of advanced cancer patients from the APPROACH study. 
  • The association of sexual assault and attempted suicide within the community. 
  • The association of suicide risk with negative life events and social support according to gender in Asian patients with major depressive disorder. 
  • The associations of late-life depression with all-cause and cardiovascular mortality: The NHANES 2005-2014. 
  • The autism brain imaging data exchange: towards a large-scale evaluation of the intrinsic brain architecture in autism. 
  • The boundaries of schizophrenia. 
  • The boundary of social phobia. Exploring the threshold. 
  • The brief assessment of cognition in schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery 
  • The caregiving environments provided to children by depressed mothers with or without an antisocial history. 
  • The case for practical clinical trials in psychiatry. 
  • The changing perspective on chronic insomnia management. 
  • The characteristics of poor outcome, 'Kraepelinian' schizophrenia 
  • The child and adolescent burden assessment (CABA): Measuring the family impact of emotional and behavioral problems 
  • The choice of stimulus intensity with ECT 
  • The chronically mentally ill in primary care. 
  • The clinical future of repetitive transcranial magnetic stimulation and depression: Separating hope from hype 
  • The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs 
  • The clinical utility of ictal EEG seizure adequacy models 
  • The clinician as the agent of change or terminator under managed care: Hasta la vista baby, au revoir, or good-bye? 
  • The complex relationship between depressive symptoms and functional limitations in community-dwelling older adults: the impact of subthreshold depression. 
  • The construct validity of the ischemic score of Hachinski for the detection of dementias. 
  • The continuous performance test, identical pairs: norms, reliability and performance in healthy controls and patients with schizophrenia in Singapore. 
  • The contribution of neuropsychology to psychiatry. 
  • The control group dilemma in clinical research: applications for psychosocial and behavioral medicine trials. 
  • The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. 
  • The cost consequences of treatment-resistant depression. 
  • The cost of assisted outpatient treatment: can it save states money? 
  • The costs of schizophrenia. 
  • The course of cognitive functioning over six months in individuals at clinical high risk for psychosis. 
  • The course of postdisaster psychiatric disorders in directly exposed civilians after the US Embassy bombing in Nairobi, Kenya: a follow-up study. 
  • The course of psychological distress following threatened and actual conjugal bereavement. 
  • The creative balance: The therapeutic relationship and thematic issues in trauma resolution 
  • The critical warzone experiences (CWE) scale: initial psychometric properties and association with PTSD, anxiety, and depression. 
  • The danger of reducing reimbursement for psychiatric disorders in late life. 
  • The depression treatment cascade in primary care: a public health perspective. 
  • The development and modelling of devices and paradigms for transcranial magnetic stimulation. 
  • The development and retrospective testing of an electroencephalographic seizure quality-based stimulus dosing paradigm with ECT. 
  • The development of clinical practice guidelines for the diagnosis and treatment of depression. 
  • The dexamethasone suppression test and quantitative cerebral anatomy in depression. 
  • The dexamethasone suppression test in borderline personality disorder. 
  • The dexamethasone suppression test in patients with mood disorders. 
  • The dissociative subtype of PTSD: a replication and extension. 
  • The dopamine D4 receptor and the hyperactivity phenotype: a developmental-epidemiological study. 
  • The dose-response relationship for memory impairment by anticholinergic drugs 
  • The double-blind in danger: untoward consequences of informed consent. 
  • The economic burden of anxiety disorders in the 1990s. 
  • The economic burden of depression. 
  • The effect of cognitive processing therapy on cognitions: impact statement coding. 
  • The effect of dosage on the dexamethasone suppression test in normal controls. 
  • The effect of draft DSM-V criteria on posttraumatic stress disorder prevalence. 
  • The effect of isocarboxazid on platelet MAO activity. 
  • The effect of lithium on the membrane molecular dynamics of normal human erythrocytes. 
  • The effect of nicotine and trauma context on acoustic startle in smokers with and without posttraumatic stress disorder. 
  • The effect of nonsedating doses of diazepam on regional cerebral blood flow 
  • The effect of prayer on depression and anxiety: maintenance of positive influence one year after prayer intervention. 
  • The effect of surgery on intraocular pressure fluctuations with electroconvulsive therapy in a patient with severe glaucoma. 
  • The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study. 
  • The effectiveness of mental health consultation and referral in ambulatory primary care: a research lacuna. 
  • The effects of Brief Behavioral Activation Therapy for Depression on cognitive control in affective contexts: An fMRI investigation. 
  • The effects of ECT modifications on autobiographical and verbal memory. 
  • The effects of ECT stimulus dose and electrode placement on the ictal electroencephalogram: an intraindividual crossover study. 
  • The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial 
  • The effects of a telehealth coping skills intervention on outcomes in chronic obstructive pulmonary disease: primary results from the INSPIRE-II study. 
  • The effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study. 
  • The effects of amantadine vs. trihexyphenidyl on memory in elderly normal volunteers 
  • The effects of amoxapine and ethanol on psychomotor skills related to driving: A placebo and standard controlled study 
  • The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial. 
  • The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression. 
  • The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. 
  • The effects of brain serotonin deficiency on behavioural disinhibition and anxiety-like behaviour following mild early life stress. 
  • The effects of childhood parental death and divorce on six-month history of anxiety disorders. 
  • The effects of electroconvulsive therapy on memory of autobiographical and public events. 
  • The effects of exercise on the Type A behavior pattern 
  • The effects of extended evaluation on depressive symptoms in children and adolescents. 
  • The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study. 
  • The effects of isocarboxazid on blood pressure and pulse. 
  • The effects of nefazodone on sleep architecture in depression. 
  • The effects of olanzapine, quetiapine, and risperidone on neurocognitive function in first-episode psychosis: A double-blind, 52-week comparison 
  • The effects of olanzapine, quetiapine, and risperidone on neurocognitive function in first-episode psychosis: A double-blind, 52-week comparison 
  • The effects of perceived racism and anger inhibition on ambulatory blood pressure in African Americans 
  • The effects of posttraumatic stress disorder symptoms on educational functioning in student veterans. 
  • The effects of psychotherapy on neural responses to rewards in major depression. 
  • The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia. 
  • The effects of state psychiatric hospital waitlist policies on length of stay and time to readmission. 
  • The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. 
  • The effects of vagus nerve stimulation on sleep EEG in depression: a preliminary report. 
  • The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. 
  • The efficacy of Focused Acceptance and Commitment Therapy in VA primary care. 
  • The efficacy of acute electroconvulsive therapy in atypical depression. 
  • The efficacy of new pharmacological treatments for panic disorder: evaluating the trials. 
  • The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. 
  • The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder. 
  • The epidemiology of at-risk and binge drinking among middle-aged and elderly community adults: National Survey on Drug Use and Health. 
  • The epidemiology of religious coping: A review of recent literature 
  • The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. 
  • The estimated rate of depressed mood in US adults: recent evidence for a peak in later life. 
  • The evolution of witchcraft and the meaning of healing in colonial Andean society. 
  • The experience of sexual trauma 
  • The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. 
  • The extent and impact of mental health problems after disaster. 
  • The fMRI BOLD response to unisensory and multisensory smoking cues in nicotine-dependent adults. 
  • The factor structure of psychiatric comorbidity among Iraq/Afghanistan-era veterans and its relationship to violence, incarceration, suicide attempts, and suicidality. 
  • The fifth psychoactive drug usage guide [1] 
  • The first clinical study of BW-234U in schizophrenia. 
  • The five-site health and risk study of blood-borne infections among persons with severe mental illness. 
  • The functional hurdle: Connecting through cognition 
  • The generalizability of cardiovascular responses across settings. 
  • The genetics of dementia in late life. 
  • The great debate editorial, revisited [1] 
  • The highs and lows of amygdala reactivity in bipolar disorders. 
  • The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT. 
  • The identification, assessment and management of difficult-to-treat depression: An international consensus statement. 
  • The impact of Tourette Syndrome in adults: results from the Tourette Syndrome impact survey. 
  • The impact of borderline personality disorder on post-traumatic stress in the community: a study of health status, health utilization, and functioning. 
  • The impact of childhood abuse among women with assault-related PTSD receiving short-term cognitive-behavioral therapy. 
  • The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations. 
  • The impact of climate change on the prevalence of mental illness symptoms. 
  • The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: the ENRICHD experience. 
  • The impact of diabetes on depression treatment outcomes. 
  • The impact of dissociation on PTSD treatment with cognitive processing therapy. 
  • The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial. 
  • The impact of evidence-based education on prescribing in a psychiatry residency. 
  • The impact of exposure therapy on stigma and mental health treatment attitudes among active duty U.S. soldiers with combat related PTSD. 
  • The impact of infection early in life on the formation of long-term memories in adulthood 
  • The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder. 
  • The impact of obesity on health care costs among persons with schizophrenia. 
  • The impact of posttraumatic stress disorder on quality of life and health service utilization among veterans who have schizophrenia. 
  • The impact of prior head injury on outcomes following group and individual cognitive processing therapy among military personnel. 
  • The impact of prolonged exposure therapy on social support and PTSD symptoms. 
  • The impact of social support on psychological distress for U.S. Afghanistan/Iraq era veterans with PTSD and other psychiatric diagnoses. 
  • The impact of sudden gains in cognitive behavioral therapy for posttraumatic stress disorder. 
  • The impact of terrorism on children: Considerations for a new era 
  • The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. 
  • The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study. 
  • The impact of treatment-resistant depression on health care utilization and costs. 
  • The impairment of Presidents Pierce and Coolidge after traumatic bereavement. 
  • The importance of dose in isocarboxazid therapy. 
  • The importance of early treatment of schizophrenia. 
  • The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication. 
  • The incidence of mental and behavioral disturbances in dementia: the cache county study. 
  • The influence of depressive symptoms on suicidal ideation among U.S. Vietnam-era and Afghanistan/Iraq-era veterans with posttraumatic stress disorder. 
  • The influence of emotional distraction on verbal working memory: an fMRI investigation comparing individuals with schizophrenia and healthy adults. 
  • The influence of interpersonal interaction on diastolic blood pressure. 
  • The influence of problems with concentration and memory on emotional distress and daily activities in chronic pain patients. 
  • The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia. 
  • The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment. 
  • The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients. 
  • The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. 
  • The inventory of depressive symptomatology (IDS): Preliminary findings 
  • The inventory of depressive symptomatology (IDS): Validity and reliability of clinician (IDS-C30) and self-report form (IDS-SR30) in patients with major depressive disorder 
  • The joint impact of cognitive performance in adolescence and familial cognitive aptitude on risk for major psychiatric disorders: a delineation of four potential pathways to illness. 
  • The ketogenic diet and remission of psychotic symptoms in schizophrenia: Two case studies. 
  • The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response. 
  • The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18. 
  • The long-term treatment of panic disorder. 
  • The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness. 
  • The management of resistant depression. 
  • The manipulative patient. 
  • The medical burden of depression 
  • The menstrual cycle in context, I: Affective syndromes associated with reproductive hormonal changes 
  • The menstrual cycle in context, II: Human gonadal steroid hormone variability 
  • The monitoring and management of electrically induced seizures. 
  • The multi-dimensional nature of active coping: differential effects of effort and enhanced control on cardiovascular reactivity. 
  • The nature and effectiveness of general hospital psychiatric services. 
  • The nature of social anxiety disorder: Comments 
  • The need for a psychosocial classification system in primary-care settings 
  • The need for paediatric registries to assess long-term brain effects of psychotropic medications: The case of bipolar disorder. 
  • The neuroactive steroid dehydroepiandrosterone sulfate (DHEAS) predicts nicotine dependence severity 
  • The neurobiology of social phobia. 
  • The neuroleptic threshold as a marker of minimum effective neuroleptic dose 
  • The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease. 
  • The neurostructural/neurofunctional basis of depression/mania 
  • The organizational effects of gonadal steroids on sexually dimorphic spatial ability. 
  • The origins of cognitive deficits in victimized children 
  • The origins of late-life depression 
  • The period of untreated psychosis before treatment initiation: a qualitative study of family members' perspectives. 
  • The persistence of electroconvulsive therapy-induced changes in the electroencephalogram. 
  • The predictive value of EEG measures in determining treatment outcomes and cognitive side effects during ECT treatment for major depression 
  • The predictive value of EEG measures in determining treatment outcomes and cognitive side effects during ECT treatment for major depression. 
  • The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. 
  • The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis. 
  • The prevalence of abnormal involuntary movements among chronic schizophrenics. 
  • The prevalence of lifetime and partial post-traumatic stress disorder in Vietnam theater veterans 
  • The prevalence of lifetime and partial post-traumatic stress disorder in vietnam theater veterans 
  • The prevalence of periodic limb movements during sleep in men with erectile dysfunction. 
  • The prevalence of post-traumatic stress disorder in the Vietnam generation: A multimethod, multisource assessment of psychiatric disorder 
  • The prevalence of post-traumatic stress disorder in the Vietnam generation: A multimethod, multisource assessment of psychiatric disorder 
  • The prevalence of posttraumatic stress disorder among American Indian Vietnam veterans: disparities and context. 
  • The prevalence of potentially traumatic events in childhood and adolescence. 
  • The primary care physician and the psychiatric epidemiologist: a symbiotic service research partnership. 
  • The process of coping with sexual trauma 
  • The prolonging remission in depressed elderly (PRIDE) Trial (NCT01028508): results from the randomised phase 
  • The psychiatric chief residency: a preliminary training experience in administrative process. 
  • The psychiatric use of electrically induced seizures. 
  • The psychological risks of Vietnam: the NVVRS perspective. 
  • The psychological well-being of people living with HIV/AIDS and the role of religious coping and social support. 
  • The psychopharmacological treatment of depression in the medically ill patient 
  • The quick inventory of depressive symptomatology (clinician and self-report versions) in patients with bipolar disorder. 
  • The relation between physical assault and psychological functioning in a sample of university women, and the relative effects of physical and sexual assault 
  • The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. 
  • The relation of stress and family environment to atopic dermatitis symptoms in children. 
  • The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and nonremission in the suicide assessment methodology study. 
  • The relationship between depressive symptoms and climacteric symptoms in women at mid-life 
  • The relationship between hostility and beta-adrenergic receptor physiology in health young males. 
  • The relationship between insurance coverage and psychiatric disorder in predicting use of mental health services. 
  • The relationship between negative symptom subdomains and cognition. 
  • The relationship between panic disorder and agoraphobia: an epidemiologic perspective. 
  • The relationship between posttraumatic stress disorder and smoking outcome expectancies among U.S. military veterans who served since September 11, 2001. 
  • The relationship between psychiatry and religion among U.S. physicians. 
  • The relationship between religious activities and blood pressure in older adults. 
  • The relationship between religious attendance and blood pressure: the HUNT Study, Norway. 
  • The relationship between spirituality and depressive symptoms: testing psychosocial mechanisms. 
  • The relationship between stress responding in family context and stress sensitivity with sleep dysfunction in individuals at clinical high-risk for psychosis. 
  • The relationship between working memory deficits and other measures sensitive to prefrontal dysfunction 
  • The relationship of age to dysthymia in primary care 
  • The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults. 
  • The relationship of cognition changes and other symptoms following antipsychotic treatment 
  • The relationship of person-specific eveningness chronotype, greater seasonality, and less rhythmicity to suicidal behavior: A literature review. 
  • The relationships between dimensions of hostility and cardiovascular reactivity as a function of task characteristics. 
  • The relative diagnostic utility of child and parent reports of oppositional defiant behaviors 
  • The relative efficiency of altering pulse frequency or train duration when determining seizure threshold. 
  • The response of an assertive community treatment program following a natural disaster. 
  • The response of depressed inpatients to isocarboxazid. 
  • The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trial. 
  • The role of couples' interacting world assumptions and relationship adjustment in women's postdisaster PTSD symptoms. 
  • The role of efficacy and effectiveness trials. 
  • The role of insight in the treatment and outcome of bipolar disorder 
  • The role of neuroimaging in geriatric psychiatry 
  • The role of nuclear magnetic resonance imaging in psychiatric research. 
  • The role of posttraumatic stress in acute postconcussive symptoms following blast injury in combat 
  • The role of psychiatric and behavioral factors in the practice of medicine. 
  • The role of psychotherapy in the treatment of depression: review of two practice guidelines. 
  • The role of stimulus waveform in therapeutic and adverse effects of ECT. 
  • The role of the dentate gyrus in stress-related disorders. 
  • The role of the ictal EEG in ECT stimulus dosing. 
  • The role of trauma-related distractors on neural systems for working memory and emotion processing in posttraumatic stress disorder. 
  • The self-assessment of resilience and anxiety: psychometric properties. 
  • The severely mentally ill in general hospital psychiatric units. 
  • The six most essential questions in psychiatric diagnosis: a pluralogue part 2: Issues of conservatism and pragmatism in psychiatric diagnosis. 
  • The six most essential questions in psychiatric diagnosis: a pluralogue part 3: issues of utility and alternative approaches in psychiatric diagnosis. 
  • The sleep effects of lurasidone: a placebo-controlled cross-over study using a 4-h phase-advance model of transient insomnia. 
  • The sleep effects of tiagabine on the first night of treatment predict post-traumatic stress disorder response at three weeks. 
  • The social brain in clinical practice 
  • The social brain: A unifying foundation for psychiatry [1] 
  • The social neuroendocrinology of human aggression. 
  • The spatial distribution of mossy fiber sprouting in a non-human primate model for electroconvulsive therapy and magnetic seizure therapy 
  • The spectrum of clozapine response in refractory schizophrenia: Four case reports 
  • The suppression of nightmares with guanfacine. 
  • The sympathetic nervous system as a model for studying drug-induced alterations of nerve development 
  • The thyrotropin-releasing hormone stimulation test: a methodological study. 
  • The trauma constellation identification scale: A measure of the psychological impact of a stressful life event 
  • The treatment effectiveness project. A comparison of the effectiveness of paroxetine, problem-solving therapy, and placebo in the treatment of minor depression and dysthymia in primary care patients: background and research plan. 
  • The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. 
  • The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. 
  • The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. 
  • The treatment of primary insomnia. 
  • The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? 
  • The undertreatment of dysthymia. 
  • The use of ECT within the Veterans Administration hospital system. 
  • The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials. 
  • The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. 
  • The use of dexmedetomidine in alcohol withdrawal. 
  • The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient. 
  • The use of placebos in unipolar major depression: the current status. 
  • The use of prazosin for the treatment of trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. 
  • The use of valerian in neuropsychiatry. 
  • The utility of the dexamethasone suppression test. 
  • The varied clinical presentations of major depressive disorder. 
  • The varied manifestations of anxiety disorder 
  • The vascular depression subtype: evidence of internal validity. 
  • The what, where, and when of catechol-O-methyltransferase. 
  • The working alliance and Clinician-assisted Emotional Disclosure for rheumatoid arthritis. 
  • The α₂-adrenergic antagonist idazoxan counteracts prepulse inhibition deficits caused by amphetamine or dizocilpine in rats. 
  • Thematic resolution, PTSD, and complex PTSD: the relationship between meaning and trauma-related diagnoses. 
  • Therapeutic Inertia: Let's Get After It. 
  • Therapeutic and prophylactic utility of the memory-enhancing drug donepezil hydrochloride on cognition of patients undergoing electroconvulsive therapy: a randomized controlled trial. 
  • Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update. 
  • Theta Burst for Cognitive Remediation in Schizophrenia: A Case Series and Feasibility Study. 
  • Thinking Carefully About Marijuana Legalization: Public Health Considerations for State Policy Makers. 
  • Thioridazine retinopathy within the upper dosage limit. 
  • This issue: Posttraumatic stress disorder 
  • Thought suppression mediates the relationship between negative mood and PTSD in sexually assaulted women. 
  • Threat-related amygdala activity is associated with peripheral CRP concentrations in men but not women. 
  • Threatened miscarriage and depressive and anxiety symptoms among women and partners in early pregnancy. 
  • Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder. 
  • Through the looking glass: risk perception. 
  • Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. 
  • Tiagabine in treatment refractory bipolar disorder: a clinical case series. 
  • Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography. 
  • Time of Day When Type 1 Diabetes Patients With Eating Disorder Symptoms Most Commonly Restrict Insulin. 
  • Time required for initial improvement during clozapine treatment of refractory schizophrenia 
  • Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia. 
  • Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release. 
  • Time-dependent recovery from the effects of 6-hydroxydopamine lesions of the rat nucleus accumbens on cocaine self-administration and the levels of dopamine in microdialysates. 
  • Timely access to mental health care among women veterans. 
  • Timing of nerve transfer for elbow flexion in neonatal brachial plexus palsy 
  • Timing of nicotine effects on learning in zebrafish. 
  • Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. 
  • Tolerability of fluoxetine in posttraumatic stress disorder. 
  • Topiramate-induced confusion following a single ingestion of 400 mg. 
  • Topographic maps of brain electrical activity--pitfalls and precautions. 
  • Tourette's syndrome and autism: A search for common ground 
  • Tourette's syndrome and the law. 
  • Toward a generalizable model of symptoms in major depressive disorder. 
  • Toward a rational pharmacotherapy of depression. 
  • Toward a very brief quality of life enjoyment and Satisfaction Questionnaire. 
  • Toward an understanding of bipolar disorder and its origin. 
  • Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention. 
  • Towards a scientific taxonomy of depression. 
  • Towards a standard documentation for behavioral health 
  • Toxic interaction between valproate and oxcarbazepine: a case detected by the free valproate level. 
  • Traditional Healers and Mental Health in Nepal: A Scoping Review. 
  • Trail making test performance in Vietnam combat veterans with and without posttraumatic stress disorder. 
  • Training Psychiatrists for Global Mental Health: Cultural Psychiatry, Collaborative Inquiry, and Ethics of Alterity. 
  • Training directors' self-assessment of forensic education within residency training. 
  • Training in Geriatric Psychiatry 
  • Training in adolescent psychiatry for general psychiatry residents: elements of a model curriculum. 
  • Trajectories of Religious Change From Adolescence to Adulthood, and Demographic, Environmental, and Psychiatric Correlates. 
  • Trajectories of depressive symptoms among mothers of preterm and full-term infants in a national sample. 
  • Trajectories of preschool disorders to full DSM depression at school age and early adolescence: continuity of preschool depression. 
  • Trajectory classes of depressive symptoms in a community sample of older adults. 
  • Transcranial magnetic stimulation (TMS) in the treatment of resistant Obsessive-Compulsive Disorder (OCD): Clinical outcomes and neurophysiological correlates 
  • Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. 
  • Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. 
  • Transcranial magnetic stimulation: Effectiveness and safety in a randomized, controlled, multisite clinical trial and an open-label extension study 
  • Transcranial magnetic stimulation: a neuroscientific probe of cortical function in schizophrenia. 
  • Transcranial magnetic stimulation: applications in basic neuroscience and neuropsychopharmacology. 
  • Transcranial magnetic stimulation: applications in neuropsychiatry. 
  • Transcriptome-based polygenic score links depression-related corticolimbic gene expression changes to sex-specific brain morphology and depression risk. 
  • Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. 
  • Transdermal nicotine effects on attention. 
  • Transient situational disturbances: course and outcome. 
  • Translational Development of Novel Pharmacotherapeutic Strategies for Psychostimulant Dependence 
  • Translational Drug Development for Pediatric CNS Disorders 
  • Translocase of outer mitochondrial membrane 40 homolog (TOMM40) poly-T length modulates lorazepam-related cognitive toxicity in healthy APOE ε4-negative elderly. 
  • Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. 
  • Trauma and Autonomic Dysregulation: Episodic - Versus Systemic - Negative Affect Underlying Cardiovascular Risk in Posttraumatic Stress Disorder. 
  • Trauma and Autonomic Dysregulation: Episodic-Versus Systemic-Negative Affect Underlying Cardiovascular Risk in Posttraumatic Stress Disorder. 
  • Trauma and posttraumatic stress in users of the Anxiety Disorders Association of America Web site. 
  • Trauma re-experiencing symptoms modulate topology of intrinsic functional networks. 
  • Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. 
  • Trauma, proximity, and developmental psychopathology: the effects of war and terrorism on children. 
  • Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder. 
  • Trauma-informed measurement-based care for children: Implementation in diverse treatment settings. 
  • Trauma-related distractors modulate neural systems for working memory in posttraumatic stress disorder 
  • Trauma-related sleep disturbance and self-reported physical health symptoms in treatment-seeking female rape victims. 
  • Trauma: prevalence, impairment, service use, and cost. 
  • Trauma: the impact of post-traumatic stress disorder. 
  • Traumatic Brain Injury in Iraq and Afghanistan Veterans: New Results From a National Random Sample Study. 
  • Traumatic Brain Injury, Sleep Quality, and Suicidal Ideation in Iraq/Afghanistan Era Veterans. 
  • Traumatic events and health in women with fibromyalgia 
  • Traumatic events and posttraumatic stress in childhood. 
  • Traumatic events and posttraumatic stress in cross-cultural mission assignments. 
  • Traumatic experiences in psychiatric outpatients 
  • Traumatic stress and accelerated DNA methylation age: A meta-analysis. 
  • Treating Chronic and Severe Mental Disorders—A Handbook of Empirically Supported Interventions 
  • Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications. 
  • Treating Psychological Trauma and PTSD 
  • Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. 
  • Treating maladaptive grief and posttraumatic stress symptoms in orphaned children in Tanzania: group-based trauma-focused cognitive-behavioral therapy. 
  • Treatment Outcomes for Adolescents Versus Adults Receiving Cognitive Processing Therapy for Posttraumatic Stress Disorder During Community Training. 
  • Treatment Outcomes of a Multi-Component Mobile Health Smoking Cessation Pilot Intervention for People with Schizophrenia. 
  • Treatment algorithm use to optimize management of symptomatic patients with a history of mania. 
  • Treatment boundaries in the case management relationship: a clinical case and discussion. 
  • Treatment considerations for clinicians in applying evidence-based practice to complex presentations in child trauma. 
  • Treatment costs for youths receiving multisystemic therapy or hospitalization after a psychiatric crisis. 
  • Treatment course with antidepressant therapy in late-life depression. 
  • Treatment engagement and violence risk in mental disorders. 
  • Treatment for PTSD related to childhood abuse: a randomized controlled trial. 
  • Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density. 
  • Treatment improves symptoms shared by PTSD and disordered eating. 
  • Treatment of Anxiety in Patients With Coronary Heart Disease: A Systematic Review. 
  • Treatment of agitation in elderly persons with Dementia: A summary of the expert consensus guidelines 
  • Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community. 
  • Treatment of cognitive deficits in first episode schizophrenia 
  • Treatment of depression by mental health specialists and primary care physicians. 
  • Treatment of depression in the medically ill. 
  • Treatment of depression--newer pharmacotherapies. 
  • Treatment of minor depression and dysthymia in primary care: Response to paroxetine and problem solving therapy-PC 
  • Treatment of neurocognitive deficits with olanzapine or low-dose haloperidol in first episode psychosis 
  • Treatment of obsessive-compulsive disorder 
  • Treatment of posttraumatic stress disorder 
  • Treatment of posttraumatic stress disorder reduces suicidal ideation. 
  • Treatment of posttraumatic stress disorder with amitriptyline and placebo. 
  • Treatment of posttraumatic stress disorder with nefazodone. 
  • Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. 
  • Treatment of posttraumatic stress disorder: the impact of paroxetine. 
  • Treatment of social anxiety disorder with citalopram. 
  • Treatment of social phobia with benzodiazepines. 
  • Treatment of social phobia with clonazepam and placebo. 
  • Treatment of social phobia with gabapentin: a placebo-controlled study. 
  • Treatment of spasmodic torticollis with ethyl chloride. 
  • Treatment of the modal patient: does one size fit nearly all? 
  • Treatment of thyrotoxicosis-induced psychosis. 
  • Treatment optimization with ECT. 
  • Treatment outcome variation between depression symptom combinations in the STAR*D study. 
  • Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia. 
  • Treatment participation and medication adherence: effects on criminal justice costs of persons with mental illness. 
  • Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. 
  • Tremorous mouth movements in rats administered chronic neuroleptics. 
  • Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. 
  • Trends in psychiatric nursing graduate education. 
  • Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. 
  • Tribulin in post-traumatic stress disorder. 
  • Trichotillomania--a review. 
  • Tricyclic antidepressant prescribing for nonpsychiatric disorders. An analysis based on data from the 1985 National Ambulatory Medical Care Survey. 
  • Tricyclic antidepressants. 
  • Tricyclic-induced akathisia in patients taking conjugated estrogens. 
  • Tridimensional Personality Questionnaire and serotonin in bulimia nervosa. 
  • Twenty-year depressive trajectories among older women. 
  • Twin studies of psychopathology: why do the concordance rates vary? 
  • Two Systems, One Population:: Achieving Equity in Mental Healthcare for Criminal Justice and Marginalized Populations. 
  • Two-Year Stability of Borderline Personality Measures 
  • Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. 
  • Type A behavior and angiographically documented coronary atherosclerosis in a sample of 2,289 patients. 
  • Type A behavior pattern and blood glucose control in diabetic children. 
  • Type A behavior, hostility, and coronary atherosclerosis. 
  • US hospitalizations and costs for illicit drug users with soft tissue infections. 
  • Ultra-brief pulse ECT and the affective and cognitive consequences of ECT. 
  • Ultrabrief Right Unilateral ECT in Geriatric Depression: Antidepressant and Cognitive Outcomes 
  • Ultradian rhythms and temporal coherence in sleep EEG in depressed children and adolescents. 
  • Uncertainty, symptoms, and quality of life in persons with chronic hepatitis C. 
  • Understanding Engagement in and Affective Experiences During Physical Activity: The Role of Meditation Interventions. 
  • Understanding borderline personality disorder across sociocultural groups: Findings, issues, and future directions 
  • Understanding confounding and mediation. 
  • Understanding depression and cognitive impairment in the elderly 
  • Understanding symbol coding in schizophrenia. 
  • Understanding the Research on Extreme Risk Protection Orders: Varying Results, Same Message. 
  • Understanding the clinical characteristics of lesbian, gay, and bisexual military service members and adult beneficiaries within an inpatient psychiatric sample. 
  • Understanding the sleep-wake cycle: sleep, insomnia, and the orexin system. 
  • Understanding therapeutic equivalence in epilepsy.